@annasmith
5Researcher for the #healthcare industry.... world-leading insight for the #pharma, #biotech, #diagnostics and #medicaldevice sectors.
steemit.com/@annasmithVOTING POWER100.00%
DOWNVOTE POWER100.00%
RESOURCE CREDITS100.00%
REPUTATION PROGRESS93.67%
Net Worth
0.000USD
STEEM
0.000STEEM
SBD
0.000SBD
Effective Power
1.200SP
├── Own SP
0.000SP
└── Incoming DelegationsDeleg
+1.200SP
Detailed Balance
| STEEM | ||
| balance | 0.000STEEM | STEEM |
| market_balance | 0.000STEEM | STEEM |
| savings_balance | 0.000STEEM | STEEM |
| reward_steem_balance | 0.000STEEM | STEEM |
| STEEM POWER | ||
| Own SP | 0.000SP | SP |
| Delegated Out | 0.000SP | SP |
| Delegation In | 1.200SP | SP |
| Effective Power | 1.200SP | SP |
| Reward SP (pending) | 0.000SP | SP |
| SBD | ||
| sbd_balance | 0.000SBD | SBD |
| sbd_conversions | 0.000SBD | SBD |
| sbd_market_balance | 0.000SBD | SBD |
| savings_sbd_balance | 0.000SBD | SBD |
| reward_sbd_balance | 0.000SBD | SBD |
{
"balance": "0.000 STEEM",
"savings_balance": "0.000 STEEM",
"reward_steem_balance": "0.000 STEEM",
"vesting_shares": "0.000000 VESTS",
"delegated_vesting_shares": "0.000000 VESTS",
"received_vesting_shares": "1953.311140 VESTS",
"sbd_balance": "0.000 SBD",
"savings_sbd_balance": "0.000 SBD",
"reward_sbd_balance": "0.000 SBD",
"conversions": []
}Account Info
| name | annasmith |
| id | 1146191 |
| rank | 1,613,387 |
| reputation | -169533774255 |
| created | 2018-10-03T09:57:54 |
| recovery_account | steem |
| proxy | None |
| post_count | 17 |
| comment_count | 0 |
| lifetime_vote_count | 0 |
| witnesses_voted_for | 0 |
| last_post | 2018-11-27T11:53:42 |
| last_root_post | 2018-11-27T11:53:42 |
| last_vote_time | 1970-01-01T00:00:00 |
| proxied_vsf_votes | 0, 0, 0, 0 |
| can_vote | 1 |
| voting_power | 0 |
| delayed_votes | 0 |
| balance | 0.000 STEEM |
| savings_balance | 0.000 STEEM |
| sbd_balance | 0.000 SBD |
| savings_sbd_balance | 0.000 SBD |
| vesting_shares | 0.000000 VESTS |
| delegated_vesting_shares | 0.000000 VESTS |
| received_vesting_shares | 1953.311140 VESTS |
| reward_vesting_balance | 0.000000 VESTS |
| vesting_balance | 0.000 STEEM |
| vesting_withdraw_rate | 0.000000 VESTS |
| next_vesting_withdrawal | 1969-12-31T23:59:59 |
| withdrawn | 0 |
| to_withdraw | 0 |
| withdraw_routes | 0 |
| savings_withdraw_requests | 0 |
| last_account_recovery | 1970-01-01T00:00:00 |
| reset_account | null |
| last_owner_update | 1970-01-01T00:00:00 |
| last_account_update | 2018-10-30T09:03:21 |
| mined | No |
| sbd_seconds | 0 |
| sbd_last_interest_payment | 1970-01-01T00:00:00 |
| savings_sbd_last_interest_payment | 1970-01-01T00:00:00 |
{
"id": 1146191,
"name": "annasmith",
"owner": {
"weight_threshold": 1,
"account_auths": [],
"key_auths": [
[
"STM5i9pSAt7NK2zzcB5cBqWajHUDQMpnyGTRxepbCN2UxANnUEtUu",
1
]
]
},
"active": {
"weight_threshold": 1,
"account_auths": [],
"key_auths": [
[
"STM7e8yXeGaueHDjAs17JWRttikYqLjZNxna6KBuPdXc4YUm51Mtg",
1
]
]
},
"posting": {
"weight_threshold": 1,
"account_auths": [],
"key_auths": [
[
"STM8e6npGCj2GRFeXxh8nGuyksdRKpzRQ3Pq8sePhMcs2BrGfvWGY",
1
]
]
},
"memo_key": "STM6E4e2kPgUodGASEMV1CCjPxjHsrM19oSACF6Xf7uVi4wnpitb4",
"json_metadata": "{\"profile\":{\"profile_image\":\"https://cdn.steemitimages.com/DQmQZMJiBuJdFvq9dEbDbrvmQ4zuhcRvvEKkRjKjFQQQoUj/17-Kate%20Upton.jpg\",\"name\":\"Healthcare Research \",\"about\":\"Researcher for the #healthcare industry.... world-leading insight for the #pharma, #biotech, #diagnostics and #medicaldevice sectors.\",\"location\":\"US\",\"website\":\"https://www.insightsandreports.com/\"}}",
"posting_json_metadata": "{\"profile\":{\"profile_image\":\"https://cdn.steemitimages.com/DQmQZMJiBuJdFvq9dEbDbrvmQ4zuhcRvvEKkRjKjFQQQoUj/17-Kate%20Upton.jpg\",\"name\":\"Healthcare Research \",\"about\":\"Researcher for the #healthcare industry.... world-leading insight for the #pharma, #biotech, #diagnostics and #medicaldevice sectors.\",\"location\":\"US\",\"website\":\"https://www.insightsandreports.com/\"}}",
"proxy": "",
"last_owner_update": "1970-01-01T00:00:00",
"last_account_update": "2018-10-30T09:03:21",
"created": "2018-10-03T09:57:54",
"mined": false,
"recovery_account": "steem",
"last_account_recovery": "1970-01-01T00:00:00",
"reset_account": "null",
"comment_count": 0,
"lifetime_vote_count": 0,
"post_count": 17,
"can_vote": true,
"voting_manabar": {
"current_mana": 1953311140,
"last_update_time": 1588919109
},
"downvote_manabar": {
"current_mana": 488327785,
"last_update_time": 1588919109
},
"voting_power": 0,
"balance": "0.000 STEEM",
"savings_balance": "0.000 STEEM",
"sbd_balance": "0.000 SBD",
"sbd_seconds": "0",
"sbd_seconds_last_update": "1970-01-01T00:00:00",
"sbd_last_interest_payment": "1970-01-01T00:00:00",
"savings_sbd_balance": "0.000 SBD",
"savings_sbd_seconds": "0",
"savings_sbd_seconds_last_update": "1970-01-01T00:00:00",
"savings_sbd_last_interest_payment": "1970-01-01T00:00:00",
"savings_withdraw_requests": 0,
"reward_sbd_balance": "0.000 SBD",
"reward_steem_balance": "0.000 STEEM",
"reward_vesting_balance": "0.000000 VESTS",
"reward_vesting_steem": "0.000 STEEM",
"vesting_shares": "0.000000 VESTS",
"delegated_vesting_shares": "0.000000 VESTS",
"received_vesting_shares": "1953.311140 VESTS",
"vesting_withdraw_rate": "0.000000 VESTS",
"next_vesting_withdrawal": "1969-12-31T23:59:59",
"withdrawn": 0,
"to_withdraw": 0,
"withdraw_routes": 0,
"curation_rewards": 0,
"posting_rewards": 0,
"proxied_vsf_votes": [
0,
0,
0,
0
],
"witnesses_voted_for": 0,
"last_post": "2018-11-27T11:53:42",
"last_root_post": "2018-11-27T11:53:42",
"last_vote_time": "1970-01-01T00:00:00",
"post_bandwidth": 0,
"pending_claimed_accounts": 0,
"vesting_balance": "0.000 STEEM",
"reputation": -169533774255,
"transfer_history": [],
"market_history": [],
"post_history": [],
"vote_history": [],
"other_history": [],
"witness_votes": [],
"tags_usage": [],
"guest_bloggers": [],
"rank": 1613387
}Withdraw Routes
| Incoming | Outgoing |
|---|---|
Empty | Empty |
{
"incoming": [],
"outgoing": []
}From Date
To Date
steemdelegated 1.200 SP to @annasmith2020/05/08 06:25:09
steemdelegated 1.200 SP to @annasmith
2020/05/08 06:25:09
| delegator | steem |
| delegatee | annasmith |
| vesting shares | 1953.311140 VESTS |
| Transaction Info | Block #43189707/Trx 4d6e70959c9bd7d23c2b7afd0309f8de96e2d5fe |
View Raw JSON Data
{
"trx_id": "4d6e70959c9bd7d23c2b7afd0309f8de96e2d5fe",
"block": 43189707,
"trx_in_block": 13,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2020-05-08T06:25:09",
"op": [
"delegate_vesting_shares",
{
"delegator": "steem",
"delegatee": "annasmith",
"vesting_shares": "1953.311140 VESTS"
}
]
}steemdelegated 6.031 SP to @annasmith2020/01/27 00:17:42
steemdelegated 6.031 SP to @annasmith
2020/01/27 00:17:42
| delegator | steem |
| delegatee | annasmith |
| vesting shares | 9821.382360 VESTS |
| Transaction Info | Block #40280032/Trx 59978cdfc22b597697260518014aa86eb1bab1b8 |
View Raw JSON Data
{
"trx_id": "59978cdfc22b597697260518014aa86eb1bab1b8",
"block": 40280032,
"trx_in_block": 13,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2020-01-27T00:17:42",
"op": [
"delegate_vesting_shares",
{
"delegator": "steem",
"delegatee": "annasmith",
"vesting_shares": "9821.382360 VESTS"
}
]
}2019/10/03 11:47:48
2019/10/03 11:47:48
| parent author | annasmith |
| parent permlink | energy-based-cancer-treatment-market-global-industry-insights-trends-and-forecast-2017-2025 |
| author | steemitboard |
| permlink | steemitboard-notify-annasmith-20191003t114748000z |
| title | |
| body | Congratulations @annasmith! You received a personal award! <table><tr><td>https://steemitimages.com/70x70/http://steemitboard.com/@annasmith/birthday1.png</td><td>Happy Birthday! - You are on the Steem blockchain for 1 year!</td></tr></table> <sub>_You can view [your badges on your Steem Board](https://steemitboard.com/@annasmith) and compare to others on the [Steem Ranking](https://steemitboard.com/ranking/index.php?name=annasmith)_</sub> ###### [Vote for @Steemitboard as a witness](https://v2.steemconnect.com/sign/account-witness-vote?witness=steemitboard&approve=1) to get one more award and increased upvotes! |
| json metadata | {"image":["https://steemitboard.com/img/notify.png"]} |
| Transaction Info | Block #36959405/Trx 92f3730781ac697def967dd4f731b35297fe4398 |
View Raw JSON Data
{
"trx_id": "92f3730781ac697def967dd4f731b35297fe4398",
"block": 36959405,
"trx_in_block": 20,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2019-10-03T11:47:48",
"op": [
"comment",
{
"parent_author": "annasmith",
"parent_permlink": "energy-based-cancer-treatment-market-global-industry-insights-trends-and-forecast-2017-2025",
"author": "steemitboard",
"permlink": "steemitboard-notify-annasmith-20191003t114748000z",
"title": "",
"body": "Congratulations @annasmith! You received a personal award!\n\n<table><tr><td>https://steemitimages.com/70x70/http://steemitboard.com/@annasmith/birthday1.png</td><td>Happy Birthday! - You are on the Steem blockchain for 1 year!</td></tr></table>\n\n<sub>_You can view [your badges on your Steem Board](https://steemitboard.com/@annasmith) and compare to others on the [Steem Ranking](https://steemitboard.com/ranking/index.php?name=annasmith)_</sub>\n\n\n###### [Vote for @Steemitboard as a witness](https://v2.steemconnect.com/sign/account-witness-vote?witness=steemitboard&approve=1) to get one more award and increased upvotes!",
"json_metadata": "{\"image\":[\"https://steemitboard.com/img/notify.png\"]}"
}
]
}steemdelegated 6.152 SP to @annasmith2019/02/26 13:09:06
steemdelegated 6.152 SP to @annasmith
2019/02/26 13:09:06
| delegator | steem |
| delegatee | annasmith |
| vesting shares | 10017.856135 VESTS |
| Transaction Info | Block #30686295/Trx 45198f0838128092034efa8e2e33dd5fc07f096e |
View Raw JSON Data
{
"trx_id": "45198f0838128092034efa8e2e33dd5fc07f096e",
"block": 30686295,
"trx_in_block": 21,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2019-02-26T13:09:06",
"op": [
"delegate_vesting_shares",
{
"delegator": "steem",
"delegatee": "annasmith",
"vesting_shares": "10017.856135 VESTS"
}
]
}steemdelegated 18.478 SP to @annasmith2019/02/06 02:13:00
steemdelegated 18.478 SP to @annasmith
2019/02/06 02:13:00
| delegator | steem |
| delegatee | annasmith |
| vesting shares | 30089.327057 VESTS |
| Transaction Info | Block #30097612/Trx 43029802c88087abf0cbe79d3f51aef8675e09fa |
View Raw JSON Data
{
"trx_id": "43029802c88087abf0cbe79d3f51aef8675e09fa",
"block": 30097612,
"trx_in_block": 31,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2019-02-06T02:13:00",
"op": [
"delegate_vesting_shares",
{
"delegator": "steem",
"delegatee": "annasmith",
"vesting_shares": "30089.327057 VESTS"
}
]
}2018/12/02 03:11:42
2018/12/02 03:11:42
| voter | steemcleaners |
| author | annasmith |
| permlink | energy-based-cancer-treatment-market-global-industry-insights-trends-and-forecast-2017-2025 |
| weight | -2000 (-20.00%) |
| Transaction Info | Block #28199519/Trx f6270c9cf6f03237388272b1a949da0d3071a9ca |
View Raw JSON Data
{
"trx_id": "f6270c9cf6f03237388272b1a949da0d3071a9ca",
"block": 28199519,
"trx_in_block": 12,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-12-02T03:11:42",
"op": [
"vote",
{
"voter": "steemcleaners",
"author": "annasmith",
"permlink": "energy-based-cancer-treatment-market-global-industry-insights-trends-and-forecast-2017-2025",
"weight": -2000
}
]
}2018/12/02 03:11:33
2018/12/02 03:11:33
| parent author | annasmith |
| parent permlink | energy-based-cancer-treatment-market-global-industry-insights-trends-and-forecast-2017-2025 |
| author | steemcleaners |
| permlink | re-annasmith-energy-based-cancer-treatment-market-global-industry-insights-trends-and-forecast-2017-2025-20181202t031134807z |
| title | |
| body | Added to @spaminator for spam. |
| json metadata | {"tags":["energy-based"],"users":["spaminator"],"app":"steemit/0.1"} |
| Transaction Info | Block #28199516/Trx 42f782074c9505f8b4b94edcbdba9dabf09aed8d |
View Raw JSON Data
{
"trx_id": "42f782074c9505f8b4b94edcbdba9dabf09aed8d",
"block": 28199516,
"trx_in_block": 15,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-12-02T03:11:33",
"op": [
"comment",
{
"parent_author": "annasmith",
"parent_permlink": "energy-based-cancer-treatment-market-global-industry-insights-trends-and-forecast-2017-2025",
"author": "steemcleaners",
"permlink": "re-annasmith-energy-based-cancer-treatment-market-global-industry-insights-trends-and-forecast-2017-2025-20181202t031134807z",
"title": "",
"body": "Added to @spaminator for spam.",
"json_metadata": "{\"tags\":[\"energy-based\"],\"users\":[\"spaminator\"],\"app\":\"steemit/0.1\"}"
}
]
}2018/11/27 12:08:39
2018/11/27 12:08:39
| voter | devsup |
| author | annasmith |
| permlink | energy-based-cancer-treatment-market-global-industry-insights-trends-and-forecast-2017-2025 |
| weight | 69 (0.69%) |
| Transaction Info | Block #28066301/Trx 9deef6c9f4f4e4cbc3abc4ebdf219cb950e17849 |
View Raw JSON Data
{
"trx_id": "9deef6c9f4f4e4cbc3abc4ebdf219cb950e17849",
"block": 28066301,
"trx_in_block": 9,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-11-27T12:08:39",
"op": [
"vote",
{
"voter": "devsup",
"author": "annasmith",
"permlink": "energy-based-cancer-treatment-market-global-industry-insights-trends-and-forecast-2017-2025",
"weight": 69
}
]
}2018/11/27 11:55:42
2018/11/27 11:55:42
| voter | anti-tabu |
| author | annasmith |
| permlink | energy-based-cancer-treatment-market-global-industry-insights-trends-and-forecast-2017-2025 |
| weight | 10000 (100.00%) |
| Transaction Info | Block #28066042/Trx c2abadf4df5660ce272c3425a62af7611e48f630 |
View Raw JSON Data
{
"trx_id": "c2abadf4df5660ce272c3425a62af7611e48f630",
"block": 28066042,
"trx_in_block": 47,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-11-27T11:55:42",
"op": [
"vote",
{
"voter": "anti-tabu",
"author": "annasmith",
"permlink": "energy-based-cancer-treatment-market-global-industry-insights-trends-and-forecast-2017-2025",
"weight": 10000
}
]
}2018/11/27 11:53:57
2018/11/27 11:53:57
| voter | sstira |
| author | annasmith |
| permlink | energy-based-cancer-treatment-market-global-industry-insights-trends-and-forecast-2017-2025 |
| weight | 10000 (100.00%) |
| Transaction Info | Block #28066007/Trx b5eb38f56739c40493640635e996a0edc599ff79 |
View Raw JSON Data
{
"trx_id": "b5eb38f56739c40493640635e996a0edc599ff79",
"block": 28066007,
"trx_in_block": 20,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-11-27T11:53:57",
"op": [
"vote",
{
"voter": "sstira",
"author": "annasmith",
"permlink": "energy-based-cancer-treatment-market-global-industry-insights-trends-and-forecast-2017-2025",
"weight": 10000
}
]
}2018/11/27 11:53:57
2018/11/27 11:53:57
| parent author | annasmith |
| parent permlink | energy-based-cancer-treatment-market-global-industry-insights-trends-and-forecast-2017-2025 |
| author | cheetah |
| permlink | cheetah-re-annasmithenergy-based-cancer-treatment-market-global-industry-insights-trends-and-forecast-2017-2025 |
| title | |
| body | Hi! I am a robot. I just upvoted you! I found similar content that readers might be interested in: https://healthcarefitnessmarket.wordpress.com/2018/10/08/energy-based-cancer-treatment-market-global-industry-insights-trends-and-forecast-2017-2025/ |
| json metadata | |
| Transaction Info | Block #28066007/Trx 70ed2729c2f001e0a2ca86373ef95329d20dad11 |
View Raw JSON Data
{
"trx_id": "70ed2729c2f001e0a2ca86373ef95329d20dad11",
"block": 28066007,
"trx_in_block": 10,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-11-27T11:53:57",
"op": [
"comment",
{
"parent_author": "annasmith",
"parent_permlink": "energy-based-cancer-treatment-market-global-industry-insights-trends-and-forecast-2017-2025",
"author": "cheetah",
"permlink": "cheetah-re-annasmithenergy-based-cancer-treatment-market-global-industry-insights-trends-and-forecast-2017-2025",
"title": "",
"body": "Hi! I am a robot. I just upvoted you! I found similar content that readers might be interested in:\nhttps://healthcarefitnessmarket.wordpress.com/2018/10/08/energy-based-cancer-treatment-market-global-industry-insights-trends-and-forecast-2017-2025/",
"json_metadata": ""
}
]
}2018/11/27 11:53:54
2018/11/27 11:53:54
| voter | cheetah |
| author | annasmith |
| permlink | energy-based-cancer-treatment-market-global-industry-insights-trends-and-forecast-2017-2025 |
| weight | 8 (0.08%) |
| Transaction Info | Block #28066006/Trx e8c1c0edea0147ed18c5bb678a42d27252efc48e |
View Raw JSON Data
{
"trx_id": "e8c1c0edea0147ed18c5bb678a42d27252efc48e",
"block": 28066006,
"trx_in_block": 2,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-11-27T11:53:54",
"op": [
"vote",
{
"voter": "cheetah",
"author": "annasmith",
"permlink": "energy-based-cancer-treatment-market-global-industry-insights-trends-and-forecast-2017-2025",
"weight": 8
}
]
}2018/11/27 11:53:42
2018/11/27 11:53:42
| author | annasmith |
| permlink | energy-based-cancer-treatment-market-global-industry-insights-trends-and-forecast-2017-2025 |
| max accepted payout | 1000000.000 SBD |
| percent steem dollars | 0 |
| allow votes | true |
| allow curation rewards | true |
| extensions | [] |
| Transaction Info | Block #28066002/Trx c9e3e0dc3f7b3499aa8e29eba12feaadb6e0ef1e |
View Raw JSON Data
{
"trx_id": "c9e3e0dc3f7b3499aa8e29eba12feaadb6e0ef1e",
"block": 28066002,
"trx_in_block": 46,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-11-27T11:53:42",
"op": [
"comment_options",
{
"author": "annasmith",
"permlink": "energy-based-cancer-treatment-market-global-industry-insights-trends-and-forecast-2017-2025",
"max_accepted_payout": "1000000.000 SBD",
"percent_steem_dollars": 0,
"allow_votes": true,
"allow_curation_rewards": true,
"extensions": []
}
]
}2018/11/27 11:53:42
2018/11/27 11:53:42
| parent author | |
| parent permlink | energy-based |
| author | annasmith |
| permlink | energy-based-cancer-treatment-market-global-industry-insights-trends-and-forecast-2017-2025 |
| title | Energy-Based Cancer Treatment Market– Global Industry Insights, Trends And Forecast, 2017-2025 |
| body | Energy-Based Cancer Treatment Market: Introduction Energy-Based Cancer treatment uses various beams of intense energy obtained from X-rays and other radioactive rays to kill cancer cells, by damaging cell DNA directly or by creating charged particles within the cell. Increasing utilization of energy-based cancer therapies like radiation therapy, in the recent years, is expected to boost the energy-based cancer treatment market, during the forecast period. Request for a sample copy of this report @ https://www.insightsandreports.com/request-sample/237 Market Dynamics: The energy-based cancer treatment market is projected to grow significantly, during the forecast period, attributed to their efficacy to kill cancer cells, coupled with rising incidences of cancer cases across the globe. According to World Health Organization (WHO), in 2015, 8.8 million people died globally due to cancer. Technological advancements and developments of radio-based medical instruments like Gamma Knife and Tomotherapy is expected to play significant role in the growth of energy-based cancer treatment. According to The Gamma Knife Center (situated at The Valley Hospital, U.S.), every year around 70,000 patients undergo Gamma Knife surgery and the success rates are extremely high. Furthermore, government inititatives, coupled with rising healthcare expenditure are further expected to boost the energy-based cancer treatment market. In 2017, Australian Government invested US$ 35.5 million in the Australian Brain Cancer Mission. However, high costs of energy-based cancer treatment, coupled with potential side-effects such as infertility, fatigue, skin problems, etc, associated with energy-based treatment might hinder the growth of energy-based cancer treatment market. The average cost of a course of radiation therapy ranges between US$ 8,600 to US$ 18,000. By Treatment Type: Energy-based cancer treatment is broadly segmented into invasive and non-invasive treatment. Non-invasive cancer treatment, which mainly consists of external beam radiation therapy (EBRT), is projected to grow significantly during the forecast period, due to development of a number of EBRT techniques and devices such as 3D-CRT, GammaKnife, LINAC, CyberKnife, IMRT, and proton beam radiation therapy. Among these, 3-Dimensional conformal radiation therapy (3D-CRT) is expected to rise enormously, due to its efficacy in precisely mapping the location where the cancer cells are present thereby targeting them without damaging the healthy cells. Invasive treatment that mainly consists of internal radiation therapy and systematic radiation therapy is expected to gain traction, due to their increased usage in the treatment of cervical and other gynecological cancer types. By Source of Energy: X-rays are the widely used source of energy that is used in the radiation therapy to treat cancer, due to their higher penetration power and ability to disrupt cancer cells. X-rays will dominate the energy-based cancer treatment market, due to their non-invasive and painless nature of treatment. The lesser side effects caused by them as compared to chemotherapy and other surgical methods are also anticipated to drive the growth of X-rays in the forecast period. By Application: The higher prevalence of prostate and breast cancer is anticipated to drive the energy-based cancer treatment market. According to the NCBI, prostate cancer is the most common cancer in men and radiotherapy is extensively used in the treatment of this cancer type. According to UCLA Urology, Intensity Modulated Radiation Therapy (IMRT) is the widely used energy-based treatment used in treating prostate and Breast Cancer. Regional Insight: North America is expected to hold the major revenue share in the global energy-based cancer treatment market, due to improved healthcare infra-structure and facilities in U.S. Higher prevalence of cancer incidences, coupled with the presence of key market players like Mevion Medical Systems and Accuray Inc. in this region will further enhance the energy-based cancer treatment market over the projected period. According to American Cancer Society, about 609,640 Americans are expected to die because of cancer, in 2018. The energy-based cancer treatment market in Asia-Pacific is also expected to grow during the forecast period, due to rise in number of cancer patients, coupled with government programs for the treatment and prevention of cancer in the region. According to the Cancer Atlas website, produced by the American Cancer Society, the Union for International Cancer Control and the International Agency for Research on Cancer, 44% of cancer cases are reported from Asia and China represents majority of the cancer burden. Competitive Landscape Key market players operating in Energy-Based Cancer Treatment market include IsoRay Inc., Mevion Medical Systems, Elekta AB, Ranor Inc., Hitachi Medical Systems Europe, NTP Radioisotopes, Siemens Healthcare, Accuray Inc., ProTom International and IBA Worldwide. Major market players are focusing on international merger and acquisition activities to enhance their global reach as well as to strengthen their specialty brand segment. For instance, In September 2015, Therakos, Inc. was acquired by Mallinckrodt Public Limited, which will expand their business across the globe, and also strengthen their specialty brand segment. For more information about this report @ https://www.insightsandreports.com/industry-reports/energy-based-cancer-treatment-market About Us: Insights and Reports is a research and consulting group assisting the clients with 360-degree insights with real time qualitative and quantitative information. The Insights and Reports team is valued for continuous client-oriented services. Our data scientists monitor the markets pertaining to their expertise on a daily basis with the help of 150+ analysts to back them with accurate market studies. Contact Us: Mr.Saby Insights And Reports, 2201 Cooperative Way #600, Herndon, VA 20171, USA. Tel: +1 703 574 4447 Email:[email protected]  |
| json metadata | {"tags":["energy-based","cancer","treatment","market"],"image":["https://cdn.steemitimages.com/DQmZLMsweJJf7vWUpVmf4vrWnVbriZ5CHhyAsgkPhU2cfKL/Energy-Based-Cancer-Treatment-Market.jpg"],"links":["https://www.insightsandreports.com/request-sample/237","https://www.insightsandreports.com/industry-reports/energy-based-cancer-treatment-market"],"app":"steemit/0.1","format":"markdown"} |
| Transaction Info | Block #28066002/Trx c9e3e0dc3f7b3499aa8e29eba12feaadb6e0ef1e |
View Raw JSON Data
{
"trx_id": "c9e3e0dc3f7b3499aa8e29eba12feaadb6e0ef1e",
"block": 28066002,
"trx_in_block": 46,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-11-27T11:53:42",
"op": [
"comment",
{
"parent_author": "",
"parent_permlink": "energy-based",
"author": "annasmith",
"permlink": "energy-based-cancer-treatment-market-global-industry-insights-trends-and-forecast-2017-2025",
"title": "Energy-Based Cancer Treatment Market– Global Industry Insights, Trends And Forecast, 2017-2025",
"body": "Energy-Based Cancer Treatment Market: Introduction\nEnergy-Based Cancer treatment uses various beams of intense energy obtained from X-rays and other radioactive rays to kill cancer cells, by damaging cell DNA directly or by creating charged particles within the cell. Increasing utilization of energy-based cancer therapies like radiation therapy, in the recent years, is expected to boost the energy-based cancer treatment market, during the forecast period.\n\nRequest for a sample copy of this report @ https://www.insightsandreports.com/request-sample/237 \nMarket Dynamics:\nThe energy-based cancer treatment market is projected to grow significantly, during the forecast period, attributed to their efficacy to kill cancer cells, coupled with rising incidences of cancer cases across the globe. According to World Health Organization (WHO), in 2015, 8.8 million people died globally due to cancer. Technological advancements and developments of radio-based medical instruments like Gamma Knife and Tomotherapy is expected to play significant role in the growth of energy-based cancer treatment. According to The Gamma Knife Center (situated at The Valley Hospital, U.S.), every year around 70,000 patients undergo Gamma Knife surgery and the success rates are extremely high. Furthermore, government inititatives, coupled with rising healthcare expenditure are further expected to boost the energy-based cancer treatment market. In 2017, Australian Government invested US$ 35.5 million in the Australian Brain Cancer Mission. However, high costs of energy-based cancer treatment, coupled with potential side-effects such as infertility, fatigue, skin problems, etc, associated with energy-based treatment might hinder the growth of energy-based cancer treatment market. The average cost of a course of radiation therapy ranges between US$ 8,600 to US$ 18,000.\n\nBy Treatment Type:\nEnergy-based cancer treatment is broadly segmented into invasive and non-invasive treatment. Non-invasive cancer treatment, which mainly consists of external beam radiation therapy (EBRT), is projected to grow significantly during the forecast period, due to development of a number of EBRT techniques and devices such as 3D-CRT, GammaKnife, LINAC, CyberKnife, IMRT, and proton beam radiation therapy. Among these, 3-Dimensional conformal radiation therapy (3D-CRT) is expected to rise enormously, due to its efficacy in precisely mapping the location where the cancer cells are present thereby targeting them without damaging the healthy cells. Invasive treatment that mainly consists of internal radiation therapy and systematic radiation therapy is expected to gain traction, due to their increased usage in the treatment of cervical and other gynecological cancer types.\n\nBy Source of Energy:\nX-rays are the widely used source of energy that is used in the radiation therapy to treat cancer, due to their higher penetration power and ability to disrupt cancer cells. X-rays will dominate the energy-based cancer treatment market, due to their non-invasive and painless nature of treatment. The lesser side effects caused by them as compared to chemotherapy and other surgical methods are also anticipated to drive the growth of X-rays in the forecast period.\n\nBy Application:\nThe higher prevalence of prostate and breast cancer is anticipated to drive the energy-based cancer treatment market. According to the NCBI, prostate cancer is the most common cancer in men and radiotherapy is extensively used in the treatment of this cancer type. According to UCLA Urology, Intensity Modulated Radiation Therapy (IMRT) is the widely used energy-based treatment used in treating prostate and Breast Cancer.\n\nRegional Insight:\nNorth America is expected to hold the major revenue share in the global energy-based cancer treatment market, due to improved healthcare infra-structure and facilities in U.S. Higher prevalence of cancer incidences, coupled with the presence of key market players like Mevion Medical Systems and Accuray Inc. in this region will further enhance the energy-based cancer treatment market over the projected period. According to American Cancer Society, about 609,640 Americans are expected to die because of cancer, in 2018. The energy-based cancer treatment market in Asia-Pacific is also expected to grow during the forecast period, due to rise in number of cancer patients, coupled with government programs for the treatment and prevention of cancer in the region. According to the Cancer Atlas website, produced by the American Cancer Society, the Union for International Cancer Control and the International Agency for Research on Cancer, 44% of cancer cases are reported from Asia and China represents majority of the cancer burden.\n\nCompetitive Landscape\nKey market players operating in Energy-Based Cancer Treatment market include IsoRay Inc., Mevion Medical Systems, Elekta AB, Ranor Inc., Hitachi Medical Systems Europe, NTP Radioisotopes, Siemens Healthcare, Accuray Inc., ProTom International and IBA Worldwide. Major market players are focusing on international merger and acquisition activities to enhance their global reach as well as to strengthen their specialty brand segment. For instance, In September 2015, Therakos, Inc. was acquired by Mallinckrodt Public Limited, which will expand their business across the globe, and also strengthen their specialty brand segment.\n\nFor more information about this report @ https://www.insightsandreports.com/industry-reports/energy-based-cancer-treatment-market \n\nAbout Us:\nInsights and Reports is a research and consulting group assisting the clients with 360-degree insights with real time qualitative and quantitative information. The Insights and Reports team is valued for continuous client-oriented services. Our data scientists monitor the markets pertaining to their expertise on a daily basis with the help of 150+ analysts to back them with accurate market studies.\n\nContact Us: \nMr.Saby\nInsights And Reports,\n2201 Cooperative Way #600, \nHerndon, VA 20171, USA.\nTel: +1 703 574 4447\nEmail:[email protected]\n\n\n\n\n",
"json_metadata": "{\"tags\":[\"energy-based\",\"cancer\",\"treatment\",\"market\"],\"image\":[\"https://cdn.steemitimages.com/DQmZLMsweJJf7vWUpVmf4vrWnVbriZ5CHhyAsgkPhU2cfKL/Energy-Based-Cancer-Treatment-Market.jpg\"],\"links\":[\"https://www.insightsandreports.com/request-sample/237\",\"https://www.insightsandreports.com/industry-reports/energy-based-cancer-treatment-market\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}"
}
]
}2018/11/06 09:03:24
2018/11/06 09:03:24
| voter | consto |
| author | annasmith |
| permlink | global-respiratory-devices-market-revenue-economic-growth-opportunities-and-challenges-2025 |
| weight | 10000 (100.00%) |
| Transaction Info | Block #27458169/Trx cb6f61210f28f1ccc0209586a4da542b907e5841 |
View Raw JSON Data
{
"trx_id": "cb6f61210f28f1ccc0209586a4da542b907e5841",
"block": 27458169,
"trx_in_block": 1,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-11-06T09:03:24",
"op": [
"vote",
{
"voter": "consto",
"author": "annasmith",
"permlink": "global-respiratory-devices-market-revenue-economic-growth-opportunities-and-challenges-2025",
"weight": 10000
}
]
}2018/11/06 08:56:30
2018/11/06 08:56:30
| author | annasmith |
| permlink | global-respiratory-devices-market-revenue-economic-growth-opportunities-and-challenges-2025 |
| max accepted payout | 1000000.000 SBD |
| percent steem dollars | 0 |
| allow votes | true |
| allow curation rewards | true |
| extensions | [] |
| Transaction Info | Block #27458031/Trx e4676132564abbe89317c0d0d843643424d2ed00 |
View Raw JSON Data
{
"trx_id": "e4676132564abbe89317c0d0d843643424d2ed00",
"block": 27458031,
"trx_in_block": 1,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-11-06T08:56:30",
"op": [
"comment_options",
{
"author": "annasmith",
"permlink": "global-respiratory-devices-market-revenue-economic-growth-opportunities-and-challenges-2025",
"max_accepted_payout": "1000000.000 SBD",
"percent_steem_dollars": 0,
"allow_votes": true,
"allow_curation_rewards": true,
"extensions": []
}
]
}2018/11/06 08:56:30
2018/11/06 08:56:30
| parent author | |
| parent permlink | global |
| author | annasmith |
| permlink | global-respiratory-devices-market-revenue-economic-growth-opportunities-and-challenges-2025 |
| title | Global Respiratory Devices Market Revenue, Economic Growth, Opportunities and Challenges 2025 |
| body | Demand for respiratory devices has gained traction on account of rising incidences of chronic pulmonary and respiratory diseases such as lung cancer, emphysema, chronic bronchitis and sleep apnea among others. Respiratory diseases aid in the treatment, management, diagnosis and control of the abnormality in the cardiopulmonary system in patients. Rising incidences of lung cancer is one of the key factors augmenting market growth for respiratory devices at present. According to the American Cancer Society, approximately 234,030 cases of lung cancer were reported in 2018 and approximately 154,050 cases of deaths were reported due to lung cancer in the U.S. in the same year. Further, according to Insights and Reports, more than 9% of the population in the U.S. suffered from asthma in 2017. Further, in 2016 more than 10% of the population suffering from asthma in the country fell in the age group of 5-14 years. Request for a sample copy of this report @ https://www.insightsandreports.com/request-sample/81 Tobacco smoking is another major cause for lung cancer, which in turn gives birth to several respiratory diseases. According to Insights and Reports, more than 6 trillion cigarettes were smoked across the globe, which China being the leading country with a share of more than 40% in terms of smoking. Moreover, steady growth of the geriatric population across the globe is another key factor pushing market growth of respiratory devices at present. However, the growth of the market is held back by low cost respiratory devices produced by the local manufacturers. North America accounted for the major market share in 2016 and is expected to retain market dominance throughout the forecast period as well. High per capita healthcare expenditure in the U.S., coupled with well-established healthcare facilities in the country is one of the key factors pushing the growth of the market for respiratory devices. Asia Pacific, however posed the fastest growth for the demand for respiratory devices throughout the forecast period, the growth of which is majorly attributed to the rising geriatric population and high tobacco consumption in the region. For more information about this report @ https://www.insightsandreports.com/industry-reports/respiratory-devices-market Some of the key players operating in the field of respiratory devices market include Medtronic Plc, Masimo Corporation, Becton, Dickinson & Company, Invacare Corporation, and Hamilton Medical A.G. among others. About Us: Insights and Reports is a research and consulting group assisting the clients with 360-degree insights with real time qualitative and quantitative information. The Insights and Reports team is valued for continuous client-oriented services. Our data scientists monitor the markets pertaining to their expertise on a daily basis with the help of 150+ analysts to back them with accurate market studies. Contact Us: Mr.Saby Insights And Reports, 2201 Cooperative Way #600, Herndon, VA 20171, USA. Tel: +1 703 574 4447 Email:[email protected]  |
| json metadata | {"tags":["global","respiratory","devices","market"],"image":["https://cdn.steemitimages.com/DQmVCbXDLAxq6YGcNiqZ1Jt9wh7dBSup2vkve6hHy92cQRx/Respiratory%20Devices%20Market%204.jpg"],"links":["https://www.insightsandreports.com/request-sample/81","https://www.insightsandreports.com/industry-reports/respiratory-devices-market"],"app":"steemit/0.1","format":"markdown"} |
| Transaction Info | Block #27458031/Trx e4676132564abbe89317c0d0d843643424d2ed00 |
View Raw JSON Data
{
"trx_id": "e4676132564abbe89317c0d0d843643424d2ed00",
"block": 27458031,
"trx_in_block": 1,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-11-06T08:56:30",
"op": [
"comment",
{
"parent_author": "",
"parent_permlink": "global",
"author": "annasmith",
"permlink": "global-respiratory-devices-market-revenue-economic-growth-opportunities-and-challenges-2025",
"title": "Global Respiratory Devices Market Revenue, Economic Growth, Opportunities and Challenges 2025",
"body": "Demand for respiratory devices has gained traction on account of rising incidences of chronic pulmonary and respiratory diseases such as lung cancer, emphysema, chronic bronchitis and sleep apnea among others. Respiratory diseases aid in the treatment, management, diagnosis and control of the abnormality in the cardiopulmonary system in patients.\nRising incidences of lung cancer is one of the key factors augmenting market growth for respiratory devices at present. According to the American Cancer Society, approximately 234,030 cases of lung cancer were reported in 2018 and approximately 154,050 cases of deaths were reported due to lung cancer in the U.S. in the same year. Further, according to Insights and Reports, more than 9% of the population in the U.S. suffered from asthma in 2017. Further, in 2016 more than 10% of the population suffering from asthma in the country fell in the age group of 5-14 years. \n\nRequest for a sample copy of this report @ https://www.insightsandreports.com/request-sample/81 \n\nTobacco smoking is another major cause for lung cancer, which in turn gives birth to several respiratory diseases. According to Insights and Reports, more than 6 trillion cigarettes were smoked across the globe, which China being the leading country with a share of more than 40% in terms of smoking. Moreover, steady growth of the geriatric population across the globe is another key factor pushing market growth of respiratory devices at present. However, the growth of the market is held back by low cost respiratory devices produced by the local manufacturers.\nNorth America accounted for the major market share in 2016 and is expected to retain market dominance throughout the forecast period as well. High per capita healthcare expenditure in the U.S., coupled with well-established healthcare facilities in the country is one of the key factors pushing the growth of the market for respiratory devices. Asia Pacific, however posed the fastest growth for the demand for respiratory devices throughout the forecast period, the growth of which is majorly attributed to the rising geriatric population and high tobacco consumption in the region.\n\nFor more information about this report @ https://www.insightsandreports.com/industry-reports/respiratory-devices-market \n\nSome of the key players operating in the field of respiratory devices market include Medtronic Plc, Masimo Corporation, Becton, Dickinson & Company, Invacare Corporation, and Hamilton Medical A.G. among others.\n\n\n\nAbout Us:\nInsights and Reports is a research and consulting group assisting the clients with 360-degree insights with real time qualitative and quantitative information. The Insights and Reports team is valued for continuous client-oriented services. Our data scientists monitor the markets pertaining to their expertise on a daily basis with the help of 150+ analysts to back them with accurate market studies.\n\nContact Us: \nMr.Saby\nInsights And Reports,\n2201 Cooperative Way #600, \nHerndon, VA 20171, USA.\nTel: +1 703 574 4447\nEmail:[email protected]\n\n",
"json_metadata": "{\"tags\":[\"global\",\"respiratory\",\"devices\",\"market\"],\"image\":[\"https://cdn.steemitimages.com/DQmVCbXDLAxq6YGcNiqZ1Jt9wh7dBSup2vkve6hHy92cQRx/Respiratory%20Devices%20Market%204.jpg\"],\"links\":[\"https://www.insightsandreports.com/request-sample/81\",\"https://www.insightsandreports.com/industry-reports/respiratory-devices-market\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}"
}
]
}2018/11/05 17:28:09
2018/11/05 17:28:09
| parent author | |
| parent permlink | antiepileptic |
| author | annasmith |
| permlink | antiepileptic-drugs-market-overview-by-drug-therapeutic-uses-distribution-and-forecast-2015 |
| title | Antiepileptic Drugs Market Overview- By Drug, Therapeutic Uses, Distribution and Forecast 2015 |
| body | @@ -4808,28 +4808,183 @@ [email protected] +!%5Bshutterstock_376098292ep-700x500.jpg%5D(https://cdn.steemitimages.com/DQmbvZTo2QXPHqvXzXAUKwP7RRTwEXXpkirQDHwRvYpi6gv/shutterstock_376098292ep-700x500.jpg) |
| json metadata | {"tags":["antiepileptic","drugs","market","research"],"links":["https://www.insightsandreports.com/request-sample/42","https://www.insightsandreports.com/industry-reports/antiepileptic-drugs-market"],"app":"steemit/0.1","format":"markdown","image":["https://cdn.steemitimages.com/DQmbvZTo2QXPHqvXzXAUKwP7RRTwEXXpkirQDHwRvYpi6gv/shutterstock_376098292ep-700x500.jpg"]} |
| Transaction Info | Block #27439470/Trx 629921d80d3b8f21a5d9b0ac2f898b451babdfe2 |
View Raw JSON Data
{
"trx_id": "629921d80d3b8f21a5d9b0ac2f898b451babdfe2",
"block": 27439470,
"trx_in_block": 13,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-11-05T17:28:09",
"op": [
"comment",
{
"parent_author": "",
"parent_permlink": "antiepileptic",
"author": "annasmith",
"permlink": "antiepileptic-drugs-market-overview-by-drug-therapeutic-uses-distribution-and-forecast-2015",
"title": "Antiepileptic Drugs Market Overview- By Drug, Therapeutic Uses, Distribution and Forecast 2015",
"body": "@@ -4808,28 +4808,183 @@\n [email protected]\n+!%5Bshutterstock_376098292ep-700x500.jpg%5D(https://cdn.steemitimages.com/DQmbvZTo2QXPHqvXzXAUKwP7RRTwEXXpkirQDHwRvYpi6gv/shutterstock_376098292ep-700x500.jpg)\n",
"json_metadata": "{\"tags\":[\"antiepileptic\",\"drugs\",\"market\",\"research\"],\"links\":[\"https://www.insightsandreports.com/request-sample/42\",\"https://www.insightsandreports.com/industry-reports/antiepileptic-drugs-market\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\",\"image\":[\"https://cdn.steemitimages.com/DQmbvZTo2QXPHqvXzXAUKwP7RRTwEXXpkirQDHwRvYpi6gv/shutterstock_376098292ep-700x500.jpg\"]}"
}
]
}2018/11/05 17:27:48
2018/11/05 17:27:48
| parent author | |
| parent permlink | antiepileptic |
| author | annasmith |
| permlink | antiepileptic-drugs-market-overview-by-drug-therapeutic-uses-distribution-and-forecast-2015 |
| title | Antiepileptic Drugs Market Overview- By Drug, Therapeutic Uses, Distribution and Forecast 2015 |
| body | Market Introduction Antiepileptic drugs refer to the anti-seizure drugs and are developed as a part of the idiopathic and asymptomatic treatment of problems related to epileptic. The problems of epileptic involves the repeating acts that normally happen because of wrong sign that are directed to the brain by the nerve cells. Such drugs are also used in the treatment of pain associated with neuropathic. In addition to this several antiepileptic drugs are also utilized as a part of different signs as neuropathic pain, psychiatry and migraine. There are several antiepileptic drugs currently present on the market, and it has helped to cure several patients. The new treatments that are discovered are usually accepted as adjunct therapies. Request for a sample copy of this report @ https://www.insightsandreports.com/request-sample/42 Market Dynamics The rapid growth in the elderly population in many of the developed countries across the globe is driving the demand for antiepileptic drugs. The aging population is rising in the countries such as Italy, Germany, Greece and also in Japan. For instance Japan recorded elderly population who are aged 65 and above constitute 26% of the total population. However, expiration of the drug patents are likely to be the major restraint to the global antiepileptic drug market. Pharmaceutical company invests huge amount of money in the development process of the drug but when the patents expire that results to the decrease in the pace of the drug flood in the market. For instance, Sabril which is antiepileptic drug expired in February 2017. The drug is used with combination of other medicines that are used to treat both adults and children. Segmentation Analysis The market has been segmented into different drug type, therapeutic uses and distribution channel. On the basis of different drug type the market has been segmented into Phenytoin, Oxycarbazepine Carbamazepine, Valproate, Topiramate, Ethosuximide, Primidone, Phenobarbital, Rufinamide, Levetiracetam, Ezogabine/retigabine among others. On the basis of therapeutic uses the market has been segmented into generalized and partial. Diazem drug is used as a generalized uses and not on partial uses. The market has been further segmented on the basis of distribution channel such as retail pharmacies, hospital pharmacies, drug store and online channel among others. Retail pharmacies dominated the market as grabbed the maximum profit over the years. Revenue in retail pharmacies continues to recover from 2014 and it has been recorded with revenue rising to US$ 16.3 billion in the year to June 2017 Regional Outlook In terms of region wise study the global antiepileptic drug market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa and South America. North America dominated the market owing to the rising expenditure on health care service in United States. For instance, epilepsy affected 2.5 million people in United States and that results to approximately US$ 15.5 billion in health care. In addition to this new introduction of antiepileptic drugs has also boosted the growth of the market inrecent years. For instance, perampanel, ezogabine/retigabine and eslicarbazepine acetate are the new drugs that are introduced. Asia-Pacific witnessed the fastest growth during the forecast period owing to the high occurrence of epilepsy in China and India. In addition to this improved penetration due to better market access options present in China has also resulted to the rise in the growth of the Asia Pacific market. Competitive Landscape The players associated with the antiepileptic drug market is expected to intensify over the years. Companies engage upon new product launch in order to grab a larger part of the market share compared to the competitors. For instance, Mylan launched innovative Version of Antiepileptic Drug Levetiracetam in 2012. Some of the major players of the market are Cephalon, Inc, Abbott Laboratories, Novartis AG, Pfizer, Inc, Sunovion Pharmaceuticals, Inc. GlaxoSmithKline plc, Valeant Pharmaceuticals International, Inc, Johnson & Johnson, among others. For more information about this report @ https://www.insightsandreports.com/industry-reports/antiepileptic-drugs-market About Us: Insights and Reports is a research and consulting group assisting the clients with 360-degree insights with real time qualitative and quantitative information. The Insights and Reports team is valued for continuous client-oriented services. Our data scientists monitor the markets pertaining to their expertise on a daily basis with the help of 150+ analysts to back them with accurate market studies. Contact Us: Mr.Saby Insights And Reports, 2201 Cooperative Way #600, Herndon, VA 20171, USA. Tel: +1 703 574 4447 Email:[email protected] |
| json metadata | {"tags":["antiepileptic","drugs","market","research"],"links":["https://www.insightsandreports.com/request-sample/42","https://www.insightsandreports.com/industry-reports/antiepileptic-drugs-market"],"app":"steemit/0.1","format":"markdown"} |
| Transaction Info | Block #27439463/Trx f7b46a8bc5a4d588559a9cc42a374b1539756a31 |
View Raw JSON Data
{
"trx_id": "f7b46a8bc5a4d588559a9cc42a374b1539756a31",
"block": 27439463,
"trx_in_block": 10,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-11-05T17:27:48",
"op": [
"comment",
{
"parent_author": "",
"parent_permlink": "antiepileptic",
"author": "annasmith",
"permlink": "antiepileptic-drugs-market-overview-by-drug-therapeutic-uses-distribution-and-forecast-2015",
"title": "Antiepileptic Drugs Market Overview- By Drug, Therapeutic Uses, Distribution and Forecast 2015",
"body": "Market Introduction\nAntiepileptic drugs refer to the anti-seizure drugs and are developed as a part of the idiopathic and asymptomatic treatment of problems related to epileptic. The problems of epileptic involves the repeating acts that normally happen because of wrong sign that are directed to the brain by the nerve cells. Such drugs are also used in the treatment of pain associated with neuropathic. In addition to this several antiepileptic drugs are also utilized as a part of different signs as neuropathic pain, psychiatry and migraine. There are several antiepileptic drugs currently present on the market, and it has helped to cure several patients. The new treatments that are discovered are usually accepted as adjunct therapies.\n\nRequest for a sample copy of this report @ https://www.insightsandreports.com/request-sample/42\n\nMarket Dynamics\nThe rapid growth in the elderly population in many of the developed countries across the globe is driving the demand for antiepileptic drugs. The aging population is rising in the countries such as Italy, Germany, Greece and also in Japan. For instance Japan recorded elderly population who are aged 65 and above constitute 26% of the total population. However, expiration of the drug patents are likely to be the major restraint to the global antiepileptic drug market. Pharmaceutical company invests huge amount of money in the development process of the drug but when the patents expire that results to the decrease in the pace of the drug flood in the market. For instance, Sabril which is antiepileptic drug expired in February 2017. The drug is used with combination of other medicines that are used to treat both adults and children.\n\nSegmentation Analysis\nThe market has been segmented into different drug type, therapeutic uses and distribution channel. On the basis of different drug type the market has been segmented into Phenytoin, Oxycarbazepine Carbamazepine, Valproate, Topiramate, Ethosuximide, Primidone, Phenobarbital, Rufinamide, Levetiracetam, Ezogabine/retigabine among others. On the basis of therapeutic uses the market has been segmented into generalized and partial. Diazem drug is used as a generalized uses and not on partial uses. The market has been further segmented on the basis of distribution channel such as retail pharmacies, hospital pharmacies, drug store and online channel among others. Retail pharmacies dominated the market as grabbed the maximum profit over the years. Revenue in retail pharmacies continues to recover from 2014 and it has been recorded with revenue rising to US$ 16.3 billion in the year to June 2017\n\nRegional Outlook\nIn terms of region wise study the global antiepileptic drug market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa and South America. North America dominated the market owing to the rising expenditure on health care service in United States. For instance, epilepsy affected 2.5 million people in United States and that results to approximately US$ 15.5 billion in health care. In addition to this new introduction of antiepileptic drugs has also boosted the growth of the market inrecent years. For instance, perampanel, ezogabine/retigabine and eslicarbazepine acetate are the new drugs that are introduced. Asia-Pacific witnessed the fastest growth during the forecast period owing to the high occurrence of epilepsy in China and India. In addition to this improved penetration due to better market access options present in China has also resulted to the rise in the growth of the Asia Pacific market.\n\nCompetitive Landscape\nThe players associated with the antiepileptic drug market is expected to intensify over the years. Companies engage upon new product launch in order to grab a larger part of the market share compared to the competitors. For instance, Mylan launched innovative Version of Antiepileptic Drug Levetiracetam in 2012. Some of the major players of the market are Cephalon, Inc, Abbott Laboratories, Novartis AG, Pfizer, Inc, Sunovion Pharmaceuticals, Inc. GlaxoSmithKline plc, Valeant Pharmaceuticals International, Inc, Johnson & Johnson, among others.\n\nFor more information about this report @ https://www.insightsandreports.com/industry-reports/antiepileptic-drugs-market \nAbout Us:\nInsights and Reports is a research and consulting group assisting the clients with 360-degree insights with real time qualitative and quantitative information. The Insights and Reports team is valued for continuous client-oriented services. Our data scientists monitor the markets pertaining to their expertise on a daily basis with the help of 150+ analysts to back them with accurate market studies.\n\nContact Us: \nMr.Saby\nInsights And Reports,\n2201 Cooperative Way #600, \nHerndon, VA 20171, USA.\nTel: +1 703 574 4447\nEmail:[email protected]",
"json_metadata": "{\"tags\":[\"antiepileptic\",\"drugs\",\"market\",\"research\"],\"links\":[\"https://www.insightsandreports.com/request-sample/42\",\"https://www.insightsandreports.com/industry-reports/antiepileptic-drugs-market\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}"
}
]
}2018/11/05 17:27:24
2018/11/05 17:27:24
| author | annasmith |
| permlink | antiepileptic-drugs-market-overview-by-drug-therapeutic-uses-distribution-and-forecast-2015 |
| max accepted payout | 1000000.000 SBD |
| percent steem dollars | 0 |
| allow votes | true |
| allow curation rewards | true |
| extensions | [] |
| Transaction Info | Block #27439455/Trx e74937d86bd0552ea4a4a97e0d02231b257e18b6 |
View Raw JSON Data
{
"trx_id": "e74937d86bd0552ea4a4a97e0d02231b257e18b6",
"block": 27439455,
"trx_in_block": 8,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-11-05T17:27:24",
"op": [
"comment_options",
{
"author": "annasmith",
"permlink": "antiepileptic-drugs-market-overview-by-drug-therapeutic-uses-distribution-and-forecast-2015",
"max_accepted_payout": "1000000.000 SBD",
"percent_steem_dollars": 0,
"allow_votes": true,
"allow_curation_rewards": true,
"extensions": []
}
]
}2018/11/05 17:27:24
2018/11/05 17:27:24
| parent author | |
| parent permlink | antiepileptic |
| author | annasmith |
| permlink | antiepileptic-drugs-market-overview-by-drug-therapeutic-uses-distribution-and-forecast-2015 |
| title | Antiepileptic Drugs Market Overview- By Drug, Therapeutic Uses, Distribution and Forecast 2015 |
| body | Market Introduction Antiepileptic drugs refer to the anti-seizure drugs and are developed as a part of the idiopathic and asymptomatic treatment of problems related to epileptic. The problems of epileptic involves the repeating acts that normally happen because of wrong sign that are directed to the brain by the nerve cells. Such drugs are also used in the treatment of pain associated with neuropathic. In addition to this several antiepileptic drugs are also utilized as a part of different signs as neuropathic pain, psychiatry and migraine. There are several antiepileptic drugs currently present on the market, and it has helped to cure several patients. The new treatments that are discovered are usually accepted as adjunct therapies. Request for a sample copy of this report @ https://www.insightsandreports.com/request-sample/42 Market Dynamics The rapid growth in the elderly population in many of the developed countries across the globe is driving the demand for antiepileptic drugs. The aging population is rising in the countries such as Italy, Germany, Greece and also in Japan. For instance Japan recorded elderly population who are aged 65 and above constitute 26% of the total population. However, expiration of the drug patents are likely to be the major restraint to the global antiepileptic drug market. Pharmaceutical company invests huge amount of money in the development process of the drug but when the patents expire that results to the decrease in the pace of the drug flood in the market. For instance, Sabril which is antiepileptic drug expired in February 2017. The drug is used with combination of other medicines that are used to treat both adults and children. Segmentation Analysis The market has been segmented into different drug type, therapeutic uses and distribution channel. On the basis of different drug type the market has been segmented into Phenytoin, Oxycarbazepine Carbamazepine, Valproate, Topiramate, Ethosuximide, Primidone, Phenobarbital, Rufinamide, Levetiracetam, Ezogabine/retigabine among others. On the basis of therapeutic uses the market has been segmented into generalized and partial. Diazem drug is used as a generalized uses and not on partial uses. The market has been further segmented on the basis of distribution channel such as retail pharmacies, hospital pharmacies, drug store and online channel among others. Retail pharmacies dominated the market as grabbed the maximum profit over the years. Revenue in retail pharmacies continues to recover from 2014 and it has been recorded with revenue rising to US$ 16.3 billion in the year to June 2017 Regional Outlook In terms of region wise study the global antiepileptic drug market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa and South America. North America dominated the market owing to the rising expenditure on health care service in United States. For instance, epilepsy affected 2.5 million people in United States and that results to approximately US$ 15.5 billion in health care. In addition to this new introduction of antiepileptic drugs has also boosted the growth of the market inrecent years. For instance, perampanel, ezogabine/retigabine and eslicarbazepine acetate are the new drugs that are introduced. Asia-Pacific witnessed the fastest growth during the forecast period owing to the high occurrence of epilepsy in China and India. In addition to this improved penetration due to better market access options present in China has also resulted to the rise in the growth of the Asia Pacific market. Competitive Landscape The players associated with the antiepileptic drug market is expected to intensify over the years. Companies engage upon new product launch in order to grab a larger part of the market share compared to the competitors. For instance, Mylan launched innovative Version of Antiepileptic Drug Levetiracetam in 2012. Some of the major players of the market are Cephalon, Inc, Abbott Laboratories, Novartis AG, Pfizer, Inc, Sunovion Pharmaceuticals, Inc. GlaxoSmithKline plc, Valeant Pharmaceuticals International, Inc, Johnson & Johnson, among others. For more information about this report @ https://www.insightsandreports.com/industry-reports/antiepileptic-drugs-market About Us: Insights and Reports is a research and consulting group assisting the clients with 360-degree insights with real time qualitative and quantitative information. The Insights and Reports team is valued for continuous client-oriented services. Our data scientists monitor the markets pertaining to their expertise on a daily basis with the help of 150+ analysts to back them with accurate market studies. Contact Us: Mr.Saby Insights And Reports, 2201 Cooperative Way #600, Herndon, VA 20171, USA. Tel: +1 703 574 4447 Email:[email protected] |
| json metadata | {"tags":["antiepileptic","drugs","market","research"],"links":["https://www.insightsandreports.com/request-sample/42","https://www.insightsandreports.com/industry-reports/antiepileptic-drugs-market"],"app":"steemit/0.1","format":"markdown"} |
| Transaction Info | Block #27439455/Trx e74937d86bd0552ea4a4a97e0d02231b257e18b6 |
View Raw JSON Data
{
"trx_id": "e74937d86bd0552ea4a4a97e0d02231b257e18b6",
"block": 27439455,
"trx_in_block": 8,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-11-05T17:27:24",
"op": [
"comment",
{
"parent_author": "",
"parent_permlink": "antiepileptic",
"author": "annasmith",
"permlink": "antiepileptic-drugs-market-overview-by-drug-therapeutic-uses-distribution-and-forecast-2015",
"title": "Antiepileptic Drugs Market Overview- By Drug, Therapeutic Uses, Distribution and Forecast 2015",
"body": "Market Introduction\nAntiepileptic drugs refer to the anti-seizure drugs and are developed as a part of the idiopathic and asymptomatic treatment of problems related to epileptic. The problems of epileptic involves the repeating acts that normally happen because of wrong sign that are directed to the brain by the nerve cells. Such drugs are also used in the treatment of pain associated with neuropathic. In addition to this several antiepileptic drugs are also utilized as a part of different signs as neuropathic pain, psychiatry and migraine. There are several antiepileptic drugs currently present on the market, and it has helped to cure several patients. The new treatments that are discovered are usually accepted as adjunct therapies.\n\nRequest for a sample copy of this report @ https://www.insightsandreports.com/request-sample/42\n\nMarket Dynamics\nThe rapid growth in the elderly population in many of the developed countries across the globe is driving the demand for antiepileptic drugs. The aging population is rising in the countries such as Italy, Germany, Greece and also in Japan. For instance Japan recorded elderly population who are aged 65 and above constitute 26% of the total population. However, expiration of the drug patents are likely to be the major restraint to the global antiepileptic drug market. Pharmaceutical company invests huge amount of money in the development process of the drug but when the patents expire that results to the decrease in the pace of the drug flood in the market. For instance, Sabril which is antiepileptic drug expired in February 2017. The drug is used with combination of other medicines that are used to treat both adults and children.\n\nSegmentation Analysis\nThe market has been segmented into different drug type, therapeutic uses and distribution channel. On the basis of different drug type the market has been segmented into Phenytoin, Oxycarbazepine Carbamazepine, Valproate, Topiramate, Ethosuximide, Primidone, Phenobarbital, Rufinamide, Levetiracetam, Ezogabine/retigabine among others. On the basis of therapeutic uses the market has been segmented into generalized and partial. Diazem drug is used as a generalized uses and not on partial uses. The market has been further segmented on the basis of distribution channel such as retail pharmacies, hospital pharmacies, drug store and online channel among others. Retail pharmacies dominated the market as grabbed the maximum profit over the years. Revenue in retail pharmacies continues to recover from 2014 and it has been recorded with revenue rising to US$ 16.3 billion in the year to June 2017\n\nRegional Outlook\nIn terms of region wise study the global antiepileptic drug market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa and South America. North America dominated the market owing to the rising expenditure on health care service in United States. For instance, epilepsy affected 2.5 million people in United States and that results to approximately US$ 15.5 billion in health care. In addition to this new introduction of antiepileptic drugs has also boosted the growth of the market inrecent years. For instance, perampanel, ezogabine/retigabine and eslicarbazepine acetate are the new drugs that are introduced. Asia-Pacific witnessed the fastest growth during the forecast period owing to the high occurrence of epilepsy in China and India. In addition to this improved penetration due to better market access options present in China has also resulted to the rise in the growth of the Asia Pacific market.\n\nCompetitive Landscape\nThe players associated with the antiepileptic drug market is expected to intensify over the years. Companies engage upon new product launch in order to grab a larger part of the market share compared to the competitors. For instance, Mylan launched innovative Version of Antiepileptic Drug Levetiracetam in 2012. Some of the major players of the market are Cephalon, Inc, Abbott Laboratories, Novartis AG, Pfizer, Inc, Sunovion Pharmaceuticals, Inc. GlaxoSmithKline plc, Valeant Pharmaceuticals International, Inc, Johnson & Johnson, among others.\n\nFor more information about this report @ https://www.insightsandreports.com/industry-reports/antiepileptic-drugs-market \nAbout Us:\nInsights and Reports is a research and consulting group assisting the clients with 360-degree insights with real time qualitative and quantitative information. The Insights and Reports team is valued for continuous client-oriented services. Our data scientists monitor the markets pertaining to their expertise on a daily basis with the help of 150+ analysts to back them with accurate market studies.\n\nContact Us: \nMr.Saby\nInsights And Reports,\n2201 Cooperative Way #600, \nHerndon, VA 20171, USA.\nTel: +1 703 574 4447\nEmail:[email protected]",
"json_metadata": "{\"tags\":[\"antiepileptic\",\"drugs\",\"market\",\"research\"],\"links\":[\"https://www.insightsandreports.com/request-sample/42\",\"https://www.insightsandreports.com/industry-reports/antiepileptic-drugs-market\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}"
}
]
}2018/10/30 09:36:03
2018/10/30 09:36:03
| voter | borishots |
| author | annasmith |
| permlink | global-asia-pacific-generic-medicines-market-reduce-healthcare-cost-research-application-and-outlook-2025 |
| weight | 10000 (100.00%) |
| Transaction Info | Block #27257374/Trx 5537f3d67401d3f744997e2c2a810505f8d4e1c8 |
View Raw JSON Data
{
"trx_id": "5537f3d67401d3f744997e2c2a810505f8d4e1c8",
"block": 27257374,
"trx_in_block": 0,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-10-30T09:36:03",
"op": [
"vote",
{
"voter": "borishots",
"author": "annasmith",
"permlink": "global-asia-pacific-generic-medicines-market-reduce-healthcare-cost-research-application-and-outlook-2025",
"weight": 10000
}
]
}2018/10/30 09:34:33
2018/10/30 09:34:33
| author | annasmith |
| permlink | global-asia-pacific-generic-medicines-market-reduce-healthcare-cost-research-application-and-outlook-2025 |
| max accepted payout | 1000000.000 SBD |
| percent steem dollars | 0 |
| allow votes | true |
| allow curation rewards | true |
| extensions | [] |
| Transaction Info | Block #27257344/Trx a36162411e40315ca65efbaa774ef4f1a720713e |
View Raw JSON Data
{
"trx_id": "a36162411e40315ca65efbaa774ef4f1a720713e",
"block": 27257344,
"trx_in_block": 37,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-10-30T09:34:33",
"op": [
"comment_options",
{
"author": "annasmith",
"permlink": "global-asia-pacific-generic-medicines-market-reduce-healthcare-cost-research-application-and-outlook-2025",
"max_accepted_payout": "1000000.000 SBD",
"percent_steem_dollars": 0,
"allow_votes": true,
"allow_curation_rewards": true,
"extensions": []
}
]
}2018/10/30 09:34:33
2018/10/30 09:34:33
| parent author | |
| parent permlink | asia |
| author | annasmith |
| permlink | global-asia-pacific-generic-medicines-market-reduce-healthcare-cost-research-application-and-outlook-2025 |
| title | Global Asia Pacific Generic Medicines Market -Reduce Healthcare Cost Research, Application & Outlook 2025 |
| body | Asia Pacific Generic Medicine Market: Introduction Generic medicine refers to drugs that have the same ingredient similar to a branded drug. These medicines also produce the same therapeutic effect and are recommended in the same medicating manner, same way of consumption and usage and with the same quality. Additionally, the inactive ingredients of generic medicines can differ when compared to their branded counter drugs. These medicines are majorly sold after the branded drug patents expire and are comparatively lower in costs when linked to the patented branded drugs. Generic medicines have same quality as compared to the branded drugs and are produced under the same care and manufacturing procedures. Request for a sample copy of this report @ https://www.insightsandreports.com/request-sample/198 Market Dynamics The key driving factor for growth of generic medicines in APAC region is, growing pharmaceutical spending by the developing nations towards generics. Continuously rising healthcare expenditures have forced third party payers and governments to look for ways to control their healthcare expenses. This is key factor that is driving the rising demand for generics against their branded counterparts. Another foremost driver of this industry is the constant patent cliff that is supplying growing pipelines opportunities for generic organizations. Segment Analysis Generic drugs market is segmented into drug type, therapeutic application, route of administration. On the basis of drug type the market has be categorized into monoclonal antibodies, vaccines, peptide hormones, peptide antibiotics, cytokines, insulin, immunoglobulin and blood factors among others. Based on therapeutic application oncology, neurology, musculoskeletal diseases, cardiovascular diseases, and infectious diseases among others. APAC generic medicines market on the basis of route of administration is divided into oral, injectable, topical, and intra-venous among others. As per Insights and Reports analysts generic medicines accounted for 20% of total spending done by the government in 2017. Generic medicines are anticipated to hold the major chunk of the APAC generic medicines market over the forecast period. Based on Geography, APAC region is further divided in to Japan, China, India, Australia, and South Korea. There is an unused market potential in Japan because of presence of key manufacturers of generic medicines market. Country Analysis The key factors driving the generic medicines market in various countries or APAC region are: • Japan: The country has high aging population and experience high medical costs incurred, in order to reduce the cost of treatment government is planning to support generic medicines and increase the productivity by to 60% in 2018 when compared to 25% in 2012. • India: Government of India rolled out a plan named Universal health plan that is anticipated to cover over all population by 2019, in order to fulfill this plan state governments are promoting usage of generic medicines in government hospitals. • Indonesia: The universal health coverage scheme implemented by the government of Indonesia improved the demand for generic medicines. For more information about this report @ https://www.insightsandreports.com/industry-reports/asia-pacific-generic-medicines-market Key Market Players Key market players of APAC Generic Medicine market include Ranbaxy Laboratories, Mylan, Inc. Industries, Ltd., Par Pharmaceutical, Inc., Celgne Corporation, Watson Pharmaceuticals, Ltd., Actavis, Dr. Reddy’s Laboratories, Sandoz International GmbH, Apotex, Inc., and Teva Pharmaceutical among others. About Us: Insights and Reports is a research and consulting group assisting the clients with 360-degree insights with real time qualitative and quantitative information. The Insights and Reports team is valued for continuous client-oriented services. Our data scientists monitor the markets pertaining to their expertise on a daily basis with the help of 150+ analysts to back them with accurate market studies. Contact Us: Mr.Saby Insights And Reports, 2201 Cooperative Way #600, Herndon, VA 20171, USA. Tel: +1 703 574 4447 Email:[email protected]  |
| json metadata | {"tags":["asia","pacific","generic","medicines","market"],"image":["https://cdn.steemitimages.com/DQmYTXxa82TjiMMbUaoqqbHF1w6aj7hbGL1LRAHicvREVgk/generic-medicine-500x500.jpg"],"links":["https://www.insightsandreports.com/request-sample/198","https://www.insightsandreports.com/industry-reports/asia-pacific-generic-medicines-market"],"app":"steemit/0.1","format":"markdown"} |
| Transaction Info | Block #27257344/Trx a36162411e40315ca65efbaa774ef4f1a720713e |
View Raw JSON Data
{
"trx_id": "a36162411e40315ca65efbaa774ef4f1a720713e",
"block": 27257344,
"trx_in_block": 37,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-10-30T09:34:33",
"op": [
"comment",
{
"parent_author": "",
"parent_permlink": "asia",
"author": "annasmith",
"permlink": "global-asia-pacific-generic-medicines-market-reduce-healthcare-cost-research-application-and-outlook-2025",
"title": "Global Asia Pacific Generic Medicines Market -Reduce Healthcare Cost Research, Application & Outlook 2025",
"body": "Asia Pacific Generic Medicine Market: Introduction\nGeneric medicine refers to drugs that have the same ingredient similar to a branded drug. These medicines also produce the same therapeutic effect and are recommended in the same medicating manner, same way of consumption and usage and with the same quality. Additionally, the inactive ingredients of generic medicines can differ when compared to their branded counter drugs. These medicines are majorly sold after the branded drug patents expire and are comparatively lower in costs when linked to the patented branded drugs. Generic medicines have same quality as compared to the branded drugs and are produced under the same care and manufacturing procedures.\n\nRequest for a sample copy of this report @ https://www.insightsandreports.com/request-sample/198 \n\nMarket Dynamics\nThe key driving factor for growth of generic medicines in APAC region is, growing pharmaceutical spending by the developing nations towards generics. Continuously rising healthcare expenditures have forced third party payers and governments to look for ways to control their healthcare expenses. This is key factor that is driving the rising demand for generics against their branded counterparts. Another foremost driver of this industry is the constant patent cliff that is supplying growing pipelines opportunities for generic organizations.\n\nSegment Analysis\nGeneric drugs market is segmented into drug type, therapeutic application, route of administration. On the basis of drug type the market has be categorized into monoclonal antibodies, vaccines, peptide hormones, peptide antibiotics, cytokines, insulin, immunoglobulin and blood factors among others. Based on therapeutic application oncology, neurology, musculoskeletal diseases, cardiovascular diseases, and infectious diseases among others. APAC generic medicines market on the basis of route of administration is divided into oral, injectable, topical, and intra-venous among others. As per Insights and Reports analysts generic medicines accounted for 20% of total spending done by the government in 2017. Generic medicines are anticipated to hold the major chunk of the APAC generic medicines market over the forecast period. Based on Geography, APAC region is further divided in to Japan, China, India, Australia, and South Korea. There is an unused market potential in Japan because of presence of key manufacturers of generic medicines market.\n\nCountry Analysis\nThe key factors driving the generic medicines market in various countries or APAC region are:\n• Japan: The country has high aging population and experience high medical costs incurred, in order to reduce the cost of treatment government is planning to support generic medicines and increase the productivity by to 60% in 2018 when compared to 25% in 2012.\n• India: Government of India rolled out a plan named Universal health plan that is anticipated to cover over all population by 2019, in order to fulfill this plan state governments are promoting usage of generic medicines in government hospitals.\n• Indonesia: The universal health coverage scheme implemented by the government of Indonesia improved the demand for generic medicines.\n\nFor more information about this report @ https://www.insightsandreports.com/industry-reports/asia-pacific-generic-medicines-market \n\nKey Market Players\nKey market players of APAC Generic Medicine market include Ranbaxy Laboratories, Mylan, Inc. Industries, Ltd., Par Pharmaceutical, Inc., Celgne Corporation, Watson Pharmaceuticals, Ltd., Actavis, Dr. Reddy’s Laboratories, Sandoz International GmbH, Apotex, Inc., and Teva Pharmaceutical among others.\n\nAbout Us:\nInsights and Reports is a research and consulting group assisting the clients with 360-degree insights with real time qualitative and quantitative information. The Insights and Reports team is valued for continuous client-oriented services. Our data scientists monitor the markets pertaining to their expertise on a daily basis with the help of 150+ analysts to back them with accurate market studies.\n\n\nContact Us: \nMr.Saby\nInsights And Reports,\n2201 Cooperative Way #600, \nHerndon, VA 20171, USA.\nTel: +1 703 574 4447\nEmail:[email protected]\n\n\n\n",
"json_metadata": "{\"tags\":[\"asia\",\"pacific\",\"generic\",\"medicines\",\"market\"],\"image\":[\"https://cdn.steemitimages.com/DQmYTXxa82TjiMMbUaoqqbHF1w6aj7hbGL1LRAHicvREVgk/generic-medicine-500x500.jpg\"],\"links\":[\"https://www.insightsandreports.com/request-sample/198\",\"https://www.insightsandreports.com/industry-reports/asia-pacific-generic-medicines-market\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}"
}
]
}2018/10/30 09:05:48
2018/10/30 09:05:48
| required auths | [] |
| required posting auths | ["annasmith"] |
| id | follow |
| json | ["follow",{"follower":"annasmith","following":"a-cmsidl","what":["blog"]}] |
| Transaction Info | Block #27256769/Trx 7c6032e9b3f096a35c1c629b8b02783666320361 |
View Raw JSON Data
{
"trx_id": "7c6032e9b3f096a35c1c629b8b02783666320361",
"block": 27256769,
"trx_in_block": 9,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-10-30T09:05:48",
"op": [
"custom_json",
{
"required_auths": [],
"required_posting_auths": [
"annasmith"
],
"id": "follow",
"json": "[\"follow\",{\"follower\":\"annasmith\",\"following\":\"a-cmsidl\",\"what\":[\"blog\"]}]"
}
]
}annasmithfollowed @a-0-labon2018/10/30 09:05:45
annasmithfollowed @a-0-labon
2018/10/30 09:05:45
| required auths | [] |
| required posting auths | ["annasmith"] |
| id | follow |
| json | ["follow",{"follower":"annasmith","following":"a-0-labon","what":["blog"]}] |
| Transaction Info | Block #27256768/Trx 9d92fea71d1924b25380ea0595e0f2950510cf54 |
View Raw JSON Data
{
"trx_id": "9d92fea71d1924b25380ea0595e0f2950510cf54",
"block": 27256768,
"trx_in_block": 8,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-10-30T09:05:45",
"op": [
"custom_json",
{
"required_auths": [],
"required_posting_auths": [
"annasmith"
],
"id": "follow",
"json": "[\"follow\",{\"follower\":\"annasmith\",\"following\":\"a-0-labon\",\"what\":[\"blog\"]}]"
}
]
}2018/10/30 09:05:36
2018/10/30 09:05:36
| required auths | [] |
| required posting auths | ["annasmith"] |
| id | follow |
| json | ["follow",{"follower":"annasmith","following":"sezenke","what":["blog"]}] |
| Transaction Info | Block #27256765/Trx 0b847684cfbab5503f5c54ceaf7f8bc5fd2f2adf |
View Raw JSON Data
{
"trx_id": "0b847684cfbab5503f5c54ceaf7f8bc5fd2f2adf",
"block": 27256765,
"trx_in_block": 7,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-10-30T09:05:36",
"op": [
"custom_json",
{
"required_auths": [],
"required_posting_auths": [
"annasmith"
],
"id": "follow",
"json": "[\"follow\",{\"follower\":\"annasmith\",\"following\":\"sezenke\",\"what\":[\"blog\"]}]"
}
]
}2018/10/30 09:05:33
2018/10/30 09:05:33
| required auths | [] |
| required posting auths | ["annasmith"] |
| id | follow |
| json | ["follow",{"follower":"annasmith","following":"alphabot","what":["blog"]}] |
| Transaction Info | Block #27256764/Trx 125f71b2a15455e8de1291b6be1a53e84a3a4eaa |
View Raw JSON Data
{
"trx_id": "125f71b2a15455e8de1291b6be1a53e84a3a4eaa",
"block": 27256764,
"trx_in_block": 10,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-10-30T09:05:33",
"op": [
"custom_json",
{
"required_auths": [],
"required_posting_auths": [
"annasmith"
],
"id": "follow",
"json": "[\"follow\",{\"follower\":\"annasmith\",\"following\":\"alphabot\",\"what\":[\"blog\"]}]"
}
]
}annasmithupdated their account properties2018/10/30 09:03:21
annasmithupdated their account properties
2018/10/30 09:03:21
| account | annasmith |
| memo key | STM6E4e2kPgUodGASEMV1CCjPxjHsrM19oSACF6Xf7uVi4wnpitb4 |
| json metadata | {"profile":{"profile_image":"https://cdn.steemitimages.com/DQmQZMJiBuJdFvq9dEbDbrvmQ4zuhcRvvEKkRjKjFQQQoUj/17-Kate%20Upton.jpg","name":"Healthcare Research ","about":"Researcher for the #healthcare industry.... world-leading insight for the #pharma, #biotech, #diagnostics and #medicaldevice sectors.","location":"US","website":"https://www.insightsandreports.com/"}} |
| Transaction Info | Block #27256720/Trx d965c4f390e3780c10dcc09087e3919e5323d7e9 |
View Raw JSON Data
{
"trx_id": "d965c4f390e3780c10dcc09087e3919e5323d7e9",
"block": 27256720,
"trx_in_block": 16,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-10-30T09:03:21",
"op": [
"account_update",
{
"account": "annasmith",
"memo_key": "STM6E4e2kPgUodGASEMV1CCjPxjHsrM19oSACF6Xf7uVi4wnpitb4",
"json_metadata": "{\"profile\":{\"profile_image\":\"https://cdn.steemitimages.com/DQmQZMJiBuJdFvq9dEbDbrvmQ4zuhcRvvEKkRjKjFQQQoUj/17-Kate%20Upton.jpg\",\"name\":\"Healthcare Research \",\"about\":\"Researcher for the #healthcare industry.... world-leading insight for the #pharma, #biotech, #diagnostics and #medicaldevice sectors.\",\"location\":\"US\",\"website\":\"https://www.insightsandreports.com/\"}}"
}
]
}2018/10/29 10:05:06
2018/10/29 10:05:06
| parent author | |
| parent permlink | anesthesia |
| author | annasmith |
| permlink | anesthesia-video-laryngoscope-market-overview-research-future-business-scope-extensive-growth-and-outlook-2025 |
| title | Anesthesia Video Laryngoscope Market Overview – Research, Future Business Scope, Extensive Growth and Outlook 2025 |
| body | Anesthesia Video Laryngoscope Market Introduction: Anesthesia video laryngoscopy is performed to facilitate tracheal intubation during various surgical procedures, general anesthesia and cardiopulmonary resuscitation on larynx or other parts of tracheobronchial region. Recent technological advancements in anesthesia video laryngoscope such as robot assisted intubation and constant difficulties in tracheal intubation in direct laryngoscope has led to the demand for video laryngoscope. Video laryngoscope as opposed to the conventional laryngoscope, incorporates a high-quality camera attached to a monitor through a video cable to guide through the whole procedure of laryngoscopy. Since its inception, anesthesia video laryngoscope market has grown exponentially and is set to follow a similar trend during the forecast period. Request for a sample copy of this report @ https://www.insightsandreports.com/request-sample/298 Market Dynamics: Video Laryngoscope is known to be superior against direct laryngoscope in terms of its application which is playing a major contributor to the market growth. According to an ICU study in 2015, it was witnessed that 74% of the Glidescope video laryngoscopy patients were successfully intubated as compared to only 40% of the patients that were successfully intubated using direct laryngoscopy. Anesthesia video laryngoscope market is expected to grow during the forecast period owing to its technological superiority and high success rates, reduction in intubation attempts, patient safety and shorter laryngoscopy time. However, handling of video laryngoscopy requires experience and expertise. Lack of handling skills and high cost of maintenance required for the equipment are some of the restraints for anesthesia video laryngoscopy market growth. Market Segmentation: Market segmentation for the Anesthesia video laryngoscopy is based on: Type of stylets: Rigid: The adoption of rigid stylets has been increasing over the recent years for the tracheal intubation, due to its usage in the predicted and unpredicted difficult tracheal intubation. Some of the common stylets manufactured produced by GlideRite are GlideRite DLT stylet, GlideRite rigid stylet and GlideRite single use stylet- Pre-shaped bio-compatible plastic stylet. Flexible:Flexible intubation tubes have long been called as flexible fibreoptic. The new technology uses a video chip attached along the distal end of the tube. Flexible stylets remains the typical instrument for much-anticipated difficult airway, improved optics and lesser degradation difficulties. Some of the popular companies manufacturing flexible stylets include Shiley intubating stylets, McGrath MAC-shaped malleable stylet and Parker flex it. Regional Insights: North America and Europe are the two of the most lucrative market for anesthesia video laryngoscope market globally due to increased number of geriatric population and owing to the technological advancements and benefits like non-invasiveness of the anesthesia video laryngoscope and improved patients’ safety. North America is leading the market for anesthesia video laryngoscope market in 2017 and is expected to follow a similar trend during the forecast period. Factors such as high adoption rate, increasing awareness, presence of key manufacturers are key to market growth in this region. In Europe, UK stands as one of the key markets for video laryngoscope owing to widespread use of anesthesia video laryngoscope across all UK NHS Anesthetic departments and Departmental airway leads. According to a survey administered by Royal College of Anesthetics in conjunction with Health Service Research Centre (HSRC) in the year 2013, it was estimated that video laryngoscopes were available in almost 91% of the operating theatres, boosting the market of anesthesia video laryngoscope in UK. Competitive Landscape: Key vendors in the market for anesthesia video laryngoscopy are developing new and innovative techniques to provide higher precision, improved support to the clinicians and better handling. Additionally, growing scope for robot-assisted laryngoscopy that results in increased efficiency, reliability will further play a key driving factor in the coming years. Some of the most prominent vendors operating in global video laryngoscope market are: Medtronic, Mercury Enterprises, Verathon Medical, Ambu A/S, Teleflex, Karl Storz, Vyaire Medical, Daiken Medical Coopdech and Zhejiang Tiansong Medical Instrument. For more information about this report @ https://www.insightsandreports.com/industry-reports/anesthesia-video-laryngoscope-market About Us: Insights and Reports is a research and consulting group assisting the clients with 360-degree insights with real time qualitative and quantitative information. The Insights and Reports team is valued for continuous client-oriented services. Our data scientists monitor the markets pertaining to their expertise on a daily basis with the help of 150+ analysts to back them with accurate market studies. Contact Us: Mr.Saby Insights And Reports, 2201 Cooperative Way #600, Herndon, VA 20171, USA. Tel: +1 703 574 4447 Email:[email protected] |
| json metadata | {"tags":["anesthesia","video","laryngoscope","market"],"links":["https://www.insightsandreports.com/request-sample/298","https://www.insightsandreports.com/industry-reports/anesthesia-video-laryngoscope-market"],"app":"steemit/0.1","format":"markdown"} |
| Transaction Info | Block #27229189/Trx fa2f87f3c6a59dacb7ffbd3045c75e1524547a09 |
View Raw JSON Data
{
"trx_id": "fa2f87f3c6a59dacb7ffbd3045c75e1524547a09",
"block": 27229189,
"trx_in_block": 0,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-10-29T10:05:06",
"op": [
"comment",
{
"parent_author": "",
"parent_permlink": "anesthesia",
"author": "annasmith",
"permlink": "anesthesia-video-laryngoscope-market-overview-research-future-business-scope-extensive-growth-and-outlook-2025",
"title": "Anesthesia Video Laryngoscope Market Overview – Research, Future Business Scope, Extensive Growth and Outlook 2025",
"body": "Anesthesia Video Laryngoscope Market Introduction:\nAnesthesia video laryngoscopy is performed to facilitate tracheal intubation during various surgical procedures, general anesthesia and cardiopulmonary resuscitation on larynx or other parts of tracheobronchial region. Recent technological advancements in anesthesia video laryngoscope such as robot assisted intubation and constant difficulties in tracheal intubation in direct laryngoscope has led to the demand for video laryngoscope. Video laryngoscope as opposed to the conventional laryngoscope, incorporates a high-quality camera attached to a monitor through a video cable to guide through the whole procedure of laryngoscopy. Since its inception, anesthesia video laryngoscope market has grown exponentially and is set to follow a similar trend during the forecast period.\n\nRequest for a sample copy of this report @ https://www.insightsandreports.com/request-sample/298 \n\nMarket Dynamics:\nVideo Laryngoscope is known to be superior against direct laryngoscope in terms of its application which is playing a major contributor to the market growth. According to an ICU study in 2015, it was witnessed that 74% of the Glidescope video laryngoscopy patients were successfully intubated as compared to only 40% of the patients that were successfully intubated using direct laryngoscopy. Anesthesia video laryngoscope market is expected to grow during the forecast period owing to its technological superiority and high success rates, reduction in intubation attempts, patient safety and shorter laryngoscopy time.\nHowever, handling of video laryngoscopy requires experience and expertise. Lack of handling skills and high cost of maintenance required for the equipment are some of the restraints for anesthesia video laryngoscopy market growth.\n \nMarket Segmentation:\nMarket segmentation for the Anesthesia video laryngoscopy is based on:\nType of stylets:\nRigid: The adoption of rigid stylets has been increasing over the recent years for the tracheal intubation, due to its usage in the predicted and unpredicted difficult tracheal intubation. Some of the common stylets manufactured produced by GlideRite are GlideRite DLT stylet, GlideRite rigid stylet and GlideRite single use stylet- Pre-shaped bio-compatible plastic stylet.\nFlexible:Flexible intubation tubes have long been called as flexible fibreoptic. The new technology uses a video chip attached along the distal end of the tube. Flexible stylets remains the typical instrument for much-anticipated difficult airway, improved optics and lesser degradation difficulties. Some of the popular companies manufacturing flexible stylets include Shiley intubating stylets, McGrath MAC-shaped malleable stylet and Parker flex it.\n\nRegional Insights:\nNorth America and Europe are the two of the most lucrative market for anesthesia video laryngoscope market globally due to increased number of geriatric population and owing to the technological advancements and benefits like non-invasiveness of the anesthesia video laryngoscope and improved patients’ safety.\nNorth America is leading the market for anesthesia video laryngoscope market in 2017 and is expected to follow a similar trend during the forecast period. Factors such as high adoption rate, increasing awareness, presence of key manufacturers are key to market growth in this region. In Europe, UK stands as one of the key markets for video laryngoscope owing to widespread use of anesthesia video laryngoscope across all UK NHS Anesthetic departments and Departmental airway leads. According to a survey administered by Royal College of Anesthetics in conjunction with Health Service Research Centre (HSRC) in the year 2013, it was estimated that video laryngoscopes were available in almost 91% of the operating theatres, boosting the market of anesthesia video laryngoscope in UK.\n\nCompetitive Landscape:\nKey vendors in the market for anesthesia video laryngoscopy are developing new and innovative techniques to provide higher precision, improved support to the clinicians and better handling. Additionally, growing scope for robot-assisted laryngoscopy that results in increased efficiency, reliability will further play a key driving factor in the coming years.\nSome of the most prominent vendors operating in global video laryngoscope market are: Medtronic, Mercury Enterprises, Verathon Medical, Ambu A/S, Teleflex, Karl Storz, Vyaire Medical, Daiken Medical Coopdech and Zhejiang Tiansong Medical Instrument.\n\nFor more information about this report @ https://www.insightsandreports.com/industry-reports/anesthesia-video-laryngoscope-market \nAbout Us:\nInsights and Reports is a research and consulting group assisting the clients with 360-degree insights with real time qualitative and quantitative information. The Insights and Reports team is valued for continuous client-oriented services. Our data scientists monitor the markets pertaining to their expertise on a daily basis with the help of 150+ analysts to back them with accurate market studies.\n\nContact Us: \nMr.Saby\nInsights And Reports,\n2201 Cooperative Way #600, \nHerndon, VA 20171, USA.\nTel: +1 703 574 4447\nEmail:[email protected]",
"json_metadata": "{\"tags\":[\"anesthesia\",\"video\",\"laryngoscope\",\"market\"],\"links\":[\"https://www.insightsandreports.com/request-sample/298\",\"https://www.insightsandreports.com/industry-reports/anesthesia-video-laryngoscope-market\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}"
}
]
}2018/10/26 08:02:51
2018/10/26 08:02:51
| voter | davidfnck |
| author | annasmith |
| permlink | global-anxiety-disorder-and-depression-treatments-market-continues-transformation-greater-efficacy-and-outlook-2025 |
| weight | 3000 (30.00%) |
| Transaction Info | Block #27140398/Trx b640acb19eb1976d0a8cd2b1fec9503ab990a70d |
View Raw JSON Data
{
"trx_id": "b640acb19eb1976d0a8cd2b1fec9503ab990a70d",
"block": 27140398,
"trx_in_block": 1,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-10-26T08:02:51",
"op": [
"vote",
{
"voter": "davidfnck",
"author": "annasmith",
"permlink": "global-anxiety-disorder-and-depression-treatments-market-continues-transformation-greater-efficacy-and-outlook-2025",
"weight": 3000
}
]
}2018/10/26 07:38:36
2018/10/26 07:38:36
| parent author | annasmith |
| parent permlink | global-anxiety-disorder-and-depression-treatments-market-continues-transformation-greater-efficacy-and-outlook-2025 |
| author | cheetah |
| permlink | cheetah-re-annasmithglobal-anxiety-disorder-and-depression-treatments-market-continues-transformation-greater-efficacy-and-outlook-2025 |
| title | |
| body | Hi! I am a robot. I just upvoted you! I found similar content that readers might be interested in: https://www.insightsandreports.com/industry-reports/anxiety-disorder-and-depression-treatments-market |
| json metadata | |
| Transaction Info | Block #27139913/Trx 2981e28e08a259836044e99f6af667fb843d7532 |
View Raw JSON Data
{
"trx_id": "2981e28e08a259836044e99f6af667fb843d7532",
"block": 27139913,
"trx_in_block": 12,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-10-26T07:38:36",
"op": [
"comment",
{
"parent_author": "annasmith",
"parent_permlink": "global-anxiety-disorder-and-depression-treatments-market-continues-transformation-greater-efficacy-and-outlook-2025",
"author": "cheetah",
"permlink": "cheetah-re-annasmithglobal-anxiety-disorder-and-depression-treatments-market-continues-transformation-greater-efficacy-and-outlook-2025",
"title": "",
"body": "Hi! I am a robot. I just upvoted you! I found similar content that readers might be interested in:\nhttps://www.insightsandreports.com/industry-reports/anxiety-disorder-and-depression-treatments-market",
"json_metadata": ""
}
]
}2018/10/26 07:38:33
2018/10/26 07:38:33
| voter | cheetah |
| author | annasmith |
| permlink | global-anxiety-disorder-and-depression-treatments-market-continues-transformation-greater-efficacy-and-outlook-2025 |
| weight | 8 (0.08%) |
| Transaction Info | Block #27139912/Trx 006cea3eec7f1b1d91ebd2175300d94e88b842fd |
View Raw JSON Data
{
"trx_id": "006cea3eec7f1b1d91ebd2175300d94e88b842fd",
"block": 27139912,
"trx_in_block": 2,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-10-26T07:38:33",
"op": [
"vote",
{
"voter": "cheetah",
"author": "annasmith",
"permlink": "global-anxiety-disorder-and-depression-treatments-market-continues-transformation-greater-efficacy-and-outlook-2025",
"weight": 8
}
]
}2018/10/26 07:38:24
2018/10/26 07:38:24
| parent author | |
| parent permlink | anxiety |
| author | annasmith |
| permlink | global-anxiety-disorder-and-depression-treatments-market-continues-transformation-greater-efficacy-and-outlook-2025 |
| title | Global Anxiety Disorder & Depression Treatments Market Continues Transformation Greater Efficacy and Outlook 2025 |
| body | Anxiety Disorder & Depression Treatments Market: Introduction Depression and anxiety are common forms of psychiatric disorders which are prevalent among a large chunk of the population. Major depression of depressive disorders is a diagnosable condition that is classified as a mood disorder and its effects can be a long-term issue with symptoms such as reduced energy, overwhelming sadness, loss of appetite, and low interest on things. Depression, if left untreated can result in severe health complications and is considered to be life-threatening. Types of depression include persistent depressive disorder, bipolar disorder, seasonal depression, postpartum depression and psychotic depression among others. Request for a sample copy of this report @ https://www.insightsandreports.com/request-sample/56 Market Dynamics Global anxiety disorder & depression treatments market is majorly driven by the rising number of people with severe anxiety and depression at the global level. According to the World Health Organization, approximately 300 million people across the globe suffer from depression. Further, according to Insights and Reports, in 2017, more than 10 million residents in the U.S. experienced incidences of depression which resulted in severe impairment. Further, according to the Anxiety & Depression Association of America, more than 40 million residents in the U.S. aged 18 and above, which is equivalent to 18.1% of the overall population of the country suffer from anxiety disorders each year. These factors have paved the way for anxiety disorder and depression treatments market. Product Insights Based on product type, anti-depressant drugs accounted for the major share of global anxiety disorder & depression treatments market in 2017, the growth of which is majorly attributed to the influx of advanced techniques to counter mental illness coupled the rising use of an antidepressant in depressive disorder treatment. Moreover, antidepressant drugs are widely used in several anxiety disorders such as traumatic stress, panic disorder, phobia, and others. Disorder Insights On the basis of disorder types, Major Depressive Disorder (MDD) is anticipated to hold prime share in the global anxiety disorder and depression treatments market, primarily owing to the rising incidences of this disorder, making it a common type disorder. According to the National Institute of National Health, more than 16.2 million adults in the U.S. suffered from at least one type of MDD in 2016. Therefore, rising cases of MDD would lead to nudge the global anxiety disorder & depression treatments market in the coming decade. Regional Analysis North America dominated the global anxiety disorder & depression treatments market in 2017 and is expected to retain market dominance throughout the forecast period. This is primarily owing to the huge chunk of the population in the U.S. are currently suffering from anxiety disorders. According to the Anxiety and Depression Association of America, 40 million adults in the U.S. are affected every year whereby making it a most common type disorder. The treatment for this disorder in the U.S. such as several antidepressant drugs is readily available on prescription. The Asia Pacific, however, is gaining rapid prominence in the global anxiety disorder & depression treatments market on account of rising working population and busier lifestyles of the younger populace. India and China are the frontrunners to the growth of this industry in the Asia Pacific. According to the Associated Chambers of Commerce and Industry of India, approximately 42% of the employees working in the Indian corporate sector were found to be suffering from depression in 2015, which marked an approximate of 40% growth over the last 8 years. These are some of the factors resulting in a high demand for anxiety disorder & depression treatments market in the country. Competitive Landscape Some of the key players operating in the global anxiety disorder & depression treatments market include GlaxoSmithKline Plc, AstraZeneca Plc, El Lily & Company, Johnson & Johnson Inc., and H Lundbeck A/S among others. Mergers and acquisition, product development and launch, investments are some of the key strategies adopted by the numerous companies in the global anxiety disorder & depression treatments market to grab a strong foothold. For instance, in May 2018, H Lundbeck announced the approval made on the supplemental new drug for Trintellix by U.S. Food and Drug Administration (FDA) to be used for the patients suffering from the major depressive disorder (MDD), majorly owing to its positive effect on processing speed. For more information about this report @ https://www.insightsandreports.com/industry-reports/anxiety-disorder-and-depression-treatments-market About Us: Insights and Reports is a research and consulting group assisting the clients with 360-degree insights with real time qualitative and quantitative information. The Insights and Reports team is valued for continuous client-oriented services. Our data scientists monitor the markets pertaining to their expertise on a daily basis with the help of 150+ analysts to back them with accurate market studies. Contact Us: Mr.Saby Insights And Reports, 2201 Cooperative Way #600, Herndon, VA 20171, USA. Tel: +1 703 574 4447 Email:[email protected] |
| json metadata | {"tags":["anxiety","disorder","depression","treatments"],"links":["https://www.insightsandreports.com/request-sample/56","https://www.insightsandreports.com/industry-reports/anxiety-disorder-and-depression-treatments-market"],"app":"steemit/0.1","format":"markdown"} |
| Transaction Info | Block #27139909/Trx ec357a58011af79a51d90957834685ad858017d4 |
View Raw JSON Data
{
"trx_id": "ec357a58011af79a51d90957834685ad858017d4",
"block": 27139909,
"trx_in_block": 6,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-10-26T07:38:24",
"op": [
"comment",
{
"parent_author": "",
"parent_permlink": "anxiety",
"author": "annasmith",
"permlink": "global-anxiety-disorder-and-depression-treatments-market-continues-transformation-greater-efficacy-and-outlook-2025",
"title": "Global Anxiety Disorder & Depression Treatments Market Continues Transformation Greater Efficacy and Outlook 2025",
"body": "Anxiety Disorder & Depression Treatments Market: Introduction\nDepression and anxiety are common forms of psychiatric disorders which are prevalent among a large chunk of the population. Major depression of depressive disorders is a diagnosable condition that is classified as a mood disorder and its effects can be a long-term issue with symptoms such as reduced energy, overwhelming sadness, loss of appetite, and low interest on things. Depression, if left untreated can result in severe health complications and is considered to be life-threatening. Types of depression include persistent depressive disorder, bipolar disorder, seasonal depression, postpartum depression and psychotic depression among others.\n\nRequest for a sample copy of this report @ https://www.insightsandreports.com/request-sample/56\n\nMarket Dynamics\nGlobal anxiety disorder & depression treatments market is majorly driven by the rising number of people with severe anxiety and depression at the global level. According to the World Health Organization, approximately 300 million people across the globe suffer from depression. Further, according to Insights and Reports, in 2017, more than 10 million residents in the U.S. experienced incidences of depression which resulted in severe impairment. Further, according to the Anxiety & Depression Association of America, more than 40 million residents in the U.S. aged 18 and above, which is equivalent to 18.1% of the overall population of the country suffer from anxiety disorders each year. These factors have paved the way for anxiety disorder and depression treatments market.\n\nProduct Insights\nBased on product type, anti-depressant drugs accounted for the major share of global anxiety disorder & depression treatments market in 2017, the growth of which is majorly attributed to the influx of advanced techniques to counter mental illness coupled the rising use of an antidepressant in depressive disorder treatment. Moreover, antidepressant drugs are widely used in several anxiety disorders such as traumatic stress, panic disorder, phobia, and others.\n\nDisorder Insights\nOn the basis of disorder types, Major Depressive Disorder (MDD) is anticipated to hold prime share in the global anxiety disorder and depression treatments market, primarily owing to the rising incidences of this disorder, making it a common type disorder. According to the National Institute of National Health, more than 16.2 million adults in the U.S. suffered from at least one type of MDD in 2016. Therefore, rising cases of MDD would lead to nudge the global anxiety disorder & depression treatments market in the coming decade.\n\nRegional Analysis\nNorth America dominated the global anxiety disorder & depression treatments market in 2017 and is expected to retain market dominance throughout the forecast period. This is primarily owing to the huge chunk of the population in the U.S. are currently suffering from anxiety disorders. According to the Anxiety and Depression Association of America, 40 million adults in the U.S. are affected every year whereby making it a most common type disorder. The treatment for this disorder in the U.S. such as several antidepressant drugs is readily available on prescription.\nThe Asia Pacific, however, is gaining rapid prominence in the global anxiety disorder & depression treatments market on account of rising working population and busier lifestyles of the younger populace. India and China are the frontrunners to the growth of this industry in the Asia Pacific. According to the Associated Chambers of Commerce and Industry of India, approximately 42% of the employees working in the Indian corporate sector were found to be suffering from depression in 2015, which marked an approximate of 40% growth over the last 8 years. These are some of the factors resulting in a high demand for anxiety disorder & depression treatments market in the country.\n\nCompetitive Landscape\nSome of the key players operating in the global anxiety disorder & depression treatments market include GlaxoSmithKline Plc, AstraZeneca Plc, El Lily & Company, Johnson & Johnson Inc., and H Lundbeck A/S among others.\nMergers and acquisition, product development and launch, investments are some of the key strategies adopted by the numerous companies in the global anxiety disorder & depression treatments market to grab a strong foothold. For instance, in May 2018, H Lundbeck announced the approval made on the supplemental new drug for Trintellix by U.S. Food and Drug Administration (FDA) to be used for the patients suffering from the major depressive disorder (MDD), majorly owing to its positive effect on processing speed.\n\nFor more information about this report @ https://www.insightsandreports.com/industry-reports/anxiety-disorder-and-depression-treatments-market \n\nAbout Us:\nInsights and Reports is a research and consulting group assisting the clients with 360-degree insights with real time qualitative and quantitative information. The Insights and Reports team is valued for continuous client-oriented services. Our data scientists monitor the markets pertaining to their expertise on a daily basis with the help of 150+ analysts to back them with accurate market studies.\n\nContact Us: \nMr.Saby\nInsights And Reports,\n2201 Cooperative Way #600, \nHerndon, VA 20171, USA.\nTel: +1 703 574 4447\nEmail:[email protected]",
"json_metadata": "{\"tags\":[\"anxiety\",\"disorder\",\"depression\",\"treatments\"],\"links\":[\"https://www.insightsandreports.com/request-sample/56\",\"https://www.insightsandreports.com/industry-reports/anxiety-disorder-and-depression-treatments-market\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}"
}
]
}2018/10/15 08:05:18
2018/10/15 08:05:18
| parent author | |
| parent permlink | global |
| author | annasmith |
| permlink | global-hair-transplant-market-growth-driver-regional-outlook-developments-and-forecast-to-2025 |
| title | Global Hair Transplant Market Growth Driver, Regional Outlook, Developments and Forecast to 2025 |
| body | Hair Transplant Market: Introduction Hair transplantation is a surgical procedure, which changes the hair follicles from one part to another part of the body. This is majorly used to treat hair baldness in both male and female. In general, there are two types of methods used in the hair transplantation processes namely Follicular Unit Extraction (FUE) and Follicular Unit Transplantation (FUT). Request for a sample copy of this report @ https://www.insightsandreports.com/request-sample/209 Market Dynamics Increasing number of hair transplant surgical procedures, coupled with high treatment success rates are some of the major factors driving the hair transplant market. Moreover, increasing consumption of drugs with high dosages, along with increasing treatment demand from the developing countries are the key factors driving the global hair transplantation market. Increasing preference regarding the physical appearance, and rising hair fall cases among the population of the Asia Pacific region will significantly augment the global hair transplantation market over the projected period. Among the Asian population, hair loss has become a common phenomenon. According to some epidemiologic stats from various Asian countries, nearly 41% to 73% of the population living in the Asia Pacific region develop a pattern hair loss in their life. With rapidly increasing awareness, and growing prevalence of hair loss problems, the hair transplantation demand is expected to rise in the coming years, thus driving the global market. The market might be restrained by the adverse side effects caused by the drugs used during the hair transplant treatment. Some of the common side effects include the appearance of rashes and skin itching. Moreover, increasing incidences among people suffering from these drug side effects are chest pain, swelling of tongue, lips, feet, or hands, unexplained weight gain, etc. will significantly hamper the growth of hair transplant market over the projected time period. By Therapy Platelet Rich Plasma (PRP) therapy is expected to dominate the global hair transplant market over the entire forecast period. Increasing practices of this therapies for hair loss treatment will further lead to increased market growth opportunities in coming years. According to recent stats by International Society of Hair Restoration Surgery (ISHRS), around 58.8% patients were given PRP as a therapy during their hair transplant process. Rising adoption, coupled with the therapy’s efficiency will further promote faster healing along with very low scarring after the procedure, which will further result in the escalating PRP therapy demand during the projected period. By Region North America hair transplant market is expected to hold the prime share, majorly contributed by the U.S. over the projected period. Rising various hair transplant surgeries including FUT and FUE treatments, along with their high success rates are majorly driving the U.S. hair transplant market over the projected years. Rising cases of hair loss problems in the U.S., among both male and female will further foster the growth of the U.S. market. American Academy of Dermatology states that hereditary hair loss is one of the common causes for hair loss, which affects more than 80 million population in the U.S. alone. Moreover, additional factors such as stressful life, dandruff, smoking, along with consumption of unhygienic fast food will further lead to the growth of hair loss cases, thus triggering the hair transplant market growth. For more information about this report @ https://www.insightsandreports.com/industry-reports/hair-transplant-market Competitive Landscape Some of the prominent players in the global hair transplant market include Beiersdorf AG, Allergan Plc, L'Oreal SA, Bosley, MEDICAMAT, Lumenis Inc, Restoration Robotics Inc., PhotoMedex Inc., and Solta Medical, Inc. among several others. These players have implemented many strategic moves to develop the treatment areas which have the potential to help the market to grow. Moreover, new product launches, along with increasing R&D activities to reduce the side effects of hair transplantation surgeries have increased, and this will further help the key player’s capabilities to sustain in the global market, thus providing better results to the customers. About Us: Insights and Reports is a research and consulting group assisting the clients with 360-degree insights with real time qualitative and quantitative information. The Insights and Reports team is valued for continuous client-oriented services. Our data scientists monitor the markets pertaining to their expertise on a daily basis with the help of 150+ analysts to back them with accurate market studies. Contact Us: Mr.Saby Insights And Reports, 2201 Cooperative Way #600, Herndon, VA 20171, USA. Tel: +1 703 574 4447 Email:[email protected] |
| json metadata | {"tags":["global","hair","transplant","market"],"links":["https://www.insightsandreports.com/request-sample/209","https://www.insightsandreports.com/industry-reports/hair-transplant-market"],"app":"steemit/0.1","format":"markdown"} |
| Transaction Info | Block #26823896/Trx 71520f3a62cd7cfdda888f6756c42416e44a0443 |
View Raw JSON Data
{
"trx_id": "71520f3a62cd7cfdda888f6756c42416e44a0443",
"block": 26823896,
"trx_in_block": 20,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-10-15T08:05:18",
"op": [
"comment",
{
"parent_author": "",
"parent_permlink": "global",
"author": "annasmith",
"permlink": "global-hair-transplant-market-growth-driver-regional-outlook-developments-and-forecast-to-2025",
"title": "Global Hair Transplant Market Growth Driver, Regional Outlook, Developments and Forecast to 2025",
"body": "Hair Transplant Market: Introduction\nHair transplantation is a surgical procedure, which changes the hair follicles from one part to another part of the body. This is majorly used to treat hair baldness in both male and female. In general, there are two types of methods used in the hair transplantation processes namely Follicular Unit Extraction (FUE) and Follicular Unit Transplantation (FUT).\n\nRequest for a sample copy of this report @ https://www.insightsandreports.com/request-sample/209 \n\nMarket Dynamics\nIncreasing number of hair transplant surgical procedures, coupled with high treatment success rates are some of the major factors driving the hair transplant market. Moreover, increasing consumption of drugs with high dosages, along with increasing treatment demand from the developing countries are the key factors driving the global hair transplantation market.\nIncreasing preference regarding the physical appearance, and rising hair fall cases among the population of the Asia Pacific region will significantly augment the global hair transplantation market over the projected period. Among the Asian population, hair loss has become a common phenomenon. According to some epidemiologic stats from various Asian countries, nearly 41% to 73% of the population living in the Asia Pacific region develop a pattern hair loss in their life. With rapidly increasing awareness, and growing prevalence of hair loss problems, the hair transplantation demand is expected to rise in the coming years, thus driving the global market.\nThe market might be restrained by the adverse side effects caused by the drugs used during the hair transplant treatment. Some of the common side effects include the appearance of rashes and skin itching. Moreover, increasing incidences among people suffering from these drug side effects are chest pain, swelling of tongue, lips, feet, or hands, unexplained weight gain, etc. will significantly hamper the growth of hair transplant market over the projected time period.\n\nBy Therapy\nPlatelet Rich Plasma (PRP) therapy is expected to dominate the global hair transplant market over the entire forecast period. Increasing practices of this therapies for hair loss treatment will further lead to increased market growth opportunities in coming years. According to recent stats by International Society of Hair Restoration Surgery (ISHRS), around 58.8% patients were given PRP as a therapy during their hair transplant process. Rising adoption, coupled with the therapy’s efficiency will further promote faster healing along with very low scarring after the procedure, which will further result in the escalating PRP therapy demand during the projected period.\n\nBy Region\nNorth America hair transplant market is expected to hold the prime share, majorly contributed by the U.S. over the projected period. Rising various hair transplant surgeries including FUT and FUE treatments, along with their high success rates are majorly driving the U.S. hair transplant market over the projected years. Rising cases of hair loss problems in the U.S., among both male and female will further foster the growth of the U.S. market. American Academy of Dermatology states that hereditary hair loss is one of the common causes for hair loss, which affects more than 80 million population in the U.S. alone. Moreover, additional factors such as stressful life, dandruff, smoking, along with consumption of unhygienic fast food will further lead to the growth of hair loss cases, thus triggering the hair transplant market growth.\n\nFor more information about this report @ https://www.insightsandreports.com/industry-reports/hair-transplant-market \n\nCompetitive Landscape\nSome of the prominent players in the global hair transplant market include Beiersdorf AG, Allergan Plc, L'Oreal SA, Bosley, MEDICAMAT, Lumenis Inc, Restoration Robotics Inc., PhotoMedex Inc., and Solta Medical, Inc. among several others.\nThese players have implemented many strategic moves to develop the treatment areas which have the potential to help the market to grow. Moreover, new product launches, along with increasing R&D activities to reduce the side effects of hair transplantation surgeries have increased, and this will further help the key player’s capabilities to sustain in the global market, thus providing better results to the customers.\n\nAbout Us:\nInsights and Reports is a research and consulting group assisting the clients with 360-degree insights with real time qualitative and quantitative information. The Insights and Reports team is valued for continuous client-oriented services. Our data scientists monitor the markets pertaining to their expertise on a daily basis with the help of 150+ analysts to back them with accurate market studies.\n\nContact Us: \nMr.Saby\nInsights And Reports,\n2201 Cooperative Way #600, \nHerndon, VA 20171, USA.\nTel: +1 703 574 4447\nEmail:[email protected]",
"json_metadata": "{\"tags\":[\"global\",\"hair\",\"transplant\",\"market\"],\"links\":[\"https://www.insightsandreports.com/request-sample/209\",\"https://www.insightsandreports.com/industry-reports/hair-transplant-market\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}"
}
]
}2018/10/12 06:43:00
2018/10/12 06:43:00
| parent author | |
| parent permlink | anti-snoring |
| author | annasmith |
| permlink | anti-snoring-devices-and-snoring-surgery-market-recent-developments-and-new-market-players-or-trends-and-forecast-2017-2025 |
| title | Anti-Snoring Devices And Snoring Surgery Market – Recent Developments and New Market Players | Trends And Forecast, 2017-2025 |
| body | Snoring is a sleeping disorder that occurs when there is a hindrance in the passage of air flow from throat and nasal tract due to thickening of carotid arteries walls, resulting in noise while sleeping. Snoring can have many negative impacts on an individual’s health such as stroke, atrial fibrillation and severe cardiovascular diseases; hence the market for anti-snoring devices and surgeries developed to treat snoring is witnessing a steep rise globally. Market Dynamics The rising awareness towards the hazardous health effects of snoring across developed nations has escalated the demand for anti-snoring treatments in the market. The increase in the number of alcohol and cigarette consuming population, who suffer from snoring problems at some point in their life, is also a major factor to foster the growth of this market. According to the World Health Organization (WHO), per capita alcohol consumption in half of the member countries of WHO such as USA, U.K, Russia, Ukraine, Kenya, Georgia, etc is expected to witness a continuous rise up until 2025. Request for a sample copy of this report @ https://www.insightsandreports.com/request-sample/159 Significant increase in the percentage of obese population across developed nations has been predicted by Organization for Economic Co-operation And Development (OECD). It has been estimated that by the year 2030 the percentage of obese population in United States, Mexico and England will reach to 47%, 39% and 35% respectively. Obese population being prone to catch sleeping disorders and snoring more rapidly are one of the major escalating factors for anti-snoring device and snoring surgery market globally. However, complications associated with snoring surgeries, high cost of surgery and anti-snoring devices and lack of awareness about the severity of the problems associated with snoring are some of the restricting factors for the growth of anti-snoring treatment market. The anti-snoring device market is anticipated to grow more strongly than the snoring surgery market during forecast period because of the ease of use for patientsas well as the presence of products like SnoreRX, ZQuite, VitalSleep, etc that have been recognized as most promising devices to treat snoring. Fastest Growing Device Market Market for oral appliances is growing at a faster pace and is segmented into Tongue-stabilizing devices (TSDs) and Mandibular advancement devices (MAD). TSD can be preferred over any other anti-snoring device by patients suffering from dental issues, as it does not cause discomfort to jaw as well as do not cause tooth shifting. One major benefit of mouthpieces especially TSDs are, they can be used just after removing from the box and does not require any extra-fittings. Nasal strips are also one of the popular anti-snoring devices as they are easy to use. In surgery, Pillar procedure, Radiofrequency Palatoplasty and Uvulopalatopharyngoplastyare the most common and popular segments that promise an effective cure from snoring. The reason for popularity of these surgery types can be contributed to low cost, fewer complications, faster recovery and less pain caused during the surgery. Regional Segment Analysis On the basis of region, North America has been anticipated to hold the largest share in the anti-snoring device and snoring surgery market due to presence of a large number of market players as well as growing awareness towards ill-effects of sleep apnea and snoring. American Sleep Foundation has evaluated that in the year 2017, around 28 % (90 million) of the total American population was suffering from different kind of respiratory disorders that leads to snoring and hence leaves the country with largest number of people suffering from snoring. Recent Developments and New Market Players Alongwith well-established companies like ZenSleep and Zelegent, Inc startup companies like assistENT (U.S.) who has launched products like N-stent at a price as low as $4, has established North America a leader in the global market for anti-snoring treatment solutions. Approval by Conformité Européene (CE) on Commercialization of Snoozeal (anti-snoring and sleep apnea device) was a major step to escalate the market growth of anti-snoring devices in Europe. Rising health issues related to sleep and respiratory disorders in Asian countries like China and India holds a considerable scope for growth of anti-snoring device and surgery market in the upcoming years. According to Chinese Sleep Research Society, in 2016 around 300 million Chinese population was suffering from one or another type of sleep disorders. With the arrival of companies like VVFly that manufactured snoring aid called “Snore circle”, a positive market growth for this industry can be anticipated in China. For more information about this report @ https://www.insightsandreports.com/industry-reports/anti-snoring-devices-and-snoring-surgery-market Major Market Players Key players operating in this market are Airway Management Inc (U.S.), Sleeping Well, LLC (U.S.), Glaxosmithkline PLC (U.K), GE Healthcare (U.S.), (U.K.),Meditas Ltd (U.K.)The Pure Sleep Company (U.S.), Somnomed Limited (Australia), Apnea Sciences Corporation (U.S.), Theravent, Inc.(U.S.), ResMed, Inc (U.S.), and Sleep Well Enjoy Life, Ltd. About Us: Insights and Reports is a research and consulting group assisting the clients with 360-degree insights with real time qualitative and quantitative information. The Insights and Reports team is valued for continuous client-oriented services. Our data scientists monitor the markets pertaining to their expertise on a daily basis with the help of 150+ analysts to back them with accurate market studies. Contact Us: Mr.Saby Insights And Reports, 2201 Cooperative Way #600, Herndon, VA 20171, USA. Tel: +1 703 574 4447 Email:[email protected] |
| json metadata | {"tags":["anti-snoring","devices","snoring","surgery","market"],"links":["https://www.insightsandreports.com/request-sample/159","https://www.insightsandreports.com/industry-reports/anti-snoring-devices-and-snoring-surgery-market"],"app":"steemit/0.1","format":"markdown"} |
| Transaction Info | Block #26735901/Trx 2fe2a832c1a5dbbc7bbf512f44408e7a450cc951 |
View Raw JSON Data
{
"trx_id": "2fe2a832c1a5dbbc7bbf512f44408e7a450cc951",
"block": 26735901,
"trx_in_block": 2,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-10-12T06:43:00",
"op": [
"comment",
{
"parent_author": "",
"parent_permlink": "anti-snoring",
"author": "annasmith",
"permlink": "anti-snoring-devices-and-snoring-surgery-market-recent-developments-and-new-market-players-or-trends-and-forecast-2017-2025",
"title": "Anti-Snoring Devices And Snoring Surgery Market – Recent Developments and New Market Players | Trends And Forecast, 2017-2025",
"body": "Snoring is a sleeping disorder that occurs when there is a hindrance in the passage of air flow from throat and nasal tract due to thickening of carotid arteries walls, resulting in noise while sleeping. Snoring can have many negative impacts on an individual’s health such as stroke, atrial fibrillation and severe cardiovascular diseases; hence the market for anti-snoring devices and surgeries developed to treat snoring is witnessing a steep rise globally.\n\nMarket Dynamics\nThe rising awareness towards the hazardous health effects of snoring across developed nations has escalated the demand for anti-snoring treatments in the market. The increase in the number of alcohol and cigarette consuming population, who suffer from snoring problems at some point in their life, is also a major factor to foster the growth of this market. According to the World Health Organization (WHO), per capita alcohol consumption in half of the member countries of WHO such as USA, U.K, Russia, Ukraine, Kenya, Georgia, etc is expected to witness a continuous rise up until 2025.\n\nRequest for a sample copy of this report @ https://www.insightsandreports.com/request-sample/159 \n\nSignificant increase in the percentage of obese population across developed nations has been predicted by Organization for Economic Co-operation And Development (OECD). It has been estimated that by the year 2030 the percentage of obese population in United States, Mexico and England will reach to 47%, 39% and 35% respectively. Obese population being prone to catch sleeping disorders and snoring more rapidly are one of the major escalating factors for anti-snoring device and snoring surgery market globally. However, complications associated with snoring surgeries, high cost of surgery and anti-snoring devices and lack of awareness about the severity of the problems associated with snoring are some of the restricting factors for the growth of anti-snoring treatment market.\nThe anti-snoring device market is anticipated to grow more strongly than the snoring surgery market during forecast period because of the ease of use for patientsas well as the presence of products like SnoreRX, ZQuite, VitalSleep, etc that have been recognized as most promising devices to treat snoring.\n\nFastest Growing Device Market\nMarket for oral appliances is growing at a faster pace and is segmented into Tongue-stabilizing devices (TSDs) and Mandibular advancement devices (MAD). TSD can be preferred over any other anti-snoring device by patients suffering from dental issues, as it does not cause discomfort to jaw as well as do not cause tooth shifting. One major benefit of mouthpieces especially TSDs are, they can be used just after removing from the box and does not require any extra-fittings. Nasal strips are also one of the popular anti-snoring devices as they are easy to use.\nIn surgery, Pillar procedure, Radiofrequency Palatoplasty and Uvulopalatopharyngoplastyare the most common and popular segments that promise an effective cure from snoring. The reason for popularity of these surgery types can be contributed to low cost, fewer complications, faster recovery and less pain caused during the surgery.\n\nRegional Segment Analysis\nOn the basis of region, North America has been anticipated to hold the largest share in the anti-snoring device and snoring surgery market due to presence of a large number of market players as well as growing awareness towards ill-effects of sleep apnea and snoring. American Sleep Foundation has evaluated that in the year 2017, around 28 % (90 million) of the total American population was suffering from different kind of respiratory disorders that leads to snoring and hence leaves the country with largest number of people suffering from snoring.\n\nRecent Developments and New Market Players\nAlongwith well-established companies like ZenSleep and Zelegent, Inc startup companies like assistENT (U.S.) who has launched products like N-stent at a price as low as $4, has established North America a leader in the global market for anti-snoring treatment solutions. Approval by Conformité Européene (CE) on Commercialization of Snoozeal (anti-snoring and sleep apnea device) was a major step to escalate the market growth of anti-snoring devices in Europe.\nRising health issues related to sleep and respiratory disorders in Asian countries like China and India holds a considerable scope for growth of anti-snoring device and surgery market in the upcoming years. According to Chinese Sleep Research Society, in 2016 around 300 million Chinese population was suffering from one or another type of sleep disorders. With the arrival of companies like VVFly that manufactured snoring aid called “Snore circle”, a positive market growth for this industry can be anticipated in China.\n\nFor more information about this report @ https://www.insightsandreports.com/industry-reports/anti-snoring-devices-and-snoring-surgery-market \n\nMajor Market Players\nKey players operating in this market are Airway Management Inc (U.S.), Sleeping Well, LLC (U.S.), Glaxosmithkline PLC (U.K), GE Healthcare (U.S.), (U.K.),Meditas Ltd (U.K.)The Pure Sleep Company (U.S.), Somnomed Limited (Australia), Apnea Sciences Corporation (U.S.), Theravent, Inc.(U.S.), ResMed, Inc (U.S.), and Sleep Well Enjoy Life, Ltd.\n\nAbout Us:\nInsights and Reports is a research and consulting group assisting the clients with 360-degree insights with real time qualitative and quantitative information. The Insights and Reports team is valued for continuous client-oriented services. Our data scientists monitor the markets pertaining to their expertise on a daily basis with the help of 150+ analysts to back them with accurate market studies.\n\nContact Us: \nMr.Saby\nInsights And Reports,\n2201 Cooperative Way #600, \nHerndon, VA 20171, USA.\nTel: +1 703 574 4447\nEmail:[email protected]",
"json_metadata": "{\"tags\":[\"anti-snoring\",\"devices\",\"snoring\",\"surgery\",\"market\"],\"links\":[\"https://www.insightsandreports.com/request-sample/159\",\"https://www.insightsandreports.com/industry-reports/anti-snoring-devices-and-snoring-surgery-market\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}"
}
]
}2018/10/11 05:52:15
2018/10/11 05:52:15
| voter | amponcut |
| author | annasmith |
| permlink | apac-cast-and-splints-market-overview-global-industry-insights-analysis-trends-and-forecast-2017-2025 |
| weight | 10000 (100.00%) |
| Transaction Info | Block #26706131/Trx 1225f017d13e1d0e2cb589c050b94a3a2aba6ce7 |
View Raw JSON Data
{
"trx_id": "1225f017d13e1d0e2cb589c050b94a3a2aba6ce7",
"block": 26706131,
"trx_in_block": 2,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-10-11T05:52:15",
"op": [
"vote",
{
"voter": "amponcut",
"author": "annasmith",
"permlink": "apac-cast-and-splints-market-overview-global-industry-insights-analysis-trends-and-forecast-2017-2025",
"weight": 10000
}
]
}2018/10/11 05:51:33
2018/10/11 05:51:33
| parent author | |
| parent permlink | apac |
| author | annasmith |
| permlink | apac-cast-and-splints-market-overview-global-industry-insights-analysis-trends-and-forecast-2017-2025 |
| title | APAC Cast and Splints Market Overview – Global Industry Insights, Analysis, Trends and Forecast 2017 – 2025 |
| body | APAC Cast and Splints Market: Introduction Casting refers to bone setting equipment commonly used for fractures having low complications. Casting are generally used for closed fractures, non-displaced fractures or often used when the fracture have been reduced. Splints are used during soft tissue injuries such as sprain, tendonitis, and joint dislocation or during complex bone fractures. Splints are generally used for open and displaced fractures or during surgery where large amount of swelling occurs. Request for a sample copy of this report @ https://www.insightsandreports.com/request-sample/82 Market Dynamics Growing incidence of pathological fractures such as osteogenesis imperfect and osteoporosis, stands to be driving the demand for casts and splints market in this region. For instance, osteoporosis, considered to be one of the most common cause of pathological fracture is on a rise in countries such as China and India. For instance, according to International Osteoporosis Foundation, it was estimated that over 50 million people were found to be either osteoporotic or have low bone mass in India. Other than this, rising bone cancer cases in this part of the region is further expected to drive the market growth. Products Insights In terms of materials, plaster casts are expected to be one of the major markets owing to its wide availability and low cost. However, fiberglass casts are expected to witness higher growth rate during the forecast period due to the factors such as being breathable, lightweight and offer higher durability. The splints segment is anticipated to have significant growth over the projected period owing to its easy manufacturing, and ease to use. Furthermore, they can be easily loosened or tightened according to the need. These splints are widely available in different shapes and sizes. It can also be customized according to the patient’s need. However, it provides lesser support than cast thereby known as half cast. Thus, owing to which the demand for splints is lower than casts. Regional Insights Casting and splinting in APAC is expected to offer lucrative growth opportunity during the forecast period owing to rising incidences of pathological and traumatic fractures. Additionally, development of bone injuries due to ageing and rising obesity among the populous leading to decrease in bone density and resulting in fracture of bones is further driving the demand for casts and splints market over the forecast period. As per Association for Safe International Road Travel, approximately 1.17 million out of 1.3 million road accidents occur in Asia and Africa region. Furthermore, Asia is perceived to have approximately 50% of osteoporotic population of the world’s population by the end of 2050, as per International Osteoporotic Foundation. Additionally, there are wide number of unreported cases of accidents. Low intake of calcium by the people in Asia is expected to contribute significant revenue growth in the global market. Numerous companies in this region provide quality casts and splints which includes Utanco India, Tynor, Darco Medical India, Shaanxi Ansen Medical technology Development Co., Ltd., Beijing Jinwei Kangda medical Instrument Ltd., Shandong Zhushitang Medical devices Co., Ltd., Qingdo carong Import & Export Co., Ltd., Suzhou Sunmed Co., Ltd. Jining kanglida Medical technology Co., Ltd Jinan reloga medical Equipment Co., Ltd, and several others. For more information about this report @ https://www.insightsandreports.com/industry-reports/apac-cast-and-splints-market Competitive Landscape Focus on R&D is further expected to create new growth opportunities in this market. For instance, the Woodcast, a mouldable material made from sustainable wood chips and biodegradable plastic manufactured by Onbone Oy is under trail in New Zealand. Some of the key leading players in the market include 3M Company, Stryker Corporation, BSN Medical GMBH, Ossur H.F., and Prime Medical. About Us: Insights and Reports is a research and consulting group assisting the clients with 360-degree insights with real time qualitative and quantitative information. The Insights and Reports team is valued for continuous client-oriented services. Our data scientists monitor the markets pertaining to their expertise on a daily basis with the help of 150+ analysts to back them with accurate market studies. Contact Us: Mr.Saby Insights And Reports, 2201 Cooperative Way #600, Herndon, VA 20171, USA. Tel: +1 703 574 4447 Email:[email protected] |
| json metadata | {"tags":["apac","cast","and","splints","market"],"links":["https://www.insightsandreports.com/request-sample/82","https://www.insightsandreports.com/industry-reports/apac-cast-and-splints-market"],"app":"steemit/0.1","format":"markdown"} |
| Transaction Info | Block #26706117/Trx e46a7a13f0b5bf86e3a47547050b9776a43e0744 |
View Raw JSON Data
{
"trx_id": "e46a7a13f0b5bf86e3a47547050b9776a43e0744",
"block": 26706117,
"trx_in_block": 29,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-10-11T05:51:33",
"op": [
"comment",
{
"parent_author": "",
"parent_permlink": "apac",
"author": "annasmith",
"permlink": "apac-cast-and-splints-market-overview-global-industry-insights-analysis-trends-and-forecast-2017-2025",
"title": "APAC Cast and Splints Market Overview – Global Industry Insights, Analysis, Trends and Forecast 2017 – 2025",
"body": "APAC Cast and Splints Market: Introduction\nCasting refers to bone setting equipment commonly used for fractures having low complications. Casting are generally used for closed fractures, non-displaced fractures or often used when the fracture have been reduced. Splints are used during soft tissue injuries such as sprain, tendonitis, and joint dislocation or during complex bone fractures. Splints are generally used for open and displaced fractures or during surgery where large amount of swelling occurs.\n\nRequest for a sample copy of this report @ https://www.insightsandreports.com/request-sample/82 \n\nMarket Dynamics\nGrowing incidence of pathological fractures such as osteogenesis imperfect and osteoporosis, stands to be driving the demand for casts and splints market in this region. For instance, osteoporosis, considered to be one of the most common cause of pathological fracture is on a rise in countries such as China and India. For instance, according to International Osteoporosis Foundation, it was estimated that over 50 million people were found to be either osteoporotic or have low bone mass in India. Other than this, rising bone cancer cases in this part of the region is further expected to drive the market growth.\n\nProducts Insights\nIn terms of materials, plaster casts are expected to be one of the major markets owing to its wide availability and low cost. However, fiberglass casts are expected to witness higher growth rate during the forecast period due to the factors such as being breathable, lightweight and offer higher durability.\nThe splints segment is anticipated to have significant growth over the projected period owing to its easy manufacturing, and ease to use. Furthermore, they can be easily loosened or tightened according to the need. These splints are widely available in different shapes and sizes. It can also be customized according to the patient’s need. However, it provides lesser support than cast thereby known as half cast. Thus, owing to which the demand for splints is lower than casts.\n\nRegional Insights\nCasting and splinting in APAC is expected to offer lucrative growth opportunity during the forecast period owing to rising incidences of pathological and traumatic fractures. Additionally, development of bone injuries due to ageing and rising obesity among the populous leading to decrease in bone density and resulting in fracture of bones is further driving the demand for casts and splints market over the forecast period. As per Association for Safe International Road Travel, approximately 1.17 million out of 1.3 million road accidents occur in Asia and Africa region. Furthermore, Asia is perceived to have approximately 50% of osteoporotic population of the world’s population by the end of 2050, as per International Osteoporotic Foundation. Additionally, there are wide number of unreported cases of accidents. Low intake of calcium by the people in Asia is expected to contribute significant revenue growth in the global market. Numerous companies in this region provide quality casts and splints which includes Utanco India, Tynor, Darco Medical India, Shaanxi Ansen Medical technology Development Co., Ltd., Beijing Jinwei Kangda medical Instrument Ltd., Shandong Zhushitang Medical devices Co., Ltd., Qingdo carong Import & Export Co., Ltd., Suzhou Sunmed Co., Ltd. Jining kanglida Medical technology Co., Ltd Jinan reloga medical Equipment Co., Ltd, and several others.\n\nFor more information about this report @ https://www.insightsandreports.com/industry-reports/apac-cast-and-splints-market \n\nCompetitive Landscape\nFocus on R&D is further expected to create new growth opportunities in this market. For instance, the Woodcast, a mouldable material made from sustainable wood chips and biodegradable plastic manufactured by Onbone Oy is under trail in New Zealand. Some of the key leading players in the market include 3M Company, Stryker Corporation, BSN Medical GMBH, Ossur H.F., and Prime Medical.\n\nAbout Us:\nInsights and Reports is a research and consulting group assisting the clients with 360-degree insights with real time qualitative and quantitative information. The Insights and Reports team is valued for continuous client-oriented services. Our data scientists monitor the markets pertaining to their expertise on a daily basis with the help of 150+ analysts to back them with accurate market studies.\n\nContact Us: \nMr.Saby\nInsights And Reports,\n 2201 Cooperative Way #600, \nHerndon, VA 20171, USA.\nTel: +1 703 574 4447\nEmail:[email protected]",
"json_metadata": "{\"tags\":[\"apac\",\"cast\",\"and\",\"splints\",\"market\"],\"links\":[\"https://www.insightsandreports.com/request-sample/82\",\"https://www.insightsandreports.com/industry-reports/apac-cast-and-splints-market\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}"
}
]
}2018/10/10 06:28:12
2018/10/10 06:28:12
| voter | modemser |
| author | annasmith |
| permlink | global-robotic-navigation-needle-surgery-market-analysis-by-share-future-trends-application-and-opportunity-assessment-2025 |
| weight | 2300 (23.00%) |
| Transaction Info | Block #26678067/Trx 73945ca192a2de346ccb7f63299394506f860671 |
View Raw JSON Data
{
"trx_id": "73945ca192a2de346ccb7f63299394506f860671",
"block": 26678067,
"trx_in_block": 10,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-10-10T06:28:12",
"op": [
"vote",
{
"voter": "modemser",
"author": "annasmith",
"permlink": "global-robotic-navigation-needle-surgery-market-analysis-by-share-future-trends-application-and-opportunity-assessment-2025",
"weight": 2300
}
]
}2018/10/10 06:25:03
2018/10/10 06:25:03
| parent author | |
| parent permlink | robotic |
| author | annasmith |
| permlink | global-robotic-navigation-needle-surgery-market-analysis-by-share-future-trends-application-and-opportunity-assessment-2025 |
| title | Global Robotic Navigation Needle Surgery Market- Analysis by Share, Future Trends, Application and Opportunity Assessment 2025 |
| body | @@ -882,16 +882,17 @@ test.%0A%0A +%0A Request |
| json metadata | {"tags":["robotic","navigation","needle","surgery","market"],"links":["https://www.insightsandreports.com/request-sample/260","https://www.insightsandreports.com/industry-reports/robotic-navigation-needle-surgery-market"],"app":"steemit/0.1","format":"markdown"} |
| Transaction Info | Block #26678004/Trx 69c94c8d3ebd18a6ca37b110d14bffa03174471a |
View Raw JSON Data
{
"trx_id": "69c94c8d3ebd18a6ca37b110d14bffa03174471a",
"block": 26678004,
"trx_in_block": 10,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-10-10T06:25:03",
"op": [
"comment",
{
"parent_author": "",
"parent_permlink": "robotic",
"author": "annasmith",
"permlink": "global-robotic-navigation-needle-surgery-market-analysis-by-share-future-trends-application-and-opportunity-assessment-2025",
"title": "Global Robotic Navigation Needle Surgery Market- Analysis by Share, Future Trends, Application and Opportunity Assessment 2025",
"body": "@@ -882,16 +882,17 @@\n test.%0A%0A\n+%0A\n Request \n",
"json_metadata": "{\"tags\":[\"robotic\",\"navigation\",\"needle\",\"surgery\",\"market\"],\"links\":[\"https://www.insightsandreports.com/request-sample/260\",\"https://www.insightsandreports.com/industry-reports/robotic-navigation-needle-surgery-market\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}"
}
]
}2018/10/10 06:23:27
2018/10/10 06:23:27
| voter | hackerzizon |
| author | annasmith |
| permlink | global-robotic-navigation-needle-surgery-market-analysis-by-share-future-trends-application-and-opportunity-assessment-2025 |
| weight | 100 (1.00%) |
| Transaction Info | Block #26677972/Trx d987e034a35245e19bbe05c181f6c278239be719 |
View Raw JSON Data
{
"trx_id": "d987e034a35245e19bbe05c181f6c278239be719",
"block": 26677972,
"trx_in_block": 1,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-10-10T06:23:27",
"op": [
"vote",
{
"voter": "hackerzizon",
"author": "annasmith",
"permlink": "global-robotic-navigation-needle-surgery-market-analysis-by-share-future-trends-application-and-opportunity-assessment-2025",
"weight": 100
}
]
}2018/10/10 06:22:39
2018/10/10 06:22:39
| parent author | |
| parent permlink | robotic |
| author | annasmith |
| permlink | global-robotic-navigation-needle-surgery-market-analysis-by-share-future-trends-application-and-opportunity-assessment-2025 |
| title | Global Robotic Navigation Needle Surgery Market- Analysis by Share, Future Trends, Application and Opportunity Assessment 2025 |
| body | Robotic Navigation Needle Surgery Market: Introduction Needle navigation and steering technology are based on an innovative approach of five degrees-of-freedom robot, and provide ongoing needle path calculation, and real-time closed-loop control. This technology relies on the automated robot that uses the real-time computed tomography (CT) data, with the robot simultaneously for the adjustment of the needle angle. The needle adjustment will be based on the live-information, which will be received from the CT machine. It is five degrees-of-freedom needle steering an insertion system, comprises of a patient-mounted robot, a control unit that is connected to CT and robot, and a workstation for observation. This system primarily allows the radiologists to organize the procedure and under the control of radiologists’, the robot will perform the needle insertion and steering test. Request for a sample copy of this report @ https://www.insightsandreports.com/request-sample/260 By Applications The market is segmented based on the applications as biopsy, brachytherapy, ablation, electrical stimulation, drug delivery, and others. The market is in the nascent stage thus, the testing is being done before it is being used in any of this application. This technology is primarily being develop for biopsies and ablations, or to inject medications in specific areas of the body. As, in the present for biopsies the manual navigation of needles is used and for critical processes such as tumor ablation, or abscess drainage, the needle-based tools are used. These process require high expertise level and are guided by imaging technologies. This technology possess various challenge such as precise needle course in 3D to avoid damage while simultaneously managing to compensate for target movement due to patient movement. Thus, this system has been developed to overcome such challenges and it is expected that the first application of this technology will be used for biopsies of lung tissue. This system has recently received CE Mark approval and will be used for CT-guided procedures in the abdomen. In addition, it is anticipated that the system's application will expand in clinical centers and with other imaging modality includes Fluoroscopy, and Cone-Beam CT, and for lung and spinal procedures during the forecast period. In addition, with the growing number of biopsies is predicted to drive the market in the coming years. Regional Insights Based on the regional presence, the market has been categorized as North America, Latin America, Europe, APAC, and MEA. North America is anticipated to dominate the market for needle navigation system due to the lucrative opportunities of advanced technologies and advanced healthcare facilities such as cancer nanotherapy, surgical robots, and others. Europe is expected to witness high growth rate as the Needle navigation and steering technology has been approved by the European Union and has introduced needle steering and insertion system for percutaneous procedures that include ablations, and biopsies. This robotic device provides physicians with an accurate and specific way of handling needles and moving them toward targets. In addition, the market in APAC and MEA is expected to witness high CAGR due to the increase in healthcare expenditure by 10-12 percent when compared to previous year and emerging medical technology companies such as Admedus Ltd, Allegra Orthopaedics, and Atlas Surgical during the forecast years. For more information about this report @ https://www.insightsandreports.com/industry-reports/robotic-navigation-needle-surgery-market Competitive Landscape The market is in the nascent stage and is expected to accelerate the market growth during the forecast period. This system was invented by XACT Robotics, a start-up company which was founded in the year 2013. The company has developed a robotic navigation and steering solution for biopsies and ablations. The system will precisely monitor the affected area in the body and will perform percutaneous image-guided procedures with modalities. In addition, in 2018, robotic navigation and steering solution has received the CE approval for percutaneous procedures like biopsies and ablations. About Us: Insights and Reports is a research and consulting group assisting the clients with 360-degree insights with real time qualitative and quantitative information. The Insights and Reports team is valued for continuous client-oriented services. Our data scientists monitor the markets pertaining to their expertise on a daily basis with the help of 150+ analysts to back them with accurate market studies. Contact Us: Mr.Saby Insights And Reports, 2201 Cooperative Way #600, Herndon, VA 20171, USA. Tel: +1 703 574 4447 Email:[email protected] |
| json metadata | {"tags":["robotic","navigation","needle","surgery","market"],"links":["https://www.insightsandreports.com/request-sample/260","https://www.insightsandreports.com/industry-reports/robotic-navigation-needle-surgery-market"],"app":"steemit/0.1","format":"markdown"} |
| Transaction Info | Block #26677956/Trx 7a118ca264330f9f9115295002621b7d8eabcb79 |
View Raw JSON Data
{
"trx_id": "7a118ca264330f9f9115295002621b7d8eabcb79",
"block": 26677956,
"trx_in_block": 9,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-10-10T06:22:39",
"op": [
"comment",
{
"parent_author": "",
"parent_permlink": "robotic",
"author": "annasmith",
"permlink": "global-robotic-navigation-needle-surgery-market-analysis-by-share-future-trends-application-and-opportunity-assessment-2025",
"title": "Global Robotic Navigation Needle Surgery Market- Analysis by Share, Future Trends, Application and Opportunity Assessment 2025",
"body": "Robotic Navigation Needle Surgery Market: Introduction\nNeedle navigation and steering technology are based on an innovative approach of five degrees-of-freedom robot, and provide ongoing needle path calculation, and real-time closed-loop control. This technology relies on the automated robot that uses the real-time computed tomography (CT) data, with the robot simultaneously for the adjustment of the needle angle. The needle adjustment will be based on the live-information, which will be received from the CT machine.\nIt is five degrees-of-freedom needle steering an insertion system, comprises of a patient-mounted robot, a control unit that is connected to CT and robot, and a workstation for observation. This system primarily allows the radiologists to organize the procedure and under the control of radiologists’, the robot will perform the needle insertion and steering test.\n\nRequest for a sample copy of this report @ https://www.insightsandreports.com/request-sample/260 \n\nBy Applications\nThe market is segmented based on the applications as biopsy, brachytherapy, ablation, electrical stimulation, drug delivery, and others. The market is in the nascent stage thus, the testing is being done before it is being used in any of this application. This technology is primarily being develop for biopsies and ablations, or to inject medications in specific areas of the body. As, in the present for biopsies the manual navigation of needles is used and for critical processes such as tumor ablation, or abscess drainage, the needle-based tools are used. These process require high expertise level and are guided by imaging technologies. This technology possess various challenge such as precise needle course in 3D to avoid damage while simultaneously managing to compensate for target movement due to patient movement. Thus, this system has been developed to overcome such challenges and it is expected that the first application of this technology will be used for biopsies of lung tissue. \nThis system has recently received CE Mark approval and will be used for CT-guided procedures in the abdomen. In addition, it is anticipated that the system's application will expand in clinical centers and with other imaging modality includes Fluoroscopy, and Cone-Beam CT, and for lung and spinal procedures during the forecast period. In addition, with the growing number of biopsies is predicted to drive the market in the coming years.\n\nRegional Insights\nBased on the regional presence, the market has been categorized as North America, Latin America, Europe, APAC, and MEA. North America is anticipated to dominate the market for needle navigation system due to the lucrative opportunities of advanced technologies and advanced healthcare facilities such as cancer nanotherapy, surgical robots, and others. Europe is expected to witness high growth rate as the Needle navigation and steering technology has been approved by the European Union and has introduced needle steering and insertion system for percutaneous procedures that include ablations, and biopsies. This robotic device provides physicians with an accurate and specific way of handling needles and moving them toward targets. In addition, the market in APAC and MEA is expected to witness high CAGR due to the increase in healthcare expenditure by 10-12 percent when compared to previous year and emerging medical technology companies such as Admedus Ltd, Allegra Orthopaedics, and Atlas Surgical during the forecast years.\n\nFor more information about this report @ https://www.insightsandreports.com/industry-reports/robotic-navigation-needle-surgery-market \n\n\nCompetitive Landscape\nThe market is in the nascent stage and is expected to accelerate the market growth during the forecast period. This system was invented by XACT Robotics, a start-up company which was founded in the year 2013. The company has developed a robotic navigation and steering solution for biopsies and ablations. The system will precisely monitor the affected area in the body and will perform percutaneous image-guided procedures with modalities. In addition, in 2018, robotic navigation and steering solution has received the CE approval for percutaneous procedures like biopsies and ablations.\n\nAbout Us:\nInsights and Reports is a research and consulting group assisting the clients with 360-degree insights with real time qualitative and quantitative information. The Insights and Reports team is valued for continuous client-oriented services. Our data scientists monitor the markets pertaining to their expertise on a daily basis with the help of 150+ analysts to back them with accurate market studies.\n\nContact Us: \nMr.Saby\nInsights And Reports,\n2201 Cooperative Way #600, \nHerndon, VA 20171, USA.\nTel: +1 703 574 4447\nEmail:[email protected]",
"json_metadata": "{\"tags\":[\"robotic\",\"navigation\",\"needle\",\"surgery\",\"market\"],\"links\":[\"https://www.insightsandreports.com/request-sample/260\",\"https://www.insightsandreports.com/industry-reports/robotic-navigation-needle-surgery-market\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}"
}
]
}2018/10/10 06:13:33
2018/10/10 06:13:33
| voter | hackerzizon |
| author | annasmith |
| permlink | global-x-ray-imaging-systems-market-analysis-by-technology-type-portability-application-and-outlook-2025 |
| weight | 100 (1.00%) |
| Transaction Info | Block #26677774/Trx 9ae076e2b8e94488993f9cb3cfc804d4fcfa92c5 |
View Raw JSON Data
{
"trx_id": "9ae076e2b8e94488993f9cb3cfc804d4fcfa92c5",
"block": 26677774,
"trx_in_block": 4,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-10-10T06:13:33",
"op": [
"vote",
{
"voter": "hackerzizon",
"author": "annasmith",
"permlink": "global-x-ray-imaging-systems-market-analysis-by-technology-type-portability-application-and-outlook-2025",
"weight": 100
}
]
}2018/10/10 06:07:51
2018/10/10 06:07:51
| parent author | |
| parent permlink | x-ray |
| author | annasmith |
| permlink | global-x-ray-imaging-systems-market-analysis-by-technology-type-portability-application-and-outlook-2025 |
| title | Global X-Ray Imaging Systems Market-Analysis by Technology Type, Portability, Application and Outlook 2025 |
| body | X-Ray Imaging Systems Market: Introduction X-ray imaging (radiation) is medical test for analyzing the medical condition of the patient. It is a non-invasive test accomplished by the x-ray imaging systems, which involves the exposure of the body part to tiny dose of ionizing radiation to have a scanned imaged of inner body. For instance, x-ray imaging system can check the broken bones, can spot pneumonia, and can also detect breast cancer. The x-ray imaging systems market is anticipated to grow significantly over the projected period owing to the rising prevalence of the numerous diseases like cardiovascular disease and breast cancer coupled with the rising R&D to bring advancement in the existing technology. Request for a sample copy of this report @ https://www.insightsandreports.com/request-sample/286 Technology enhancement in the x-ray imaging systems The growing enhancements like miniaturization of the systems and upgradation of stationary x-ray imaging systems in the existing x-ray imaging systems is fostering the global x-ray imaging systems market. The invention of mobile x-ray imaging systems is driving the market growth globally due to its wireless connectivity, mobility and image quality. For instance, GE healthcare manufactures next generation mobile x-ray systems with digital imaging capabilities. Thus, it would propel the growth of x-ray imaging systems market. With the advancements in stationary systems such as low dose imaging, storage of the diagnostic image in the form of digital signals, wide area detection and others are anticipated to accelerate the global x-ray imaging system market in the coming years. For instance, IBM Watson Healthcare has introduced CuattroDR™ Digital Radiography, that facilitates the workflow efficiency and provide emphasis on the patient via instant digital imaging acquisition. In addition, in 2015, new advancement in the stationary system has been provided by Siemens. For instance, Siemens Healthcare has introduced the twin robotic x-ray systems. The robotic arms permit the detector and tube to have accurate position, which facilitates the numerous body parts to be 3D x-rayed. Segment Insights Digital x-ray system is expected to have significant market share due to rising adaption of digital x-ray system by the healthcare professional owing to its simpler use and higher quality of x-ray images. Moreover, with high image quality that can be taken on single take and digital images is being provided to patient without any delay, thereby reduces time of the patient. The digital images captured from digital x-ray imaging system are easily manageable, accessed and stored in the software, which highly reduces cost of film and processing chemicals and also reduces the labor requirements. Owing to its various advantages, the global x-ray imaging market is expected to grow significantly during the forecast period. Orthopedics application segment is expected to grow with the highest CAGR during the forecast period, due to the rising prevalence of chronic rheumatic conditions including Rheumatoid Arthritis (RA), Spinal Disorders, Severe limb trauma. According to the World Health Organization, the prevalence of RA lies between 0.3% and 1%, and is the most common type of disease found, especially in women in the developed countries. The rising number of such cases may increase the use of sophisticated and highly advanced x-ray imaging system for diagnostics, thereby increasing the demand growth of the x-ray imaging systems in the x-ray imaging systems market in near future. Regional Outlook North America to hold major share in the x-ray imaging systems market, owing to the rising prevalence of arthritis disease, and is responsible for stiffness, disability and swelling joints which is widely affecting the American people. According to the American College of Rheumatology, estimated arthritis in 54.4 million U.S. adults in 2015. Additionally, by 2040, 78 million U.S. adults aged 18 and above is expected to be diagnosed with arthritis. X-ray imaging systems are widely used to detect the arthritis owing to which it may lead to rise in demand for x-ray imaging systems. Other growth factors for the global x-ray imaging systems market are improved healthcare facilities, growing technology advancement, rising geriatric population and others. Asia Pacific is expected to grow substantially during the forecast period, which is attributable to the transition to digital x-ray imaging systems from analog x-ray systems in the Chinese economy. This transition is due to the policies of the Chinese government to have robust imaging systems which are highly integrated and affordable. This in turn is expecting to fuel the demand for the x-ray imaging systems market in this region. For more information about this report @ https://www.insightsandreports.com/industry-reports/x-ray-imaging-systems-market Competitive Landscape The key players operating in the x-ray imaging systems market are Hitachi Ltd., Samsung, Toshiba Corporation, General Electric Company, Philips N.V., and Siemen AG among others. Technology enhancement and research and development are the underlying growth strategies adapted by numerous companies in x-ray image systems market to expand their businesses. For instance, in 2016, GE Healthcare showcased the advanced magnetic resonance imaging (MRI) system based on SIGNATM platform which ensured productivity and results for customers. Moreover, company also showcased its new x-ray technology named “OptimaTMXR240amx” including flash pad, digital detectors that provides for conducting x-rays. About Us: Insights and Reports is a research and consulting group assisting the clients with 360-degree insights with real time qualitative and quantitative information. The Insights and Reports team is valued for continuous client-oriented services. Our data scientists monitor the markets pertaining to their expertise on a daily basis with the help of 150+ analysts to back them with accurate market studies. Contact Us: Mr.Saby Insights And Reports, 2201 Cooperative Way #600, Herndon, VA 20171, USA. Tel: +1 703 574 4447 Email:[email protected] |
| json metadata | {"tags":["x-ray","imaging","systems","market"],"links":["https://www.insightsandreports.com/request-sample/286","https://www.insightsandreports.com/industry-reports/x-ray-imaging-systems-market"],"app":"steemit/0.1","format":"markdown"} |
| Transaction Info | Block #26677660/Trx 755b12b901f11b059ed3d3a2176f99583a3f504c |
View Raw JSON Data
{
"trx_id": "755b12b901f11b059ed3d3a2176f99583a3f504c",
"block": 26677660,
"trx_in_block": 7,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-10-10T06:07:51",
"op": [
"comment",
{
"parent_author": "",
"parent_permlink": "x-ray",
"author": "annasmith",
"permlink": "global-x-ray-imaging-systems-market-analysis-by-technology-type-portability-application-and-outlook-2025",
"title": "Global X-Ray Imaging Systems Market-Analysis by Technology Type, Portability, Application and Outlook 2025",
"body": "X-Ray Imaging Systems Market: Introduction\nX-ray imaging (radiation) is medical test for analyzing the medical condition of the patient. It is a non-invasive test accomplished by the x-ray imaging systems, which involves the exposure of the body part to tiny dose of ionizing radiation to have a scanned imaged of inner body. For instance, x-ray imaging system can check the broken bones, can spot pneumonia, and can also detect breast cancer. The x-ray imaging systems market is anticipated to grow significantly over the projected period owing to the rising prevalence of the numerous diseases like cardiovascular disease and breast cancer coupled with the rising R&D to bring advancement in the existing technology.\n\nRequest for a sample copy of this report @ https://www.insightsandreports.com/request-sample/286 \nTechnology enhancement in the x-ray imaging systems\nThe growing enhancements like miniaturization of the systems and upgradation of stationary x-ray imaging systems in the existing x-ray imaging systems is fostering the global x-ray imaging systems market. The invention of mobile x-ray imaging systems is driving the market growth globally due to its wireless connectivity, mobility and image quality. For instance, GE healthcare manufactures next generation mobile x-ray systems with digital imaging capabilities. Thus, it would propel the growth of x-ray imaging systems market.\nWith the advancements in stationary systems such as low dose imaging, storage of the diagnostic image in the form of digital signals, wide area detection and others are anticipated to accelerate the global x-ray imaging system market in the coming years. For instance, IBM Watson Healthcare has introduced CuattroDR™ Digital Radiography, that facilitates the workflow efficiency and provide emphasis on the patient via instant digital imaging acquisition. In addition, in 2015, new advancement in the stationary system has been provided by Siemens. For instance, Siemens Healthcare has introduced the twin robotic x-ray systems. The robotic arms permit the detector and tube to have accurate position, which facilitates the numerous body parts to be 3D x-rayed.\n\nSegment Insights\nDigital x-ray system is expected to have significant market share due to rising adaption of digital x-ray system by the healthcare professional owing to its simpler use and higher quality of x-ray images. Moreover, with high image quality that can be taken on single take and digital images is being provided to patient without any delay, thereby reduces time of the patient. The digital images captured from digital x-ray imaging system are easily manageable, accessed and stored in the software, which highly reduces cost of film and processing chemicals and also reduces the labor requirements. Owing to its various advantages, the global x-ray imaging market is expected to grow significantly during the forecast period.\nOrthopedics application segment is expected to grow with the highest CAGR during the forecast period, due to the rising prevalence of chronic rheumatic conditions including Rheumatoid Arthritis (RA), Spinal Disorders, Severe limb trauma. According to the World Health Organization, the prevalence of RA lies between 0.3% and 1%, and is the most common type of disease found, especially in women in the developed countries. The rising number of such cases may increase the use of sophisticated and highly advanced x-ray imaging system for diagnostics, thereby increasing the demand growth of the x-ray imaging systems in the x-ray imaging systems market in near future.\n\n\n\nRegional Outlook\nNorth America to hold major share in the x-ray imaging systems market, owing to the rising prevalence of arthritis disease, and is responsible for stiffness, disability and swelling joints which is widely affecting the American people. According to the American College of Rheumatology, estimated arthritis in 54.4 million U.S. adults in 2015. Additionally, by 2040, 78 million U.S. adults aged 18 and above is expected to be diagnosed with arthritis. X-ray imaging systems are widely used to detect the arthritis owing to which it may lead to rise in demand for x-ray imaging systems. Other growth factors for the global x-ray imaging systems market are improved healthcare facilities, growing technology advancement, rising geriatric population and others. \nAsia Pacific is expected to grow substantially during the forecast period, which is attributable to the transition to digital x-ray imaging systems from analog x-ray systems in the Chinese economy. This transition is due to the policies of the Chinese government to have robust imaging systems which are highly integrated and affordable. This in turn is expecting to fuel the demand for the x-ray imaging systems market in this region.\n\nFor more information about this report @ https://www.insightsandreports.com/industry-reports/x-ray-imaging-systems-market \n\nCompetitive Landscape\nThe key players operating in the x-ray imaging systems market are Hitachi Ltd., Samsung, Toshiba Corporation, General Electric Company, Philips N.V., and Siemen AG among others. Technology enhancement and research and development are the underlying growth strategies adapted by numerous companies in x-ray image systems market to expand their businesses. For instance, in 2016, GE Healthcare showcased the advanced magnetic resonance imaging (MRI) system based on SIGNATM platform which ensured productivity and results for customers. Moreover, company also showcased its new x-ray technology named “OptimaTMXR240amx” including flash pad, digital detectors that provides for conducting x-rays.\n\n\n\nAbout Us:\nInsights and Reports is a research and consulting group assisting the clients with 360-degree insights with real time qualitative and quantitative information. The Insights and Reports team is valued for continuous client-oriented services. Our data scientists monitor the markets pertaining to their expertise on a daily basis with the help of 150+ analysts to back them with accurate market studies.\n\n\nContact Us: \nMr.Saby\nInsights And Reports,\n2201 Cooperative Way #600, \nHerndon, VA 20171, USA.\nTel: +1 703 574 4447\nEmail:[email protected]",
"json_metadata": "{\"tags\":[\"x-ray\",\"imaging\",\"systems\",\"market\"],\"links\":[\"https://www.insightsandreports.com/request-sample/286\",\"https://www.insightsandreports.com/industry-reports/x-ray-imaging-systems-market\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}"
}
]
}steemdelegated 18.601 SP to @annasmith2018/10/08 15:42:30
steemdelegated 18.601 SP to @annasmith
2018/10/08 15:42:30
| delegator | steem |
| delegatee | annasmith |
| vesting shares | 30290.044772 VESTS |
| Transaction Info | Block #26631574/Trx 2f9f3d79775a2dee00a7090da73ebf5751a2f1a9 |
View Raw JSON Data
{
"trx_id": "2f9f3d79775a2dee00a7090da73ebf5751a2f1a9",
"block": 26631574,
"trx_in_block": 0,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-10-08T15:42:30",
"op": [
"delegate_vesting_shares",
{
"delegator": "steem",
"delegatee": "annasmith",
"vesting_shares": "30290.044772 VESTS"
}
]
}2018/10/08 06:27:24
2018/10/08 06:27:24
| parent author | annasmith |
| parent permlink | global-medical-computer-carts-market-complete-analysis-by-type-application-growth-prediction-and-forecast-2025 |
| author | minibot |
| permlink | re-global-medical-computer-carts-market-complete-analysis-by-type-application-growth-prediction-and-forecast-2025-20181008t062721 |
| title | |
| body | This post has been upvoted for free by @minibot with 0.1%! Get better upvotes by bidding on me. More profits? 100% Payout! Delegate some SteemPower to @minibot: [1 SP](https://v2.steemconnect.com/sign/delegateVestingShares?delegator=&delegatee=minibot&vesting_shares=2049%20VESTS), [5 SP](https://v2.steemconnect.com/sign/delegateVestingShares?delegator=&delegatee=minibot&vesting_shares=10245%20VESTS), [10 SP](https://v2.steemconnect.com/sign/delegateVestingShares?delegator=&delegatee=minibot&vesting_shares=20489%20VESTS), [custom amount](https://steembottracker.com/delegation.html) You like to bet and win 20x your bid? Have a look at @gtw and [this description](https://steemit.com/guessthewitness/@isnochys/guess-the-witness-steemdice-for-witnesses)! |
| json metadata | |
| Transaction Info | Block #26620475/Trx ae4c5c050c91c7be4902d253f582e84e043784fd |
View Raw JSON Data
{
"trx_id": "ae4c5c050c91c7be4902d253f582e84e043784fd",
"block": 26620475,
"trx_in_block": 6,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-10-08T06:27:24",
"op": [
"comment",
{
"parent_author": "annasmith",
"parent_permlink": "global-medical-computer-carts-market-complete-analysis-by-type-application-growth-prediction-and-forecast-2025",
"author": "minibot",
"permlink": "re-global-medical-computer-carts-market-complete-analysis-by-type-application-growth-prediction-and-forecast-2025-20181008t062721",
"title": "",
"body": "This post has been upvoted for free by @minibot with 0.1%! \n Get better upvotes by bidding on me.\nMore profits? 100% Payout! Delegate some SteemPower to @minibot: [1 SP](https://v2.steemconnect.com/sign/delegateVestingShares?delegator=&delegatee=minibot&vesting_shares=2049%20VESTS), [5 SP](https://v2.steemconnect.com/sign/delegateVestingShares?delegator=&delegatee=minibot&vesting_shares=10245%20VESTS), [10 SP](https://v2.steemconnect.com/sign/delegateVestingShares?delegator=&delegatee=minibot&vesting_shares=20489%20VESTS), [custom amount](https://steembottracker.com/delegation.html)\nYou like to bet and win 20x your bid? Have a look at @gtw and [this description](https://steemit.com/guessthewitness/@isnochys/guess-the-witness-steemdice-for-witnesses)!",
"json_metadata": ""
}
]
}2018/10/08 06:27:18
2018/10/08 06:27:18
| voter | minibot |
| author | annasmith |
| permlink | global-medical-computer-carts-market-complete-analysis-by-type-application-growth-prediction-and-forecast-2025 |
| weight | 10 (0.10%) |
| Transaction Info | Block #26620473/Trx cf3cec71f09daac7f8e4a6edeedbb7a03a2e3288 |
View Raw JSON Data
{
"trx_id": "cf3cec71f09daac7f8e4a6edeedbb7a03a2e3288",
"block": 26620473,
"trx_in_block": 11,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-10-08T06:27:18",
"op": [
"vote",
{
"voter": "minibot",
"author": "annasmith",
"permlink": "global-medical-computer-carts-market-complete-analysis-by-type-application-growth-prediction-and-forecast-2025",
"weight": 10
}
]
}2018/10/08 06:26:12
2018/10/08 06:26:12
| parent author | |
| parent permlink | global |
| author | annasmith |
| permlink | global-medical-computer-carts-market-complete-analysis-by-type-application-growth-prediction-and-forecast-2025 |
| title | Global Medical Computer Carts Market–Complete Analysis by Type, Application Growth Prediction and Forecast 2025 |
| body | Medical Computer Carts Market: Introduction Medical computer carts are manufactured such that it reduces the workload of healthcare specialists and improve patient care. It is utilized for wide range of applications such as in medical recording, medical training, surgeries, charting, and medicine dispensing. There are various types of medical computer cart products distinguished on the basis of their features that varies depending upon prices and heights and based on their specific application base for large, medium or small hospitals, pharmacies and clinics. Medical computer cart consists of workflow solutions and features in order to assist daily tasks related with patient care. These carts are basically mounted with trays, shelves, drawers, and cabinets attached with computer and its components. Request for a sample copy of this report @ https://www.insightsandreports.com/request-sample/214 Medical Computer Carts: Improving Hospital Services The global medical computer carts market has experienced a swift growth in the recent years and is anticipated to grow at a higher CAGR over the forecast period. The market is expected to be driven by various advantages offered by medical carts such as time reduction, quicker appointment rate, improving the interaction time with doctors, maintaining patient’s confidentiality, and others. The approval of electronic health records (EHR), and mandating them in hospitals and other healthcare sectors by the Food and Drug Administration (FDA), has helped hospitals to reduce technology cost, maintaining seamless workflows, and improving patient’s safety. However, factors such as lack of awareness among the medical practitioners regarding the usage of medical computer carts stands to be one the key factor restraining the market over the forecast period. Market Segmentation The Medical Computer Carts Market has been categorized into type, monitor type, application, end-user and geography. On the basis of type the market is segmented into integrated medical computer carts and powered medical computer carts. Based on monitor type the market is divided into one monitor, two monitor, tablet and laptops. Medical computer carts based on applications is segmented into medical equipment, telehealth workstation, medical documentation, and medication delivery among others. End-users segment is divided into clinics, hospitals and ambulatory surgical centers. Among the monitor type the laptops, and tablets are anticipated to lead the market share over the forecast period due to the portability and the ease of movement. Regional Analysis North America held the largest market share in the year 2017 due to the rising healthcare facilities and starting up of new ambulatory surgical centers in this region. According to the Centers for Medicare & Medicaid Services (CMS), the healthcare spending of U.S. populous increased by 4.3% form 2015 in 2016, which accounted to US$ 3.3 trillion, with an average of US$ 10,348 per person in 2016. The hospital care sector has a share of 32%, which in turn in expected to boost the medical computer carts market in North America during the forecast period. Europe and Asia Pacific are creating new opportunities to medical computer cart producers owing to increasing healthcare spending in this region. Furthermore, growing healthcare industry due to the to rise in elderly population, growing medical tourism, rising prevalence of various disorders, rising government initiatives for manufacturers, and increasing demand for quality health care are further supplementing the growth. For more information about this report @ https://www.insightsandreports.com/industry-reports/medical-computer-carts-market Medical Computer Carts Market: Competitive Landscape The key players in Medical Computer Carts Market are Ergotron, Inc., Enovate Medical, AFC Industries, AFC Industries, ITD GmbH, Jaco Inc., Harloff Manufacturing Co., Hergo Ergonomic Support System, Advantech Co., Ltd., Medline Manufacturing Co., and Performace Health among other key players. To pace up with the increasing competition and also to meet the consumer requirements, the key players in the medical computer carts market are continuously investing in development of new and innovative products. For instance, Enovate Medical launched a mobile workstation that is particularly developed for hospitals. This innovative product helps the medical staff to take their respective computers with them along with keeping the device powered whole time they named this product “The Envoy”. About Us: Insights and Reports is a research and consulting group assisting the clients with 360-degree insights with real time qualitative and quantitative information. The Insights and Reports team is valued for continuous client-oriented services. Our data scientists monitor the markets pertaining to their expertise on a daily basis with the help of 150+ analysts to back them with accurate market studies. Contact Us: Mr.Saby Insights And Reports, 2201 Cooperative Way #600, Herndon, VA 20171, USA. Tel: +1 703 574 4447 Email:[email protected] |
| json metadata | {"tags":["global","medical","computer","carts","market"],"links":["https://www.insightsandreports.com/request-sample/214","https://www.insightsandreports.com/industry-reports/medical-computer-carts-market"],"app":"steemit/0.1","format":"markdown"} |
| Transaction Info | Block #26620451/Trx a90657dd04d4af75a98d0bfd95e09f3108e6cb81 |
View Raw JSON Data
{
"trx_id": "a90657dd04d4af75a98d0bfd95e09f3108e6cb81",
"block": 26620451,
"trx_in_block": 10,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-10-08T06:26:12",
"op": [
"comment",
{
"parent_author": "",
"parent_permlink": "global",
"author": "annasmith",
"permlink": "global-medical-computer-carts-market-complete-analysis-by-type-application-growth-prediction-and-forecast-2025",
"title": "Global Medical Computer Carts Market–Complete Analysis by Type, Application Growth Prediction and Forecast 2025",
"body": "Medical Computer Carts Market: Introduction\nMedical computer carts are manufactured such that it reduces the workload of healthcare specialists and improve patient care. It is utilized for wide range of applications such as in medical recording, medical training, surgeries, charting, and medicine dispensing. There are various types of medical computer cart products distinguished on the basis of their features that varies depending upon prices and heights and based on their specific application base for large, medium or small hospitals, pharmacies and clinics. Medical computer cart consists of workflow solutions and features in order to assist daily tasks related with patient care. These carts are basically mounted with trays, shelves, drawers, and cabinets attached with computer and its components.\n\nRequest for a sample copy of this report @ https://www.insightsandreports.com/request-sample/214 \n\nMedical Computer Carts: Improving Hospital Services\nThe global medical computer carts market has experienced a swift growth in the recent years and is anticipated to grow at a higher CAGR over the forecast period. The market is expected to be driven by various advantages offered by medical carts such as time reduction, quicker appointment rate, improving the interaction time with doctors, maintaining patient’s confidentiality, and others. The approval of electronic health records (EHR), and mandating them in hospitals and other healthcare sectors by the Food and Drug Administration (FDA), has helped hospitals to reduce technology cost, maintaining seamless workflows, and improving patient’s safety. However, factors such as lack of awareness among the medical practitioners regarding the usage of medical computer carts stands to be one the key factor restraining the market over the forecast period.\n\nMarket Segmentation\nThe Medical Computer Carts Market has been categorized into type, monitor type, application, end-user and geography. On the basis of type the market is segmented into integrated medical computer carts and powered medical computer carts. Based on monitor type the market is divided into one monitor, two monitor, tablet and laptops. Medical computer carts based on applications is segmented into medical equipment, telehealth workstation, medical documentation, and medication delivery among others. End-users segment is divided into clinics, hospitals and ambulatory surgical centers. Among the monitor type the laptops, and tablets are anticipated to lead the market share over the forecast period due to the portability and the ease of movement.\n\nRegional Analysis\nNorth America held the largest market share in the year 2017 due to the rising healthcare facilities and starting up of new ambulatory surgical centers in this region. According to the Centers for Medicare & Medicaid Services (CMS), the healthcare spending of U.S. populous increased by 4.3% form 2015 in 2016, which accounted to US$ 3.3 trillion, with an average of US$ 10,348 per person in 2016. The hospital care sector has a share of 32%, which in turn in expected to boost the medical computer carts market in North America during the forecast period. Europe and Asia Pacific are creating new opportunities to medical computer cart producers owing to increasing healthcare spending in this region. Furthermore, growing healthcare industry due to the to rise in elderly population, growing medical tourism, rising prevalence of various disorders, rising government initiatives for manufacturers, and increasing demand for quality health care are further supplementing the growth.\n\nFor more information about this report @ https://www.insightsandreports.com/industry-reports/medical-computer-carts-market \n\nMedical Computer Carts Market: Competitive Landscape\nThe key players in Medical Computer Carts Market are Ergotron, Inc., Enovate Medical, AFC Industries, AFC Industries, ITD GmbH, Jaco Inc., Harloff Manufacturing Co., Hergo Ergonomic Support System, Advantech Co., Ltd., Medline Manufacturing Co., and Performace Health among other key players.\nTo pace up with the increasing competition and also to meet the consumer requirements, the key players in the medical computer carts market are continuously investing in development of new and innovative products. For instance, Enovate Medical launched a mobile workstation that is particularly developed for hospitals. This innovative product helps the medical staff to take their respective computers with them along with keeping the device powered whole time they named this product “The Envoy”.\n\nAbout Us:\nInsights and Reports is a research and consulting group assisting the clients with 360-degree insights with real time qualitative and quantitative information. The Insights and Reports team is valued for continuous client-oriented services. Our data scientists monitor the markets pertaining to their expertise on a daily basis with the help of 150+ analysts to back them with accurate market studies.\n\nContact Us: \nMr.Saby\nInsights And Reports,\n2201 Cooperative Way #600, \nHerndon, VA 20171, USA.\nTel: +1 703 574 4447\nEmail:[email protected]",
"json_metadata": "{\"tags\":[\"global\",\"medical\",\"computer\",\"carts\",\"market\"],\"links\":[\"https://www.insightsandreports.com/request-sample/214\",\"https://www.insightsandreports.com/industry-reports/medical-computer-carts-market\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}"
}
]
}2018/10/05 07:54:33
2018/10/05 07:54:33
| parent author | |
| parent permlink | globalnematicidemarket |
| author | annasmith |
| permlink | global-nematicide-market-by-product-type-applications-manufacturers-and-challenges-2025 |
| title | Global Nematicide Market -by Product Type, Applications, Manufacturers and Challenges 2025 |
| body | Nematicide Market has grown enormously in the last decade owing to rising demand to increase the crop yields and to overcome arable land reduction, which is hindering the overall crop production. Nematicide Market: Market Dynamics The rise in demand for the production of high-quality and organic crops, especially organic fruits and vegetables has escalated the need for nematicides, which favored the growth of nematicide market. Production of bio-nematicides from fungal or bacterial spores are less toxic than the traditional chemical pesticides, hence various governmental bodies are supporting the production of bionematicides, and this acts as one of the major driving factors of nematicide market. Adoption of advanced agricultural technologies and modern farming practices has led to the increased application of nematicides to provide better plant protection and improved yield. NemaStrike is one such advanced technology introduced by Monsanto which will target root-knot and nematode species present in the soil. However, the highly toxic nature of chemical nematicides likes ethylene dibromide and carbofurais acts as a restraint for the growth of nematicide market. Developments in nematode resistant transgenic or genetically modified crops might also restrict the global market growth. Request for a sample copy of this report @ https://www.insightsandreports.com/request-sample/165 Nematicide Market: By Product By product type, the nematicides market is segmented into fumigants, organophosphates, carbamates, and bionematicides. Fumigant nematicide market is expected to witness a significant growth rate in the forecast period, owing to its high volatility at ambient temperatures and effective post-harvest loss reduction. Chloropicrin is projected to be the widely adopted fumigant by agriculture industry because of its efficacy to fight against a range of nematodes. Bionematicides are also anticipated to witness a steep rise in the upcoming years which will be contributed by the rise in development and adaptation of biopesticides, biofertilizers, and other biocontrol solutions. Nematicide Market: By Application The nematicides market is majorly associated with agriculture and hence the growing demand for high-quality crops coupled with sustainable and safe farming practices will boost the market. The development of non-fumigant nematicides such as NIMITZ that has received federal registration from the Environmental Protection Agency (EPA) can be considered as one of the crucial market boosters in the agriculture sector. The nematicide market for seed-treatment is expected to grow at a higher rate in the forecast period due to nematicides’ eradication response towards root-knot nematodes like Meloidogyne Incognita. Moreover, it is further attributed by the lesser health hazards imposed by the nematicides. Increase in cost of fertilizers and pesticides have also assisted in the market growth among small and mid-sized farm growers. Nematicide Market: By Region North America nematicide market is anticipated to hold the largest share in the nematicide market followed by Europe, due to the reduction in arable land coupled with increasing food demand in these regions. Asia Pacific nematicide market is accounted to grow significantly in the forecast period due to expansion in the agriculture sector and growing awareness of crop protection techniques among farmers. For more information about this report @ https://www.insightsandreports.com/industry-reports/nematicide-market Nematicide Market: Competitive Landscape Some of the major players in global nematicide market include ADAMA Agricultural Solutions Limited, Bayer CropScience AG, BASF SE, American Vanguard Corporation, FMC Corporation, Bioworks Incorporated, The Dow Chemical Company, E.I. Du Pont De Nemours and Company, Isagro Group Spa, Ishihara Sangyo Kaisha Ltd., Nufarm Ltd, Syngenta AG, UPL Limited, and Valent USA among others. AMVAC Chemical Corporation has confirmed its distribution agreement with Rotam North America, in November 2017 to market and sell ReTurn XL, which is a novel nematicide that offers above-and-below-ground protection. About Us: Insights and Reports is a research and consulting group assisting the clients with 360-degree insights with real time qualitative and quantitative information. The Insights and Reports team is valued for continuous client-oriented services. Our data scientists monitor the markets pertaining to their expertise on a daily basis with the help of 150+ analysts to back them with accurate market studies. Contact Us: Mr.Saby Insights And Reports, 2201 Cooperative Way #600, Herndon, VA 20171, USA. Tel: +1 703 574 4447 Email:[email protected] |
| json metadata | {"tags":["globalnematicidemarket","application","type","size","growth"],"links":["https://www.insightsandreports.com/request-sample/165","https://www.insightsandreports.com/industry-reports/nematicide-market"],"app":"steemit/0.1","format":"markdown"} |
| Transaction Info | Block #26535878/Trx 1a1e91aa064a7026a90a08d3273381c971ba4221 |
View Raw JSON Data
{
"trx_id": "1a1e91aa064a7026a90a08d3273381c971ba4221",
"block": 26535878,
"trx_in_block": 133,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-10-05T07:54:33",
"op": [
"comment",
{
"parent_author": "",
"parent_permlink": "globalnematicidemarket",
"author": "annasmith",
"permlink": "global-nematicide-market-by-product-type-applications-manufacturers-and-challenges-2025",
"title": "Global Nematicide Market -by Product Type, Applications, Manufacturers and Challenges 2025",
"body": "Nematicide Market has grown enormously in the last decade owing to rising demand to increase the crop yields and to overcome arable land reduction, which is hindering the overall crop production.\n\nNematicide Market: Market Dynamics\nThe rise in demand for the production of high-quality and organic crops, especially organic fruits and vegetables has escalated the need for nematicides, which favored the growth of nematicide market. Production of bio-nematicides from fungal or bacterial spores are less toxic than the traditional chemical pesticides, hence various governmental bodies are supporting the production of bionematicides, and this acts as one of the major driving factors of nematicide market. Adoption of advanced agricultural technologies and modern farming practices has led to the increased application of nematicides to provide better plant protection and improved yield. NemaStrike is one such advanced technology introduced by Monsanto which will target root-knot and nematode species present in the soil. However, the highly toxic nature of chemical nematicides likes ethylene dibromide and carbofurais acts as a restraint for the growth of nematicide market. Developments in nematode resistant transgenic or genetically modified crops might also restrict the global market growth.\n\nRequest for a sample copy of this report @ https://www.insightsandreports.com/request-sample/165 \n\nNematicide Market: By Product\nBy product type, the nematicides market is segmented into fumigants, organophosphates, carbamates, and bionematicides. Fumigant nematicide market is expected to witness a significant growth rate in the forecast period, owing to its high volatility at ambient temperatures and effective post-harvest loss reduction. Chloropicrin is projected to be the widely adopted fumigant by agriculture industry because of its efficacy to fight against a range of nematodes. Bionematicides are also anticipated to witness a steep rise in the upcoming years which will be contributed by the rise in development and adaptation of biopesticides, biofertilizers, and other biocontrol solutions.\n\nNematicide Market: By Application\nThe nematicides market is majorly associated with agriculture and hence the growing demand for high-quality crops coupled with sustainable and safe farming practices will boost the market. The development of non-fumigant nematicides such as NIMITZ that has received federal registration from the Environmental Protection Agency (EPA) can be considered as one of the crucial market boosters in the agriculture sector. The nematicide market for seed-treatment is expected to grow at a higher rate in the forecast period due to nematicides’ eradication response towards root-knot nematodes like Meloidogyne Incognita. Moreover, it is further attributed by the lesser health hazards imposed by the nematicides. Increase in cost of fertilizers and pesticides have also assisted in the market growth among small and mid-sized farm growers.\nNematicide Market: By Region\nNorth America nematicide market is anticipated to hold the largest share in the nematicide market followed by Europe, due to the reduction in arable land coupled with increasing food demand in these regions. Asia Pacific nematicide market is accounted to grow significantly in the forecast period due to expansion in the agriculture sector and growing awareness of crop protection techniques among farmers.\n\nFor more information about this report @ https://www.insightsandreports.com/industry-reports/nematicide-market \n\nNematicide Market: Competitive Landscape\nSome of the major players in global nematicide market include ADAMA Agricultural Solutions Limited, Bayer CropScience AG, BASF SE, American Vanguard Corporation, FMC Corporation, Bioworks Incorporated, The Dow Chemical Company, E.I. Du Pont De Nemours and Company, Isagro Group Spa, Ishihara Sangyo Kaisha Ltd., Nufarm Ltd, Syngenta AG, UPL Limited, and Valent USA among others. AMVAC Chemical Corporation has confirmed its distribution agreement with Rotam North America, in November 2017 to market and sell ReTurn XL, which is a novel nematicide that offers above-and-below-ground protection.\n\nAbout Us:\nInsights and Reports is a research and consulting group assisting the clients with 360-degree insights with real time qualitative and quantitative information. The Insights and Reports team is valued for continuous client-oriented services. Our data scientists monitor the markets pertaining to their expertise on a daily basis with the help of 150+ analysts to back them with accurate market studies.\n\n\nContact Us: \nMr.Saby\nInsights And Reports,\n2201 Cooperative Way #600, \nHerndon, VA 20171, USA.\nTel: +1 703 574 4447\nEmail:[email protected]",
"json_metadata": "{\"tags\":[\"globalnematicidemarket\",\"application\",\"type\",\"size\",\"growth\"],\"links\":[\"https://www.insightsandreports.com/request-sample/165\",\"https://www.insightsandreports.com/industry-reports/nematicide-market\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}"
}
]
}2018/10/04 11:01:12
2018/10/04 11:01:12
| voter | davidfnck |
| author | annasmith |
| permlink | asia-pacific-generic-medicines-market-global-industry-insights-trends-and-forecast-2017-2025 |
| weight | 3000 (30.00%) |
| Transaction Info | Block #26510831/Trx 04cb4e0b86d0016cf747ae3f3a43857f6c389783 |
View Raw JSON Data
{
"trx_id": "04cb4e0b86d0016cf747ae3f3a43857f6c389783",
"block": 26510831,
"trx_in_block": 0,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-10-04T11:01:12",
"op": [
"vote",
{
"voter": "davidfnck",
"author": "annasmith",
"permlink": "asia-pacific-generic-medicines-market-global-industry-insights-trends-and-forecast-2017-2025",
"weight": 3000
}
]
}2018/10/04 10:36:57
2018/10/04 10:36:57
| parent author | |
| parent permlink | asia |
| author | annasmith |
| permlink | asia-pacific-generic-medicines-market-global-industry-insights-trends-and-forecast-2017-2025 |
| title | Asia Pacific Generic Medicines Market– Global Industry Insights, Trends And Forecast (2017-2025) |
| body | Asia Pacific Generic Medicine Market: Introduction Generic medicine refers to drugs that have the same ingredient similar to a branded drug. These medicines also produce the same therapeutic effect and are recommended in the same medicating manner, same way of consumption and usage and with the same quality. Additionally, the inactive ingredients of generic medicines can differ when compared to their branded counter drugs. These medicines are majorly sold after the branded drug patents expire and are comparatively lower in costs when linked to the patented branded drugs. Generic medicines have same quality as compared to the branded drugs and are produced under the same care and manufacturing procedures. Request for a sample copy of this report @ https://www.insightsandreports.com/request-sample/198 Market Dynamics The key driving factor for growth of generic medicines in APAC region is, growing pharmaceutical spending by the developing nations towards generics. Continuously rising healthcare expenditures have forced third party payers and governments to look for ways to control their healthcare expenses. This is key factor that is driving the rising demand for generics against their branded counterparts. Another foremost driver of this industry is the constant patent cliff that is supplying growing pipelines opportunities for generic organizations. Segment Analysis Generic drugs market is segmented into drug type, therapeutic application, route of administration. On the basis of drug type the market has be categorized into monoclonal antibodies, vaccines, peptide hormones, peptide antibiotics, cytokines, insulin, immunoglobulin and blood factors among others. Based on therapeutic application oncology, neurology, musculoskeletal diseases, cardiovascular diseases, and infectious diseases among others. APAC generic medicines market on the basis of route of administration is divided into oral, injectable, topical, and intra-venous among others. As per Insights and Reports analysts generic medicines accounted for 20% of total spending done by the government in 2017. Generic medicines are anticipated to hold the major chunk of the APAC generic medicines market over the forecast period. Based on Geography, APAC region is further divided in to Japan, China, India, Australia, and South Korea. There is an unused market potential in Japan because of presence of key manufacturers of generic medicines market. Country Analysis The key factors driving the generic medicines market in various countries or APAC region are: • Japan: The country has high aging population and experience high medical costs incurred, in order to reduce the cost of treatment government is planning to support generic medicines and increase the productivity by to 60% in 2018 when compared to 25% in 2012. • India: Government of India rolled out a plan named Universal health plan that is anticipated to cover over all population by 2019, in order to fulfill this plan state governments are promoting usage of generic medicines in government hospitals. • Indonesia: The universal health coverage scheme implemented by the government of Indonesia improved the demand for generic medicines. For more information about this report @ https://www.insightsandreports.com/industry-reports/asia-pacific-generic-medicines-market Key Market Players Key market players of APAC Generic Medicine market include Ranbaxy Laboratories, Mylan, Inc. Industries, Ltd., Par Pharmaceutical, Inc., Celgne Corporation, Watson Pharmaceuticals, Ltd., Actavis, Dr. Reddy’s Laboratories, Sandoz International GmbH, Apotex, Inc., and Teva Pharmaceutical among others. About Us: Insights and Reports is a research and consulting group assisting the clients with 360-degree insights with real time qualitative and quantitative information. The Insights and Reports team is valued for continuous client-oriented services. Our data scientists monitor the markets pertaining to their expertise on a daily basis with the help of 150+ analysts to back them with accurate market studies. Contact Us: Mr.Saby Insights And Reports, 2201 Cooperative Way #600, Herndon, VA 20171, USA. Tel: +1 703 574 4447 Email:[email protected] |
| json metadata | {"tags":["asia","pacific","generic","medicines","market"],"links":["https://www.insightsandreports.com/request-sample/198","https://www.insightsandreports.com/industry-reports/asia-pacific-generic-medicines-market"],"app":"steemit/0.1","format":"markdown"} |
| Transaction Info | Block #26510346/Trx 7ad290157dce08e21b42c7bdcf6b6d692b2dcaaa |
View Raw JSON Data
{
"trx_id": "7ad290157dce08e21b42c7bdcf6b6d692b2dcaaa",
"block": 26510346,
"trx_in_block": 10,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-10-04T10:36:57",
"op": [
"comment",
{
"parent_author": "",
"parent_permlink": "asia",
"author": "annasmith",
"permlink": "asia-pacific-generic-medicines-market-global-industry-insights-trends-and-forecast-2017-2025",
"title": "Asia Pacific Generic Medicines Market– Global Industry Insights, Trends And Forecast (2017-2025)",
"body": "Asia Pacific Generic Medicine Market: Introduction\nGeneric medicine refers to drugs that have the same ingredient similar to a branded drug. These medicines also produce the same therapeutic effect and are recommended in the same medicating manner, same way of consumption and usage and with the same quality. Additionally, the inactive ingredients of generic medicines can differ when compared to their branded counter drugs. These medicines are majorly sold after the branded drug patents expire and are comparatively lower in costs when linked to the patented branded drugs. Generic medicines have same quality as compared to the branded drugs and are produced under the same care and manufacturing procedures.\n\nRequest for a sample copy of this report @ https://www.insightsandreports.com/request-sample/198 \n\nMarket Dynamics\nThe key driving factor for growth of generic medicines in APAC region is, growing pharmaceutical spending by the developing nations towards generics. Continuously rising healthcare expenditures have forced third party payers and governments to look for ways to control their healthcare expenses. This is key factor that is driving the rising demand for generics against their branded counterparts. Another foremost driver of this industry is the constant patent cliff that is supplying growing pipelines opportunities for generic organizations.\nSegment Analysis\nGeneric drugs market is segmented into drug type, therapeutic application, route of administration. On the basis of drug type the market has be categorized into monoclonal antibodies, vaccines, peptide hormones, peptide antibiotics, cytokines, insulin, immunoglobulin and blood factors among others. Based on therapeutic application oncology, neurology, musculoskeletal diseases, cardiovascular diseases, and infectious diseases among others. APAC generic medicines market on the basis of route of administration is divided into oral, injectable, topical, and intra-venous among others. As per Insights and Reports analysts generic medicines accounted for 20% of total spending done by the government in 2017. Generic medicines are anticipated to hold the major chunk of the APAC generic medicines market over the forecast period. Based on Geography, APAC region is further divided in to Japan, China, India, Australia, and South Korea. There is an unused market potential in Japan because of presence of key manufacturers of generic medicines market.\nCountry Analysis\nThe key factors driving the generic medicines market in various countries or APAC region are:\n• Japan: The country has high aging population and experience high medical costs incurred, in order to reduce the cost of treatment government is planning to support generic medicines and increase the productivity by to 60% in 2018 when compared to 25% in 2012.\n• India: Government of India rolled out a plan named Universal health plan that is anticipated to cover over all population by 2019, in order to fulfill this plan state governments are promoting usage of generic medicines in government hospitals.\n• Indonesia: The universal health coverage scheme implemented by the government of Indonesia improved the demand for generic medicines.\n\nFor more information about this report @ https://www.insightsandreports.com/industry-reports/asia-pacific-generic-medicines-market \n\nKey Market Players\nKey market players of APAC Generic Medicine market include Ranbaxy Laboratories, Mylan, Inc. Industries, Ltd., Par Pharmaceutical, Inc., Celgne Corporation, Watson Pharmaceuticals, Ltd., Actavis, Dr. Reddy’s Laboratories, Sandoz International GmbH, Apotex, Inc., and Teva Pharmaceutical among others.\n\nAbout Us:\nInsights and Reports is a research and consulting group assisting the clients with 360-degree insights with real time qualitative and quantitative information. The Insights and Reports team is valued for continuous client-oriented services. Our data scientists monitor the markets pertaining to their expertise on a daily basis with the help of 150+ analysts to back them with accurate market studies.\n\n\nContact Us: \nMr.Saby\nInsights And Reports,\n2201 Cooperative Way #600, \nHerndon, VA 20171, USA.\nTel: +1 703 574 4447\nEmail:[email protected]",
"json_metadata": "{\"tags\":[\"asia\",\"pacific\",\"generic\",\"medicines\",\"market\"],\"links\":[\"https://www.insightsandreports.com/request-sample/198\",\"https://www.insightsandreports.com/industry-reports/asia-pacific-generic-medicines-market\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}"
}
]
}2018/10/04 09:52:27
2018/10/04 09:52:27
| parent author | |
| parent permlink | influenza |
| author | annasmith |
| permlink | influenza-vaccines-market-global-industry-insights-trends-and-forecast-2017-2025 |
| title | Influenza Vaccines Market– Global Industry Insights, Trends And Forecast, 2017-2025 |
| body | Influenza Vaccines Market Size: Introduction Influenza virus, generally referred to as flu is a common infectious disease. Its symptoms include a cough, fever, muscle pain, joint pain, and severe headaches. Sometimes, influenza illness can even occasionally lead to death. As per World Health Organization (WHO), hospitalization related to severe illness affected with influenza ranged between 3.0 to 5.0 million and in which deaths related to influenza virus ranged in between 290,000 to 650,000 in the year 2017. There are various types of influenza vaccines such as adjuvant inactivated influenza vaccine, inactivated influenza vaccine, live attenuated influenza vaccine, toxoid vaccine, and recombinant influenza vaccine. The worldwide spread of influenza virus epidemic is expected to drive the influenza vaccines market size over the projected period. Request for a sample copy of this report @ https://www.insightsandreports.com/request-sample/61 Market Dynamics The rising number of influenza vaccines approvals is expected to augment the influenza vaccines market size on a global scale. Increasing number of government initiatives towards the development of various vaccines to treat multiple health disorders is further anticipated to push the influenza vaccines market towards growth. For example, the Bill and Malinda Gates Foundation in April 2018, announced a sum of US$ 12.0 million along with Lucy and Larry page for researchers to present innovative ideas, affordable and effective flu vaccines. Additionally, National Institute of Allergy and Infectious Disease (NIAID) in May 2018, supported the trial of universal influenza vaccines, which will, in turn, provide significant growth opportunities for the global influenza vaccines market size. Continual mutation of the influenza virus has resulted in the advent of a newer virus, which is unaffected by the existing vaccines, which in turn leading to newer R&D practices to come up with newer vaccine formulae which creates a significant hike in the vaccines’ price. This is expected to be one of the major restraining factors of the global influenza vaccines market size. Segment Analysis Live attenuated influenza vaccines (LAIV) segment is expected to dominate the global influenza vaccines market over the forecast period, due to their immunity-boosting abilities by weakening the influenza viruses. Lesser side effects associated with LAIV and availability of a wide range of approved LAIV Such as Fluenz and FluMist is also contributing a significant share in driving the growth of this segment. Among vaccine types, multivalent vaccines especially quadrivalent influenza vaccines are expected to dominate the market during the forecast period, due to their approval from FDA, low cost and their suitability to be consumed by population belonging above the age group of 2 years. Regional Insight North America is expected to hold a prime market share in the global influenza vaccines market owing to rising numbers of R&D activities by some of the major players of the market along with government support to come up with novel vaccine portfolio for the treatment of influenza virus. Asia Pacific influenza vaccines market is expected to witness a prime growth rate during the forecast period, owing to the increase in geriatric population, coupled with the economic growth in developing nations like China and India, which can lead to the expanding healthcare expenditure capacity in the region, which in turn will drive the Asia Pacific influenza vaccines market over the projected period. For more information about this report @ https://www.insightsandreports.com/industry-reports/influenza-vaccines-market Competitive Landscape Some of the key players operating in the influenza vaccines market include GlaxoSmithKline plc, Novartis International A.G., Sanofi S.A., Johnson & Johnson Inc., and CSL Limited among others. Major market players are focusing on acquisition activities to expand their product portfolio, along with concerns to improve their market share and geographical reach. For instance, In August 2017, Sanofi acquired Protein Sciences, a U.S.-based vaccines biotechnology company for the expansion of its influenza vaccine product portfolio. As a result of this acquisition, Flubok that was the only recombinant protein-based influenza vaccine approved by the U.S. Food and Drug Administration (FDA), which got added to Sanofi Pasteur’s influenza vaccine product portfolio. About Us: Insights and Reports is a research and consulting group assisting the clients with 360-degree insights with real time qualitative and quantitative information. The Insights and Reports team is valued for continuous client-oriented services. Our data scientists monitor the markets pertaining to their expertise on a daily basis with the help of 150+ analysts to back them with accurate market studies. Contact Us: Mr.Saby Insights And Reports, 2201 Cooperative Way #600, Herndon, VA 20171, USA. Tel: +1 703 574 4447 Email:[email protected] |
| json metadata | {"tags":["influenza","vaccines","market"],"links":["https://www.insightsandreports.com/request-sample/61","https://www.insightsandreports.com/industry-reports/influenza-vaccines-market"],"app":"steemit/0.1","format":"markdown"} |
| Transaction Info | Block #26509457/Trx b1bf78fb6a4d28ea3112b591ac6279d412839452 |
View Raw JSON Data
{
"trx_id": "b1bf78fb6a4d28ea3112b591ac6279d412839452",
"block": 26509457,
"trx_in_block": 10,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-10-04T09:52:27",
"op": [
"comment",
{
"parent_author": "",
"parent_permlink": "influenza",
"author": "annasmith",
"permlink": "influenza-vaccines-market-global-industry-insights-trends-and-forecast-2017-2025",
"title": "Influenza Vaccines Market– Global Industry Insights, Trends And Forecast, 2017-2025",
"body": "Influenza Vaccines Market Size: Introduction\nInfluenza virus, generally referred to as flu is a common infectious disease. Its symptoms include a cough, fever, muscle pain, joint pain, and severe headaches. Sometimes, influenza illness can even occasionally lead to death. As per World Health Organization (WHO), hospitalization related to severe illness affected with influenza ranged between 3.0 to 5.0 million and in which deaths related to influenza virus ranged in between 290,000 to 650,000 in the year 2017. There are various types of influenza vaccines such as adjuvant inactivated influenza vaccine, inactivated influenza vaccine, live attenuated influenza vaccine, toxoid vaccine, and recombinant influenza vaccine. The worldwide spread of influenza virus epidemic is expected to drive the influenza vaccines market size over the projected period.\n\nRequest for a sample copy of this report @ https://www.insightsandreports.com/request-sample/61 \n\nMarket Dynamics\nThe rising number of influenza vaccines approvals is expected to augment the influenza vaccines market size on a global scale. Increasing number of government initiatives towards the development of various vaccines to treat multiple health disorders is further anticipated to push the influenza vaccines market towards growth. For example, the Bill and Malinda Gates Foundation in April 2018, announced a sum of US$ 12.0 million along with Lucy and Larry page for researchers to present innovative ideas, affordable and effective flu vaccines. Additionally, National Institute of Allergy and Infectious Disease (NIAID) in May 2018, supported the trial of universal influenza vaccines, which will, in turn, provide significant growth opportunities for the global influenza vaccines market size.\nContinual mutation of the influenza virus has resulted in the advent of a newer virus, which is unaffected by the existing vaccines, which in turn leading to newer R&D practices to come up with newer vaccine formulae which creates a significant hike in the vaccines’ price. This is expected to be one of the major restraining factors of the global influenza vaccines market size.\n\nSegment Analysis\nLive attenuated influenza vaccines (LAIV) segment is expected to dominate the global influenza vaccines market over the forecast period, due to their immunity-boosting abilities by weakening the influenza viruses. Lesser side effects associated with LAIV and availability of a wide range of approved LAIV Such as Fluenz and FluMist is also contributing a significant share in driving the growth of this segment.\nAmong vaccine types, multivalent vaccines especially quadrivalent influenza vaccines are expected to dominate the market during the forecast period, due to their approval from FDA, low cost and their suitability to be consumed by population belonging above the age group of 2 years.\n\nRegional Insight\nNorth America is expected to hold a prime market share in the global influenza vaccines market owing to rising numbers of R&D activities by some of the major players of the market along with government support to come up with novel vaccine portfolio for the treatment of influenza virus.\nAsia Pacific influenza vaccines market is expected to witness a prime growth rate during the forecast period, owing to the increase in geriatric population, coupled with the economic growth in developing nations like China and India, which can lead to the expanding healthcare expenditure capacity in the region, which in turn will drive the Asia Pacific influenza vaccines market over the projected period.\n\nFor more information about this report @ https://www.insightsandreports.com/industry-reports/influenza-vaccines-market \n\nCompetitive Landscape\nSome of the key players operating in the influenza vaccines market include GlaxoSmithKline plc, Novartis International A.G., Sanofi S.A., Johnson & Johnson Inc., and CSL Limited among others. Major market players are focusing on acquisition activities to expand their product portfolio, along with concerns to improve their market share and geographical reach. For instance, In August 2017, Sanofi acquired Protein Sciences, a U.S.-based vaccines biotechnology company for the expansion of its influenza vaccine product portfolio. As a result of this acquisition, Flubok that was the only recombinant protein-based influenza vaccine approved by the U.S. Food and Drug Administration (FDA), which got added to Sanofi Pasteur’s influenza vaccine product portfolio.\n\nAbout Us:\nInsights and Reports is a research and consulting group assisting the clients with 360-degree insights with real time qualitative and quantitative information. The Insights and Reports team is valued for continuous client-oriented services. Our data scientists monitor the markets pertaining to their expertise on a daily basis with the help of 150+ analysts to back them with accurate market studies.\n\nContact Us: \nMr.Saby\nInsights And Reports,\n2201 Cooperative Way #600, \nHerndon, VA 20171, USA.\nTel: +1 703 574 4447\nEmail:[email protected]",
"json_metadata": "{\"tags\":[\"influenza\",\"vaccines\",\"market\"],\"links\":[\"https://www.insightsandreports.com/request-sample/61\",\"https://www.insightsandreports.com/industry-reports/influenza-vaccines-market\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}"
}
]
}2018/10/03 11:04:09
2018/10/03 11:04:09
| parent author | |
| parent permlink | needle |
| author | annasmith |
| permlink | needle-free-injection-systems-market-south-africa-industry-insights-trends-and-forecast-2017-to-2025 |
| title | Needle Free Injection Systems Market- South Africa Industry Insights, Trends And Forecast – 2017 To 2025 |
| body | • This report provides detailed analysis of the Needle Free Injection Systems Market in South Africa that includes market size and growth rate for the forecast period (2018–2025) considering 2017 as the base year. • This report analyzes the different segments and will also help in offering potential revenue opportunity across different segments covered in the study. Request for a sample copy of this report @ https://www.insightsandreports.com/request-sample/130 • This report includes insights discussing the key drivers, challenges and trends per taining the market. Furthermore, this report will further help you in analyzing the market at regional level and also discussing about the key players and the key strategies adopted by them • Analysis shared in this report will allow the key management authorities to make come up with key strategic decisions that may include market expansion, product launch and other business opportunities. For more information about this report @ https://www.insightsandreports.com/industry-reports/needle-free-injection-systems-market About Us: Insights and Reports is a research and consulting group assisting the clients with 360-degree insights with real time qualitative and quantitative information. The Insights and Reports team is valued for continuous client-oriented services. Our data scientists monitor the markets pertaining to their expertise on a daily basis with the help of 150+ analysts to back them with accurate market studies. Contact Us: Mr.Saby Insights And Reports, 2201 Cooperative Way #600, Herndon, VA 20171, USA. Tel: +1 703 574 4447 Email:[email protected] |
| json metadata | {"tags":["needle","free","injection","systems","market"],"links":["https://www.insightsandreports.com/request-sample/130","https://www.insightsandreports.com/industry-reports/needle-free-injection-systems-market"],"app":"steemit/0.1","format":"markdown"} |
| Transaction Info | Block #26482106/Trx 62451f993c2ba3e1b0dfc54e4caa80eadb1b44a6 |
View Raw JSON Data
{
"trx_id": "62451f993c2ba3e1b0dfc54e4caa80eadb1b44a6",
"block": 26482106,
"trx_in_block": 7,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-10-03T11:04:09",
"op": [
"comment",
{
"parent_author": "",
"parent_permlink": "needle",
"author": "annasmith",
"permlink": "needle-free-injection-systems-market-south-africa-industry-insights-trends-and-forecast-2017-to-2025",
"title": "Needle Free Injection Systems Market- South Africa Industry Insights, Trends And Forecast – 2017 To 2025",
"body": "•\tThis report provides detailed analysis of the Needle Free Injection Systems Market in South Africa that includes market size and growth rate for the forecast period (2018–2025) considering 2017 as the base year.\n•\tThis report analyzes the different segments and will also help in offering potential revenue opportunity across different segments covered in the study.\nRequest for a sample copy of this report @ https://www.insightsandreports.com/request-sample/130 \n\n•\tThis report includes insights discussing the key drivers, challenges and trends per taining the market. Furthermore, this report will further help you in analyzing the market at regional level and also discussing about the key players and the key strategies adopted by them\n•\tAnalysis shared in this report will allow the key management authorities to make come up with key strategic decisions that may include market expansion, product launch and other business opportunities.\n\nFor more information about this report @ https://www.insightsandreports.com/industry-reports/needle-free-injection-systems-market \n\nAbout Us:\nInsights and Reports is a research and consulting group assisting the clients with 360-degree insights with real time qualitative and quantitative information. The Insights and Reports team is valued for continuous client-oriented services. Our data scientists monitor the markets pertaining to their expertise on a daily basis with the help of 150+ analysts to back them with accurate market studies.\n\nContact Us: \nMr.Saby\nInsights And Reports,\n 2201 Cooperative Way #600, \nHerndon, VA 20171, USA.\nTel: +1 703 574 4447\nEmail:[email protected]",
"json_metadata": "{\"tags\":[\"needle\",\"free\",\"injection\",\"systems\",\"market\"],\"links\":[\"https://www.insightsandreports.com/request-sample/130\",\"https://www.insightsandreports.com/industry-reports/needle-free-injection-systems-market\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}"
}
]
}2018/10/03 10:28:39
2018/10/03 10:28:39
| voter | alphabot |
| author | annasmith |
| permlink | dental-equipment-market-global-industry-insights-trends-and-forecast-2017-to-2025 |
| weight | 100 (1.00%) |
| Transaction Info | Block #26481397/Trx a63c425e549481c2bab65a44e3e510de3128d493 |
View Raw JSON Data
{
"trx_id": "a63c425e549481c2bab65a44e3e510de3128d493",
"block": 26481397,
"trx_in_block": 5,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-10-03T10:28:39",
"op": [
"vote",
{
"voter": "alphabot",
"author": "annasmith",
"permlink": "dental-equipment-market-global-industry-insights-trends-and-forecast-2017-to-2025",
"weight": 100
}
]
}2018/10/03 10:28:30
2018/10/03 10:28:30
| parent author | |
| parent permlink | detalequipmentmearket |
| author | annasmith |
| permlink | dental-equipment-market-global-industry-insights-trends-and-forecast-2017-to-2025 |
| title | Dental Equipment Market– Global Industry Insights, Trends And Forecast – 2017 To 2025 |
| body | • This report provides detailed analysis of the Dental Equipment Market that includes market size and growth rate for the forecast period (2018–2025) considering 2017 as the base year. • This report analyzes the different segments and will also help in offering potential revenue opportunity across different segments covered in the study. Request for a sample copy of this report @ https://www.insightsandreports.com/request-sample/125 • This report includes insights discussing the key drivers, challenges and trends pertaining the market. Furthermore, this report will further help you in analyzing the market at regional level and also discussing about the key players and the key strategies adopted by them • Analysis shared in this report will allow the key management authorities to make come up with key strategic decisions that may include market expansion, product launch and other business opportunities. For more information about this report @ https://www.insightsandreports.com/industry-reports/dental-equipment-market Research approach steps: • Market Outlining • Framing discussion guide • Data Validation • Data Analysis • Re-Validation and finalization of data • Report Insights and Publishing About Us: Insights and Reports is a research and consulting group assisting the clients with 360-degree insights with real time qualitative and quantitative information. The Insights and Reports team is valued for continuous client-oriented services. Our data scientists monitor the markets pertaining to their expertise on a daily basis with the help of 150+ analysts to back them with accurate market studies. Contact Us: Mr.Saby Insights And Reports, 2201 Cooperative Way #600, Herndon, VA 20171, USA. Tel: +1 703 574 4447 Email:[email protected] |
| json metadata | {"tags":["detalequipmentmearket"],"links":["https://www.insightsandreports.com/request-sample/125","https://www.insightsandreports.com/industry-reports/dental-equipment-market"],"app":"steemit/0.1","format":"markdown"} |
| Transaction Info | Block #26481394/Trx 0070abf0ebbd9a419817f8c4f5f72dfa23c69913 |
View Raw JSON Data
{
"trx_id": "0070abf0ebbd9a419817f8c4f5f72dfa23c69913",
"block": 26481394,
"trx_in_block": 0,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-10-03T10:28:30",
"op": [
"comment",
{
"parent_author": "",
"parent_permlink": "detalequipmentmearket",
"author": "annasmith",
"permlink": "dental-equipment-market-global-industry-insights-trends-and-forecast-2017-to-2025",
"title": "Dental Equipment Market– Global Industry Insights, Trends And Forecast – 2017 To 2025",
"body": "•\tThis report provides detailed analysis of the Dental Equipment Market that includes market size and growth rate for the forecast period (2018–2025) considering 2017 as the base year.\n•\tThis report analyzes the different segments and will also help in offering potential revenue opportunity across different segments covered in the study.\n\nRequest for a sample copy of this report @ https://www.insightsandreports.com/request-sample/125 \n\n•\tThis report includes insights discussing the key drivers, challenges and trends pertaining the market. Furthermore, this report will further help you in analyzing the market at regional level and also discussing about the key players and the key strategies adopted by them\n•\tAnalysis shared in this report will allow the key management authorities to make come up with key strategic decisions that may include market expansion, product launch and other business opportunities.\n\nFor more information about this report @ https://www.insightsandreports.com/industry-reports/dental-equipment-market \n\nResearch approach steps:\n•\tMarket Outlining\n•\tFraming discussion guide\n•\tData Validation\n•\tData Analysis\n•\tRe-Validation and finalization of data\n•\tReport Insights and Publishing\n\n\t\nAbout Us:\nInsights and Reports is a research and consulting group assisting the clients with 360-degree insights with real time qualitative and quantitative information. The Insights and Reports team is valued for continuous client-oriented services. Our data scientists monitor the markets pertaining to their expertise on a daily basis with the help of 150+ analysts to back them with accurate market studies.\n\nContact Us: \nMr.Saby\nInsights And Reports,\n 2201 Cooperative Way #600, \nHerndon, VA 20171, USA.\nTel: +1 703 574 4447\nEmail:[email protected]",
"json_metadata": "{\"tags\":[\"detalequipmentmearket\"],\"links\":[\"https://www.insightsandreports.com/request-sample/125\",\"https://www.insightsandreports.com/industry-reports/dental-equipment-market\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}"
}
]
}2018/10/03 10:28:21
2018/10/03 10:28:21
| voter | hackerzizon |
| author | annasmith |
| permlink | dental-equipment-market-global-industry-insights-trends-and-forecast-2017-to-2025 |
| weight | 100 (1.00%) |
| Transaction Info | Block #26481391/Trx 53dc4ff31361f0a1c9d5796a0a0fede570f81ae1 |
View Raw JSON Data
{
"trx_id": "53dc4ff31361f0a1c9d5796a0a0fede570f81ae1",
"block": 26481391,
"trx_in_block": 5,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-10-03T10:28:21",
"op": [
"vote",
{
"voter": "hackerzizon",
"author": "annasmith",
"permlink": "dental-equipment-market-global-industry-insights-trends-and-forecast-2017-to-2025",
"weight": 100
}
]
}2018/10/03 10:27:57
2018/10/03 10:27:57
| voter | fastresteem |
| author | annasmith |
| permlink | dental-equipment-market-global-industry-insights-trends-and-forecast-2017-to-2025 |
| weight | 100 (1.00%) |
| Transaction Info | Block #26481383/Trx a8b07bd0aed7b2253e47609b8641fe53a50706f2 |
View Raw JSON Data
{
"trx_id": "a8b07bd0aed7b2253e47609b8641fe53a50706f2",
"block": 26481383,
"trx_in_block": 7,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-10-03T10:27:57",
"op": [
"vote",
{
"voter": "fastresteem",
"author": "annasmith",
"permlink": "dental-equipment-market-global-industry-insights-trends-and-forecast-2017-to-2025",
"weight": 100
}
]
}2018/10/03 10:27:48
2018/10/03 10:27:48
| parent author | |
| parent permlink | detalequipmentmearket |
| author | annasmith |
| permlink | dental-equipment-market-global-industry-insights-trends-and-forecast-2017-to-2025 |
| title | Dental Equipment Market– Global Industry Insights, Trends And Forecast – 2017 To 2025 |
| body | • This report provides detailed analysis of the Dental Equipment Market that includes market size and growth rate for the forecast period (2018–2025) considering 2017 as the base year. • This report analyzes the different segments and will also help in offering potential revenue opportunity across different segments covered in the study. Request for a sample copy of this report @ https://www.insightsandreports.com/request-sample/125 • This report includes insights discussing the key drivers, challenges and trends pertaining the market. Furthermore, this report will further help you in analyzing the market at regional level and also discussing about the key players and the key strategies adopted by them • Analysis shared in this report will allow the key management authorities to make come up with key strategic decisions that may include market expansion, product launch and other business opportunities. For more information about this report @ https://www.insightsandreports.com/industry-reports/dental-equipment-market Research approach steps: • Market Outlining • Framing discussion guide • Data Validation • Data Analysis • Re-Validation and finalization of data • Report Insights and Publishing About Us: Insights and Reports is a research and consulting group assisting the clients with 360-degree insights with real time qualitative and quantitative information. The Insights and Reports team is valued for continuous client-oriented services. Our data scientists monitor the markets pertaining to their expertise on a daily basis with the help of 150+ analysts to back them with accurate market studies. Contact Us: Mr.Saby Insights And Reports, 2201 Cooperative Way #600, Herndon, VA 20171, USA. Tel: +1 703 574 4447 Email:[email protected] |
| json metadata | {"tags":["detalequipmentmearket"],"links":["https://www.insightsandreports.com/request-sample/125","https://www.insightsandreports.com/industry-reports/dental-equipment-market"],"app":"steemit/0.1","format":"markdown"} |
| Transaction Info | Block #26481380/Trx 162223eeaa9ed20c0a6a4002f268545365833c71 |
View Raw JSON Data
{
"trx_id": "162223eeaa9ed20c0a6a4002f268545365833c71",
"block": 26481380,
"trx_in_block": 11,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-10-03T10:27:48",
"op": [
"comment",
{
"parent_author": "",
"parent_permlink": "detalequipmentmearket",
"author": "annasmith",
"permlink": "dental-equipment-market-global-industry-insights-trends-and-forecast-2017-to-2025",
"title": "Dental Equipment Market– Global Industry Insights, Trends And Forecast – 2017 To 2025",
"body": "•\tThis report provides detailed analysis of the Dental Equipment Market that includes market size and growth rate for the forecast period (2018–2025) considering 2017 as the base year.\n•\tThis report analyzes the different segments and will also help in offering potential revenue opportunity across different segments covered in the study.\n\nRequest for a sample copy of this report @ https://www.insightsandreports.com/request-sample/125 \n\n•\tThis report includes insights discussing the key drivers, challenges and trends pertaining the market. Furthermore, this report will further help you in analyzing the market at regional level and also discussing about the key players and the key strategies adopted by them\n•\tAnalysis shared in this report will allow the key management authorities to make come up with key strategic decisions that may include market expansion, product launch and other business opportunities.\n\nFor more information about this report @ https://www.insightsandreports.com/industry-reports/dental-equipment-market \n\nResearch approach steps:\n•\tMarket Outlining\n•\tFraming discussion guide\n•\tData Validation\n•\tData Analysis\n•\tRe-Validation and finalization of data\n•\tReport Insights and Publishing\n\n\t\nAbout Us:\nInsights and Reports is a research and consulting group assisting the clients with 360-degree insights with real time qualitative and quantitative information. The Insights and Reports team is valued for continuous client-oriented services. Our data scientists monitor the markets pertaining to their expertise on a daily basis with the help of 150+ analysts to back them with accurate market studies.\n\nContact Us: \nMr.Saby\nInsights And Reports,\n 2201 Cooperative Way #600, \nHerndon, VA 20171, USA.\nTel: +1 703 574 4447\nEmail:[email protected]",
"json_metadata": "{\"tags\":[\"detalequipmentmearket\"],\"links\":[\"https://www.insightsandreports.com/request-sample/125\",\"https://www.insightsandreports.com/industry-reports/dental-equipment-market\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}"
}
]
}steemdelegated 18.846 SP to @annasmith2018/10/03 09:57:54
steemdelegated 18.846 SP to @annasmith
2018/10/03 09:57:54
| delegator | steem |
| delegatee | annasmith |
| vesting shares | 30690.000000 VESTS |
| Transaction Info | Block #26480782/Trx 5575e04f181d81ee47262808a0978a736e4f74e1 |
View Raw JSON Data
{
"trx_id": "5575e04f181d81ee47262808a0978a736e4f74e1",
"block": 26480782,
"trx_in_block": 26,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-10-03T09:57:54",
"op": [
"delegate_vesting_shares",
{
"delegator": "steem",
"delegatee": "annasmith",
"vesting_shares": "30690.000000 VESTS"
}
]
}steemcreated a new account: @annasmith2018/10/03 09:57:54
steemcreated a new account: @annasmith
2018/10/03 09:57:54
| creator | steem |
| new account name | annasmith |
| owner | {"weight_threshold":1,"account_auths":[],"key_auths":[["STM5i9pSAt7NK2zzcB5cBqWajHUDQMpnyGTRxepbCN2UxANnUEtUu",1]]} |
| active | {"weight_threshold":1,"account_auths":[],"key_auths":[["STM7e8yXeGaueHDjAs17JWRttikYqLjZNxna6KBuPdXc4YUm51Mtg",1]]} |
| posting | {"weight_threshold":1,"account_auths":[],"key_auths":[["STM8e6npGCj2GRFeXxh8nGuyksdRKpzRQ3Pq8sePhMcs2BrGfvWGY",1]]} |
| memo key | STM6E4e2kPgUodGASEMV1CCjPxjHsrM19oSACF6Xf7uVi4wnpitb4 |
| json metadata | {} |
| extensions | [] |
| Transaction Info | Block #26480782/Trx 5575e04f181d81ee47262808a0978a736e4f74e1 |
View Raw JSON Data
{
"trx_id": "5575e04f181d81ee47262808a0978a736e4f74e1",
"block": 26480782,
"trx_in_block": 26,
"op_in_trx": 0,
"virtual_op": 0,
"timestamp": "2018-10-03T09:57:54",
"op": [
"create_claimed_account",
{
"creator": "steem",
"new_account_name": "annasmith",
"owner": {
"weight_threshold": 1,
"account_auths": [],
"key_auths": [
[
"STM5i9pSAt7NK2zzcB5cBqWajHUDQMpnyGTRxepbCN2UxANnUEtUu",
1
]
]
},
"active": {
"weight_threshold": 1,
"account_auths": [],
"key_auths": [
[
"STM7e8yXeGaueHDjAs17JWRttikYqLjZNxna6KBuPdXc4YUm51Mtg",
1
]
]
},
"posting": {
"weight_threshold": 1,
"account_auths": [],
"key_auths": [
[
"STM8e6npGCj2GRFeXxh8nGuyksdRKpzRQ3Pq8sePhMcs2BrGfvWGY",
1
]
]
},
"memo_key": "STM6E4e2kPgUodGASEMV1CCjPxjHsrM19oSACF6Xf7uVi4wnpitb4",
"json_metadata": "{}",
"extensions": []
}
]
}Manabar
Voting Power100.00%
Downvote Power100.00%
Resource Credits100.00%
Reputation Progress93.67%
{
"voting_manabar": {
"current_mana": 1953311140,
"last_update_time": 1588919109
},
"downvote_manabar": {
"current_mana": 488327785,
"last_update_time": 1588919109
},
"rc_account": {
"account": "annasmith",
"rc_manabar": {
"current_mana": "15881099983",
"last_update_time": 1588919109
},
"max_rc_creation_adjustment": {
"amount": "6059717623",
"precision": 6,
"nai": "@@000000037"
},
"max_rc": "8013028763"
}
}Account Metadata
| POSTING JSON METADATA | |
| profile | {"profile_image":"https://cdn.steemitimages.com/DQmQZMJiBuJdFvq9dEbDbrvmQ4zuhcRvvEKkRjKjFQQQoUj/17-Kate%20Upton.jpg","name":"Healthcare Research ","about":"Researcher for the #healthcare industry.... world-leading insight for the #pharma, #biotech, #diagnostics and #medicaldevice sectors.","location":"US","website":"https://www.insightsandreports.com/"} |
| JSON METADATA | |
| profile | {"profile_image":"https://cdn.steemitimages.com/DQmQZMJiBuJdFvq9dEbDbrvmQ4zuhcRvvEKkRjKjFQQQoUj/17-Kate%20Upton.jpg","name":"Healthcare Research ","about":"Researcher for the #healthcare industry.... world-leading insight for the #pharma, #biotech, #diagnostics and #medicaldevice sectors.","location":"US","website":"https://www.insightsandreports.com/"} |
{
"posting_json_metadata": {
"profile": {
"profile_image": "https://cdn.steemitimages.com/DQmQZMJiBuJdFvq9dEbDbrvmQ4zuhcRvvEKkRjKjFQQQoUj/17-Kate%20Upton.jpg",
"name": "Healthcare Research ",
"about": "Researcher for the #healthcare industry.... world-leading insight for the #pharma, #biotech, #diagnostics and #medicaldevice sectors.",
"location": "US",
"website": "https://www.insightsandreports.com/"
}
},
"json_metadata": {
"profile": {
"profile_image": "https://cdn.steemitimages.com/DQmQZMJiBuJdFvq9dEbDbrvmQ4zuhcRvvEKkRjKjFQQQoUj/17-Kate%20Upton.jpg",
"name": "Healthcare Research ",
"about": "Researcher for the #healthcare industry.... world-leading insight for the #pharma, #biotech, #diagnostics and #medicaldevice sectors.",
"location": "US",
"website": "https://www.insightsandreports.com/"
}
}
}Auth Keys
Owner
Single Signature
Public Keys
STM5i9pSAt7NK2zzcB5cBqWajHUDQMpnyGTRxepbCN2UxANnUEtUu1/1
Active
Single Signature
Public Keys
STM7e8yXeGaueHDjAs17JWRttikYqLjZNxna6KBuPdXc4YUm51Mtg1/1
Posting
Single Signature
Public Keys
STM8e6npGCj2GRFeXxh8nGuyksdRKpzRQ3Pq8sePhMcs2BrGfvWGY1/1
Memo
STM6E4e2kPgUodGASEMV1CCjPxjHsrM19oSACF6Xf7uVi4wnpitb4
{
"owner": {
"weight_threshold": 1,
"account_auths": [],
"key_auths": [
[
"STM5i9pSAt7NK2zzcB5cBqWajHUDQMpnyGTRxepbCN2UxANnUEtUu",
1
]
]
},
"active": {
"weight_threshold": 1,
"account_auths": [],
"key_auths": [
[
"STM7e8yXeGaueHDjAs17JWRttikYqLjZNxna6KBuPdXc4YUm51Mtg",
1
]
]
},
"posting": {
"weight_threshold": 1,
"account_auths": [],
"key_auths": [
[
"STM8e6npGCj2GRFeXxh8nGuyksdRKpzRQ3Pq8sePhMcs2BrGfvWGY",
1
]
]
},
"memo": "STM6E4e2kPgUodGASEMV1CCjPxjHsrM19oSACF6Xf7uVi4wnpitb4"
}Witness Votes
0 / 30
No active witness votes.
[]